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Abstract 
 
Recent epidemiological data indicate that more than half of SCI patients have injuries of 
the cervical spine. There is no satisfactory treatment for these injuries either in the acute 
or the chronic phase. Docosahexaenoic acid (DHA) is an omega-3 polyunsaturated fatty 
acid that is essential in brain development and has structural and signalling roles. Acute 
DHA administration has been shown to improve neurological functional recovery 
following injury in rodent thoracic spinal cord injury (SCI) animal models.  
 
In this thesis, we characterized a cervical SCI model comprising a hemisection lesion 
applied at the C4-5 level of the rat spinal cord, and tested the effects of an acute 
treatment with 250 nmol/kg DHA delivered intravenously 30 minutes after injury. The 
acute intravenous bolus of DHA not only increased the number of neuronal cells spared 
at three weeks following injury but also resulted in robust sprouting of uninjured 
corticospinal and serotonergic fibres. Next, we used a mouse pyramidotomy model to 
confirm that this robust sprouting was not species or injury model specific. We 
demonstrated that the number of V2a interneurons contacted by collateral corticospinal 
sprouting fibres is positively correlated with skilled motor recovery. To address the 
mechanism behind the neuroplasticity-promoting effect of DHA, we investigated the 
expression of miR-21 and phosphatase and tensin homolog (PTEN) in cortical neurons 
and raphe nuclei after DHA treatment. We found that DHA significantly up-regulates 
miR-21 and down-regulates PTEN in corticospinal neurons one day after SCI. Down-
regulation of PTEN by DHA was also seen in dorsal root ganglion (DRG) neuron 
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cultures and was accompanied by increased neurite outgrowth. Lastly, we investigated 
whether DHA treatment combined with specific-task rehabilitation maximized the 
recovery of skilled forelimb function following cervical SCI. The rats receiving combined 
therapy achieved greater skilled forelimb functional recovery compared to DHA 
treatment or rehabilitation only. 
In summary, this study shows that DHA has therapeutic potential in cervical SCI and 
provides evidence that DHA could exert its beneficial effects in SCI via enhancement of 
neuroplasticity. 
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1 General Introduction 
Spinal cord injury (SCI) is a devastating and debilitating condition that affects the ability 
of individuals to carry out normal activities. According to World Health Organization 
statistics, it is estimated that the global annual incidence of SCI is 40 to 80 cases per 
million population. Most SCI patients are young adults (Cripps et al. 2011). In addition to 
the poor life quality associated with paralysis, sensory loss, intractable pain, pressure 
sores, and urinary tract infections, people with SCI are 2 to 5 times more likely to die 
prematurely than people without SCI (http://www.who.int/mediacentre/factsheets/fs384/en/). 
 
There is currently no effective treatment for SCI. Current treatments in the acute stage, 
such as acute decompression (Fehlings et al. 2006; Fehlings et al. 2012) or 
administration of methylprednisolone (Hurlbert et al. 2008) are controversial or have 
limited efficacy. In the late stage, neuroplasticity within the central nervous system 
(CNS) following rehabilitative training is one of the most successful strategies clinically 
(Wang et al. 2011; Fouad et al. 2012). 
 
The phospholipids in CNS membranes contain several different fatty acids. One 
compound, the omega-3 polyunsaturated fatty acid DHA, accounts for approximately 
50% of the polyunsaturated fatty acid (PUFA) in CNS membranes and plays an 
essential role in brain development and plasticity. Omega-3 PUFAs have been shown to 
have therapeutic potential in a variety of neurological conditions (Hashimoto et al. 2002; 
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Wu et al. 2004; Michael-Titus 2007; Dyall et al. 2008). 
Before I was involved in these doctoral studies, our laboratory had demonstrated that 
DHA improved locomotor function following compression or hemisection injury in rodent 
animal models of thoracic SCI (King et al. 2006; Huang et al. 2007). The aim of this 
thesis is to study the effects of DHA after an injury of the spinal cord at cervical level. 
We will characterize the neuroprotective effect of DHA and also the potential of this 
treatment to enhance neuroplasticity after injury, with or without rehabilitative training. 
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1.1 Cervical SCI 
SCI is a very disabling condition that has a profound impact on the patients‘ lives. 
Epidemiological data show that 51% of SCI patients have injuries in the cervical spine, 
with the most common neurological level being C5, followed by C4 and C6 (Sekhon et 
al. 2001; Dunham et al. 2010). This type of injury can cause severe impairments, 
including impaired use of the upper and lower extremities, loss of physical sensation, 
respiratory problems, bowel, bladder, and sexual dysfunction. Regaining partial or full 
function of the arm and/or hand could lead to significant improvements in the patient‘s 
quality of life, and is considered to be a priority for patients suffering cervical cord 
injuries (Anderson 2004).  
 
Neurorecovery in the upper extremities is of paramount importance for the degree of 
functional independence. Patients with high level injuries (i.e. C1-4) require complete 
assistance with activities of daily living, bed mobility and transfers. Sometimes, these 
patients also require permanent mechanical ventilation and suctioning to clear 
secretions (Lanig et al. 2000). Patients with C5 injuries can perform active elbow flexion 
and can therefore perform some simple tasks. These patients typically require 10 hours 
a day of personal care. Patients with C6 injuries have active wrist extension, passive 
finger flexion, and opposition of the second digit and the thumb. Shoulder stability is 
supported because they retain full innervation of the rotator cuff. Grip strength can be 
improved using orthosis. The patients typically require 6 hours a day of personal care 
(Medicine 2000). Patients with C7 injuries have retained strength of the triceps. Some 
assistance may be required for toileting and dressing activities, particularly for the lower 
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extremities. However, eating, grooming, and dressing of the upper extremities can be 
performed independently (Medicine 2000) . 
 
1.1.1 Motor deficits following cervical SCI 
After SCI, one of the most devastating consequences is the loss of motor system 
control. In humans, the American Spinal Injury Association (ASIA) Impairment Scale is 
widely used to determine the level of SCI and the extent and severity of a patient‘s SCI 
and help determine future rehabilitation and recovery needs. The assessment is ideally 
completed within 72 hours after the initial injury. The patient‘s grade is based on how 
much sensation he or she can feel at multiple points on the body, as well as their 
performance in tests of motor function. Clinically, an improvement in ASIA score is the 
main outcome measure for the efficacy of treatments and ranges from A to E, where A is 
a complete lack of motor and sensory function below the level of injury (including the 
anal area) and E is normal motor and sensory function. In rodent experimental models, 
the main functional measurement that is taken in thoracic SCI is an assessment of 
locomotor recovery, whereas in cervical SCI the evaluation of skilled forelimb control is 
used as an endpoint. 
 
All movement produced by the skeletal musculature is dependent on lower motor 
neurons in the ventral horn spinal cord gray matter. The lower motor neurons form a 
pool that innervates a single muscle and their axons extend up and down for several 
spinal cord segments. Ventral horns contain motor neurons of various type (-
motoneurons reaching skeletal muscle fibres, and -motoneurons innervating intra-fusal 
motor fibres in muscle spindles). The ventral horns are larger at the levels of the cervical 
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and lumbar enlargements because of motor neurons innervating limb muscles. After 
SCI, there is damage to lower motor neurons in the spinal cord, which results in 
paralysis of the affected muscles and loss of reflexes and muscle tone. 
 
1.1.1.1 Hindlimb: locomotion function 
After SCI, all animals suffer locomotor deficits, including human beings. However, there 
are differences in the degree of recovery between rodents and primates. Considerable 
recovery of locomotor function is generally achieved when the ventral and lateral white 
matter is preserved (Basso et al. 2002). Experimental studies have led to the discovery 
that the basic rhythmic patterns of each limb involved in locomotion are dependent on 
―central pattern generators‖- a local circuit in the spinal cord responsible for the 
alternation of flexion and extension of limbs. Following transection of the thoracic spinal 
cord, a cat or rat‘s hindlimb still makes coordinated locomotor movements if the animal 
is supported and placed on a moving treadmill (Grillner et al. 1979; Edgerton et al. 
2002). However, in non-human primates or humans, the ability to execute rhythmic 
stepping is permanently impaired after SCI (Courtine et al. 2005). Another possible 
reason for the lack of stepping is that the corticospinal tract (CST) projections to the 
lumbosacral enlargement are less than to the cervical cord in rodents (Muir et al. 1999). 
Injury to the dorsal CST does not produce persistent and severe locomotion deficits, 
except deprivation of fine paw and digit movements (Muir et al. 1999; Metz et al. 2000). 
In addition, it seems that the occurrence of bipedal locomotion relies greatly on upper 
motor neuron pathways, such as those involved in postural control (Rossignol et al. 
2011). 
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1.1.1.2 Forelimb: skilled movement  
More than half of the people with SCI have injuries involving the cervical spinal cord 
(National Spinal Cord Injury Statistical Center, 2014), and neurological impairment in 
those patients involves not only the ability of lower limb movement but also upper limb 
function (e.g. skilled upper limb use). A majority of quadriplegic patients have agreed 
that regaining arm and hand function, not locomotor ability or trunk ability, is the highest 
priority for improving life quality (Anderson 2004). 
 
Skilled forelimb reaching is a sensorimotor ability shared by many species of animals 
including humans (Iwaniuk et al. 2000). Skilled reaching requires both sensory 
information and motor input, which involves a variety of neuronal structures including 
the brain cortex (Martinez et al. 2009), the CST (Li et al. 1997; Starkey et al. 2005), the 
red nucleus (Whishaw et al. 1998), cerebellum (Garwicz 2000), reticular formation 
(Davidson et al. 2006; Riddle et al. 2009), and the basal ganglia (Whishaw et al. 1986; 
Miklyaeva et al. 1994) (Fig 1.1). Recently, skilled forelimb reaching has been examined 
in rats with unilateral spinal cord hemisection. After cervical SCI, the rats make fewer 
attempts to retrieve food pellets and are less successful at grasping the food pellets 
when compared to sham-operated animals (Anderson et al. 2005). Skilled forelimb task 
evaluation is useful to determine the effect of a particular therapy in rat cervical SCI 
models. 
 
27 
 
 
Figure 1-1 Pathways from the sensorimotor cortex to hand motoneurons 
The direct corticomotoneuronal pathway is primarily originated from the primary motor 
cortex. There are several indirect routes, which could mediate the cortical command to 
hand and arm motoneurons located in cervical segments, such rubrospinal tract and 
reticulospinal tract. In addition, the propriospinal neurons (PNs) and segmental 
interneurons (sINs) could relay the cortical inputs to motoneurons. Adapted from (Riddle 
et al. 2009). 
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1.1.2 Cervical spinal cord hemisection in human beings 
High cervical unilateral hemisection injuries in humans result in the Brown-Séquard 
syndrome (Brown-Séquard 1868), in which one-half of the spinal cord is completely 
injured. The classical clinical presentation is ipsilateral motor paralysis from the injury 
level due to damage to the descending CST. Remarkably, the limbs on the contralateral 
side are insensitive to pain and temperature due to interruption in the crossed 
spinothalamic tract, while the limbs on the ipsilateral side retain their perception of pain 
and temperature (Herr et al. 1987). Interestingly, patients with Brown-Séquard 
syndrome are known to have good recovery of leg control and locomotor function (Little 
et al. 1985; Roth et al. 1991). On the contrary, arm and hand functions have limited 
recovery. They remain severely impaired or fully paralyzed in these patients (Levi et al. 
1996). 
 
1.1.3 Cervical spinal cord hemisection in rats  
Numerous studies have investigated motor function after cervical spinal cord 
hemisection in rats (Webb et al. 2002; Anderson et al. 2005; Martinez et al. 2009; 
Martinez et al. 2010; Filli et al. 2011). In rats, the ispilateral forelimb and both hindlimbs 
are severely impaired following cervical hemisection at the acute stage. After 2-4 weeks, 
the rats display no impairment of locomotor function of the hindlimbs (Webb et al. 2002; 
Filli et al. 2011). In contrast, the ipsilateral forelimb remains rigid or flaccid, with constant 
dragging. These findings parallel the clinical observations in patients with Brown-
Séquard syndrome, who present good recovery of leg function, but poor performance of 
arm and hand function (Levi et al. 1996). The similarity in lesion outcome across 
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different species with cervical hemisection could be explained by unilateral cervical 
hemisection leading to a full unilateral ablation of commands from each supraspinal 
pathway, independent of its specific function. Given the similar anatomy of most 
descending tracts (Lemon 2008), this results in a similar neurological deficit between 
species. 
 
Skilled forelimb reaching has been examined in rats with cervical hemisection. Rats with 
this type of injury make fewer attempts to reach for food pellets and are less successful 
at retrieving food pellets when compared to sham operated animals (Anderson et al. 
2005). The impairment of skilled forelimb reaching results from unilateral damage to the 
ascending (dorsal column-medial lemniscal and post-synaptic dorsal column) pathways 
or the descending component (main crossed corticospinal tract) of the cervical spinal 
cord dorsal column pathway (Webb et al. 2005). The ascending component of the 
dorsal columns was investigated with respect to its importance in performing skilled 
movement in rats (McKenna et al. 1999). The data showed that rats recovered food 
retrieval ability by making adjustments in the whole body and forelimb movement when 
retrieving a food pellet (McKenna et al. 1999). However, following unilateral injury to the 
main dorsal corticospinal tract (descending pathway), rats are less successful at 
retrieving food pellets with the forelimb ipsilateral to the SCI (Li et al. 1997). 
Consequently, it seems that impairment in reaching following cervical hemisection is 
due to the CST injury and not the damage to the ascending pathways of the dorsal 
columns. 
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1.2  General pathophysiology following SCI  
Information regarding the pathophysiology of human SCI is limited, but various studies 
indicate that there are strong correlations between human and rodent spinal injuries 
(Metz et al. 2000; Cheriyan et al. 2014). The similarities between the human and rodent 
inflammatory response (Fleming et al. 2006) and the morphological response 
(Norenberg et al. 2004) after SCI permit useful translation to clinical use of treatments 
developed in animals. Experimental rat SCI models are also similar to the human SCI 
with respect to motor function recovery related to electrophysiological changes, such as 
motor evoked potentials and somatosensory evoked potentials, and lesion size 
assessed using MRI examination (Metz et al. 2000). 
 
The pathophysiological mechanism of SCI is more than a simple mechanical disruption 
of nerve transmission following injury. In addition to the primary lesion of the spinal cord, 
a multi-step cascade results in progressive enlargement of the injury, due to factors that 
include an inflammatory reaction, ischaemia, oedema, haemorrhage and cytotoxicity 
(Ronsyn et al. 2008). Although there is little or no loss of interneurons and motor 
neurons several segments beyond the injury, there are significant changes in their 
biochemical, and consequently physiological, properties (Petruska et al. 2007; Button et 
al. 2008; Roy et al. 2012). Thus, it is essential to use reliable animal models to assess 
the pathophysiological mechanisms of SCI and to investigate neuroplasticity in the 
intact spinal cord caudal to the lesion site. Animal models are also important for 
assessing novel therapeutic strategies. The pathological sequelae following acute SCI 
are divided into two broad chronological events: the primary injury and the secondary 
31 
 
injury, due to the additional damaging processes initiated by the primary injury (Taoka et 
al. 1998; Dumont et al. 2001; Priestley et al. 2012). 
 
1.2.1 Primary injury 
The primary injury corresponds to the immediate mechanical damage to neuronal 
structure, leading to a haemorrhagic zone of necrosis in the grey matter. Cells, 
especially neurons and their axons, become permeabilized acutely following injury due 
to compressive and shear forces. Animal studies have demonstrated that neurological 
impairment increases relative to the force of trauma and the duration of compression. 
Basically, there are several types of primary injury clinically. The most common 
mechanism involves impact plus persistent compression (Tator 1996). This insult 
happens in burst fracture with bony fragment compression of the spinal cord, fracture-
dislocation and disc rupture following injury. Another mechanism of primary injury is 
caused by flexion, extension, rotation, or dislocation producing shearing or stretching of 
the spinal cord and/or its blood supply. This type of injury may be present without 
obvious radiological evidence of trauma, but it is common in adults with underlying 
degenerative spine disease (Tator 1996). Missile injury, sharp knife cutting and severe 
distraction leads to laceration and transection injury, which is another type of 
mechanism. This type of injury may occur to varying degrees in SCI, from minor injury to 
complete transection. The primary mechanical injury also serves as the nidus from 
which additional secondary mechanisms of injury extend. Consequently, the damage 
can spread from the lesion epicenter to caudal and rostral segments. 
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1.2.2 Secondary injury 
Following the primary physical damage and death of neural cells, the secondary phase 
of the injury begins. This response of SCI can be divided into three phases, an acute 
phase, subacute phase and a chronic phase (Tator 1995; Bareyre et al. 2003). 
Typically, the acute phase represents the first 24 to 48 hours following injury. The phase 
is characterized by vascular dysfunction, including disruption in blood flow leading to 
local infarction caused by hypoxia and ischaemia (Dumont, Okonkwo et al. 2001). 
Oedema and haemorrhaging, which correlate with injury severity, result in additional 
necrotic cell death (Fig 1.1). Microglia, responding to by-products of necrosis (DNA, 
ATP, K+), become activated and secrete inflammatory cytokines that act to recruit 
systemic inflammatory cells. Injury leads to increased intracellular sodium and calcium 
ions due to failure of ion pumps, inactivation of ion channels, reverse function of ion 
exchangers, and membrane depolarization (Stys et al. 1998). Excessive intracellular 
Ca2+ results in neuronal cell death and axonal degradation through activation of 
proteases and mitochondrial dysfunction. Calpains are activated after injury and lead to 
degradation of cytoskeletal proteins, such as neurofilaments and microtubules, that 
cause axon dysfunction (Banik et al. 1997). Increased production of reactive oxygen 
species (ROS) occurs following SCI because of mitochondria dysfunction caused by 
metabolic imbalances and excess intracellular Ca2+. ROS include superoxide and 
hydrogen peroxide that can cause apoptosis of oligodendrocytes and neurons (Mronga 
et al. 2004). 
The subacute phase is a period that lasts 2 days to 2 weeks following injury in animal 
models of SCI. In humans, it likely lasts from 2 weeks to 6 months. This phase is 
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characterized by excessive release of excitatory neurotransmitters, massive immune 
cell infiltration, delayed cell death, and demyelination/degeneration. SCI leads to a 
strong inflammatory response, with the recruitment of peripherally derived immune cells 
such as neutrophils (6-24 hours), macrophages (24 hours to 2 weeks) and T cells 
(Bethea et al. 2002). In addition to massive ischaemic necrosis, apoptosis has also 
been identified as a significant event in the injury pathophysiology, especially for 
vulnerable neurons and oligodendrocytes (Liu et al. 1997). 
In the chronic phase, continued activation of the immune system, apoptotic cell death, 
channel and receptor dysfunction, and demyelination accompany Wallerian 
degeneration and are ongoing in perilesional areas (Bareyre et al. 2003). There is some 
attempt by CNS axons to sprout after injury but the newly formed growth becomes 
dystrophic (Kerschensteiner et al. 2005) after exposure to the inhibitory extracellular 
matrix molecules (Fitch et al. 2008). Growth-associated inhibitors such as myelin 
associated glycoproteins, Nogo and oligodendrocyte myelin glycoprotein are also 
expressed in the vicinity of the lesion and hinder any axonal growth (Sekhon et al. 2001; 
Filbin 2003). All these processes contribute to conduction deficits. 
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Figure 1-2 Pathophysiological processes following SCI.  
The timeline summarizes the phases after SCI. The events that occur after SCI are 
divided into the immediate (seconds to minutes), acute (minutes to hours), subacute 
(hours to weeks), and chronic (weeks to months). The phases are characterized by 
vascular alterations, inflammation processes, biochemical/metabolic alterations, and 
anatomical change (adapted from (Bareyre et al. 2003; Priestley et al. 2012; Siddiqui et 
al. 2015). 
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1.3 Spontaneous functional recovery following SCI 
There are many studies showing that some degree of functional recovery occurs after 
SCI in both humans and rodents, particularly after partial, incomplete injuries (Weidner 
et al. 2001; Tetzlaff et al. 2009). This finding indicates that reorganization throughout the 
neuraxis can compensate for the disrupted pathways and rebuild a circuit for control of 
motion. The processes underlying the diverse neurological changes are summarized by 
the term ―neuroplasticity‖. Although this neuroplasticity has been related to spontaneous 
functional recovery (Onifer et al. 2011), the underlying mechanisms are still not fully 
characterized. 
 
1.3.1 Molecular and cellular changes following SCI guide neuroplasticity 
Following injury, even though successful regeneration does not occur in the CNS, 
neurons are capable of mounting a transient regenerative response, as evidenced by 
the expression of regeneration associated proteins and genes (Kruse et al. 2011). The 
most commonly upregulated genes and transcription factors that are found to be 
associated with regeneration are: c-jun, activating transcription factor 3 (ATF-3), heat 
shock protein 27 (HSP-27), growth associated protein – 43 (Gap-43), signal transducer 
and activator of transcription – 3 (STAT3) (Sun et al. 2010). This indicates that the 
intrinsic growth program inherent to neurons is activated in response to injury; however, 
it is not sustained. The upregulation of molecules that contribute to axonal regrowth, 
such as neuronal calcium sensor-1 (NCS-1) (Yip et al. 2010) and mammalian target of 
rapamycin (mTOR) (Liu et al. 2010), can induce compensatory sprouting from 
unlesioned nerve pathways. A number of the molecules that can guide growing axons in 
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the developing nervous system are also present in the injured spinal cord (Jacobi et al. 
2014). These factors can support growing collaterals and initiate synaptogenesis during 
circuit remodelling. 
 
1.3.2 Reorganization of descending pathways after SCI 
Recently, it has been recognized that spontaneous and treatment-induced functional 
recovery is correlated to sprouting of lesioned and spared descending axons (Fouad et 
al. 2001; Weidner et al. 2001; Bareyre et al. 2004). It has been demonstrated using 
secondary lesions (Weidner et al. 2001; Kanagal et al. 2009), electrophysiology, and 
retrograde neurotracing (Bareyre et al. 2004) that the new neuronal circuits make 
functional connections. Adult neurons in the CNS cannot regenerate over long 
distances, but axotomized neurons can form short sprouts from their damaged axons 
(Fawcett et al. 1998). The injury provides a stimulus for intact interneurons, white matter 
tracts and sensory neurons to replace inputs to the spinal neurons that have lost 
synapses. Collateral or regenerative sprouting of intraspinal axons after SCI may 
provide an opportunity to make new connections or to strengthen existing synapses on 
denervated spinal neurons (Brown et al. 2012). A probable mechanism that leads to 
collateral formation is the upregulation of diffusible attracting factors by the denervated 
tissue. One study showed that the reorganization of CST circuits is guided by brain 
derived neurotrophic factor (BDNF) secretion by the target interneurons. Furthermore, 
knockdown of BDNF in spinal neurons diminished the formation of new CST pathways 
(Ueno et al. 2012). 
37 
 
1.3.3 Modulation of the synaptic transmission of individual neurons 
The function of the nervous system critically relies on the establishment of precise 
synaptic connections. There are three different mechanisms able to alter neural activity: 
(1) modifying the strength or efficacy of synaptic transmission at pre-existing synapses, 
(2) eliciting the growth of new synaptic connections or the pruning away of existing 
ones, or (3) modulating the excitability properties of individual neurons (Crupi et al. 
2013). SCI denervates spinal neurons by disrupting ascending and descending 
pathways to and from the brain as well as output to lower motor neurons. The loss of 
part or all synaptic inputs results in structural modifications in the number, size, and 
distribution of synaptic contacts on interneurons and motor neurons (Raineteau et al. 
2001). 
One way that synaptic changes after SCI have been detected is by comparing the 
synaptophysin level in intact versus lesioned spinal tissues (Nacimiento et al. 1995). 
Synaptophysin is a protein within synaptic vesicles in the presynaptic terminal. The 
expression of synaptophysin is decreased after a spinal cord lesion, but the level 
recovers to normal after a few weeks. This finding suggests that new synapses form on 
motor neurons following SCI, and this formation could arise from interneurons or 
sensory afferents transmitting tactile and proprioceptive signals. 
Synaptic efficiency could be modified by neurotransmitter changes within neuronal 
networks. Gamma-aminobutyric acid (GABA) is a widely distributed inhibitory 
neurotransmitter in the spinal cord and plays a ―counter balance‖ role against enhanced 
synaptic transmission in the spinal cord as a result of glutamate-mediated excitation of 
neurons following SCI. GABAergic pathways play the principal role in reducing neuronal 
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excitability throughout the nervous system. GABA has a presynaptic inhibitory action on 
primary afferents and on postsynaptic membranes of interneurons and motor neurons 
(Alvarez et al. 1996). After complete SCI, GABA neurotransmission is increased in the 
spinal cord below the injury site, as indicated by an increase in GABA synthesizing 
enzymes, resulting in altered inhibition during the postlesion period (Tillakaratne et al. 
2000). These changes in synaptic efficiency and neurotransmission may be important 
during the period of postlesion recovery. 
 
1.3.4 Reorganization of cortical areas after SCI  
Following traumatic SCI axonal architecture is disturbed and the brain grey matter 
becomes atrophic (Jurkiewicz et al. 2006; Freund et al. 2011; Henderson et al. 2011; 
Rao et al. 2013). However, in response to SCI, the sensorimotor cortex can undergo a 
dramatic reorganization. Remodeling of the S1 map correlates with tactile discrimination 
performance (Xerri et al. 2005; Rao et al. 2013), while different populations of cortical 
neurons in M1 cortex selectively contribute to the execution and regulation of 
movements during locomotion in cats (Drew et al. 2002). This cortical reorganization is 
sometimes found to be compatible with functional recovery (Schmidlin et al. 2004; Rao 
et al. 2013). Several studies indicate that cortical territories controlling intact body parts 
tend to enlarge and invade cortical areas that have lost their peripheral targets.(Franchi 
et al. 2004; Schmidlin et al. 2004; Martinez et al. 2010). Although the underlying 
mechanism of cortical reorganization is not well clarified, some studies have suggested 
these results are partly due to changes in neuronal circuits, such as axonal sprouting 
(Bareyre et al. 2004; Schmidlin et al. 2004; Martinez et al. 2010). 
39 
 
1.4 Pharmacological neuroprotective intervention for SCI 
A substantial number of studies have been devoted to the development of new 
pharmacological therapies in the treatment of SCI. One promising approach in pre-
clinical testing is a treatment given immediately after the injury to achieve better 
neurological recovery. Neurological efficacy in such an experimental setting suggests 
that the therapy has a neuroprotective role in SCI. The concept of neuroprotection is 
based on limiting the evolution of secondary damage due to pathophysiological 
processes following acute SCI and maximizing the extent of uninjured spinal cord 
tissue. Currently, there is a lack of clinically accepted pharmacological treatment for 
SCI. This following section will briefly highlight some of the pharmacological 
neuroprotective treatments which have undergone clinical trials in traumatic SCI 
patients. 
 
Methylprednisolone 
Methylprednisolone was the only clinically approved drug for SCI until 2013. 
Experimental studies showed that its neuroprotective effect may be due to inhibition of 
oxygen-induced lipid peroxidation (Hall 1992), and reduction of ED1-positive cells, 
leading to spinal tissue protection, and reduced posttraumatic axonal die back via the 
NFB pathway (Oudega et al. 1999). The National Acute Spinal Cord Injury Study 
recommended treatment with methylprednisolone for either 24 or 48 hours, within 8 
hours after SCI (Bracken et al. 1997). However, based on new Level 1 
recommendations in 2013 by the American Association of Neurological Surgeons 
(AANS) and the Congress of Neurological Surgeons (CNS) (Hurlbert et al. 2013), 
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methylprednisolone should not be given in the treatment of acute SCI, because of  
associated harmful side effects such as a higher infection rate, respiratory 
complications, gastrointestinal haemorrhage and even death (Molano Mdel et al. 2002). 
However, there still remains controversy regarding the new AANS/CNS guidelines. They 
suggest methylprednisolone could be applied to patients with cervical SCI undergoing 
decompression, based on a Cochrane meta-analysis showing some benefit of treating 
these patients (Bracken 2012; Fehlings et al. 2014). Therefore, it becomes important to 
further investigate the application of steroids in SCI patients. 
 
Minocycline 
Minocycline, a broad spectrum tetracycline antibiotic, has been shown to have 
neuroprotective effects through the inhibition of M1 macrophage/microglia (Festoff et al. 
2006; Kobayashi et al. 2013). The drug also decreases formation of ROS, reduces 
matrix metalloproteinase activity and inhibits apoptotic cell death (Yong et al. 2004). 
Minocycline is an attractive drug for clinicians because it is known to be well tolerated in 
human, where it has been used for acne treatment for decades. 
A randomized Phase II trial has demonstrated that treatment with minocycline leads to a 
trend to improve functional outcome in patients with cervical motor-incomplete injury, 
although the improvement was not statistically significantly. The study also showed no 
serious adverse events in patients receiving treatment (Casha et al. 2012). At present, 
two Phase III clinical trials are in progress for patients with acute SCI. (NCT01828203, 
NCT01813240 identified in ClinicalTrials.gov). 
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Riluzole 
Riluzole is a sodium channel blocker, which is FDA-approved for amyotrophic lateral 
sclerosis (ALS) patients. Several SCI animal studies have reported that sodium channel 
blockers can attenuate secondary damage by preventing excessive influx of sodium and 
calcium, which triggers pathological extracellular release of the excitatory 
neurotransmitter glutamate, leading to cell death (Kobrine et al. 1984; Teng et al. 1997). 
Riluzole may also exert its neuroprotective effects through neurotrophic factor 
upregulation (Mizuta et al. 2001; Katoh-Semba et al. 2002). In pre-clinical studies, 
riluzole-treated animals also had greater preservation of white matter, better 
mitochondrial function, somatosensory-evoked potentials, and motor neurons following 
thoracic SCI (Schwartz et al. 2001). Riluzole was also found to have neuroprotective 
efficacy when the intervention was delayed 1 and 3 h post-injury and continued for 7 
days after injury, in a cervical SCI animal experiment (Wu et al. 2013). In the first clinical 
trials of riluzole for acute SCI, the results showed some functional improvements in 
cervical SCI patients treated with riluzole, and no complications and side effects were 
noted (Grossman et al. 2014). Currently, a prospective, randomized, multicenter Phase 
II/III trial is ongoing in patients with acute C4-C8 SCI (NCT01597518 identified in 
ClinicalTrials.gov). 
 
Magnesium 
Magnesium has been investigated in animals as a neuroprotective agent for traumatic 
brain injury (TBI) and SCI (Suzer et al. 1999; Kaptanoglu et al. 2003; Gok et al. 2007; 
Hoane 2007; Wiseman et al. 2009). The biological rationale for magnesium in SCI 
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includes the attenuation of excitotoxicity through a voltage-dependent blockade of 
NMDA receptors (Zhang et al. 1996), and the replacement of depleted magnesium 
levels following injury (Vink et al. 2000). In acute SCI animal models, magnesium sulfate 
administration has been shown to decrease membrane damage, protect axonal function 
and improve electrophysiology and behavioural outcome (Suzer et al. 1999; Kaptanoglu 
et al. 2003). However, the neuroprotective effect was achieved with extremely high 
doses of magnesium that far exceed the tolerable human dose. More recently, 
magnesium chloride formulated within polyethylene glycerol (PEG) has been 
developed, and the dose of magnesium is similar to the clinically-acceptable dose. This 
formula has been investigated as a potential neuroprotective agent for SCI in thoracic 
and cervical SCI animal models (Kwon et al. 2009; Lee et al. 2010). A clinical trial of a 
proprietary form of PEG with magnesium chloride, AC105 (NCT01750684 identified in 
ClinicalTrials.gov), is currently underway to determine the efficacy of the drug in patients 
who have a SCI. 
 
Fibroblast growth factor 
Fibroblast growth factor-2 (FGF-2; or basic fibroblast growth factor) is a protein that has 
been shown to promote neurological functional recovery by rescuing neurons adjacent 
to the lesion site, promoting angiogenesis and a reduction in cavitation (Teng et al. 
1999; Kang et al. 2010; Kang et al. 2013). The underlying mechanism is not well 
defined. A recent study suggested that FGF-2 activates the downstream signal 
PI3K/Akt, which is correlated to neuronal survival and regeneration (Zhang et al. 2013). 
A Phase II randomized, clinical trial for patients with acute cervical SCI began in 2012 
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(NCT01502631 identified in ClinicalTrials.gov). 
 
Rho protein antagonist 
Rho is a small intracellular GTPase. After SCI, myelin-associated inhibitors and CSPG 
can activate the Rho signaling pathway. Rho activation in neurons has been shown to 
result in neuronal growth cone collapse, neurite retraction, and cell body rounding 
(Jalink et al. 1994). In experimental studies, the activity of the Rho/Rho kinase pathway 
is enhanced, contributing to increased levels of apoptosis in neurons, astrocytes and 
oligodendrocytes (Dubreuil et al. 2003; Sung et al. 2003).  
 
Recent evidence suggests that the inactivation of Rho allows neurons to enhance axon 
growth on growth inhibitory substrates (Jain et al. 2004; McKerracher et al. 2006). 
However, there are some studies that report Rho inhibition exerting neuroprotective 
effects after SCI (Dubreuil et al. 2003; Lord-Fontaine et al. 2008). C3 transferase (C3), 
an enzyme from Clostridium botulinum, has the ability to block Rho function. In a mouse 
model of SCI, C3 treatment enhanced axonal regeneration and improved motor function 
(Dergham et al. 2002). In addition, C3 treatment can significantly reduce the number of 
apoptotic cells and increase tissue sparing following SCI (Dubreuil et al. 2003; Lord-
Fontaine et al. 2008), suggesting that C3 has neuroprotective effects. A phase I/IIa 
clinical trial has been conducted to investigate the safety and pharmacokinetics of the 
Rho pathway antagonist, Cethrin® (BA-210) (Fehlings et al. 2011). BA-210 is a 
recombinant fusion protein composed of C3 and a transport sequence that aids the 
proteins‘ penetrative ability to cross cellular membranes in combination with a fibrin 
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sealant. Although the number of patients was small and there was no control group, 
these results suggest that BA-210 contributes to functional recovery following SCI 
without adverse effects. A phase IIb/III clinical trial has been planned for subjects with 
acute cervical SCI (NCT02053883 identified in ClinicalTrials.gov). 
 
Additional pharmacological therapies that have been explored in human SCI trials but 
have not demonstrated significant clinical efficacy include: naloxone (Bracken et al. 
1990), thyrotropin releasing hormone (Pitts et al. 1995), trilazad mesylate (Bracken et 
al. 1997), nimodipine (Pointillart et al. 2000) GM-1 ganglioside (Geisler et al. 2001), 
gacyclidine (Lepeintre et al. 2004),  and granulocyte colony stimulating factor (Yoon et 
al. 2007).  
 
Because of the limited effective treatments after SCI, it is not surprising that many 
pharmacological and non-pharmacological approaches (e.g. systemic hypothermia, 
rehabilitation) are being investigated to provide better treatment for SCI patients. 
Although therapeutic effects have been observed in preclinical work, we have not seen 
any treatments translated successfully into clinical use. One of the reasons for this is 
the complexity and multi-factorial nature of the secondary pathophysiological change 
following SCI. Most treatments only target one aspect of this response; however, a 
successful approach is likely to depend on a combination of different treatments.  
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1.5 Strategies promoting neuroplasticity following SCI 
The existence of spontaneous structural and functional plasticity in the CNS following 
SCI raises the possibility that this could be a therapeutic target for enhancing functional 
recovery. However, this endogenous effect is often suboptimal and highly variable, and 
new strategies need to be developed to enhance the process of plasticity in order to 
maximise the potential for recovery. In order to obtain efficient functional recovery, these 
strategies may involve treatment to strengthen existing connections or improve nerve 
conduction in axons that survived but are functionally impaired, or promotion of 
collateral sprouting of either damaged or spared pathways which can lead to the 
formation of new neuronal pathways which can pass around the lesion site (Fig 1.2). It 
is thought that the development of novel therapeutic approaches for promoting 
meaningful neuroplasticity changes following SCI could involve several strategies. 
 
46 
 
 
Figure 1-3 Neuroplasticity changes in spinal cord after SCI 
(B) Aberrant and non-functional sprouting in injured or intact CST. (C) After 
neuroplasticity promoting treatment, sprouting contralateral CST axons cross the 
midline and rebuild functional contacts with interneurons, which bypass the lesion site. 
 
1.5.1 Increase intrinsic regenerative ability  
There have been several novel methods to increase the intrinsic regenerative ability of 
neurons. To promote axonal sprouting and remodelling, one generally used strategy is 
the application of exogenous neurotrophic factors, such as BDNF and neurotrophin-3 
(NT3) (Lu et al. 2008; Fouad et al. 2013). Following pyramidotomy, transduction of 
spinal motoneurons with NT3 resulted in a significant sprouting of fibres across the 
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midline towards the motor neurons (Zhou et al. 2003). Sustained expression of BDNF 
and NT3 in the cortex and spinal cord, respectively, further enhanced the axonal 
sprouting from the intact side in animal models of SCI (Zhou et al. 2003; Fouad et al. 
2013). Injection, or grafts of genetically modified cells which can secrete neurotrophic 
molecules, or viral delivery systems, can be used to deliver neurotrophic factors to the 
lesion (Lacroix et al. 2000). Work from other laboratories revealed that administration of 
cyclic adenosine monophosphate (cAMP) influences intracellular signalling pathways 
and can promote CNS regeneration (Hannila et al. 2008). An alternative approach is the 
manipulation of key regulatory genes involved in the intrinsic growth program. 
Genetically overexpressing factors such as STAT3 (Lang et al. 2013), NCS-1 (Yip et al. 
2010) and mTOR (Liu et al. 2010) has been reported to stimulate spared fibres 
sprouting into the denervated side, which promoted functional recovery. The approach 
to upregulate the intrinsic growth potential of a neuron would be a promising strategy to 
promote neuroplasticity following SCI. 
 
1.5.2 Cell based transplantation 
Key experiments using peripheral nerve grafts, rich in Schwann cells, demonstrate that 
CNS neurons do retain the capacity to mount a regenerative response following SCI 
(David et al. 1981). Several transplanted cell types contribute to anatomical 
neuroplasticity by greatly increasing axonal regeneration and fibre density in the injured 
spinal cord. For example, Schwann cell and olfactory ensheathing glia (OEG) grafts 
promote extensive axonal growth and elongation (Xu et al. 1995; Ramon-Cueto et al. 
1998) with axonal sprouting (Guest et al. 1997). The transplanted cells can modify the 
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peri-lesional environment. Gliosis and astrocyte reactivity have been shown to be 
reduced with transplantation of OECs in acute SCI (Lakatos et al., 2003; López-Vales et 
al., 2006) and of bone marrow stem cells in acute and chronic SCI (Lu et al., 2007). One 
essential role of stem and associated cell transplantation for SCI lies in the considerable 
capacity of trophic mediator secretion, promoting neuroplasticity (Teng et al. 2002). 
 
1.5.3 Inactivation of the growth-inhibitory extracellular environment  
The intrinsic barrier to growth, attributed to the decline in neuroplasticity of CNS 
neurons as they mature, affects the capability of injured CNS neuron to both grow and 
remodel. Neutralization of the inhibitory environment that is formed after injury is one 
approach used to promote neuroplasticity (Maier et al. 2006). One major barrier to 
axonal regeneration and plasticity in the injured CNS in the presence of growth-
inhibitory factors associated with CNS myelin (Gonzenbach et al. 2008; Xie et al. 2008). 
A wide spectrum of inhibitors has been observed to limit neurite outgrowth in vitro, such 
as Nogo (Chen et al. 2000), myelin-associated glycoprotein (McKerracher et al. 1994) 
and oligodendrocyte myelin glycoprotein (Wang et al. 2002). When these inhibitors are 
antagonized in animal models of SCI, there is significant regeneration of severed axons 
in vivo. Recently, numbers of studies demonstrated uninjured axons could sprout robust 
collateral axonal processes in the absence of myelin inhibitory factors. In rodent models 
of SCI, deletion of Nogo-A leads to a significant increase in collateral sprouting that 
crosses the midline and correlates with significant functional recovery (Kim et al. 2003; 
Simonen et al. 2003). Moreover, in primate models of SCI, anti-Nogo-A antibodies can 
significantly improve functional recovery, that correlates with an increase in sprouting of 
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CST collaterals, but not with CST regeneration (Fouad et al. 2004; Freund et al. 2006). 
These results suggest that non-regenerative anatomical plasticity is a substrate for 
functional recovery under conditions of myelin protein inhibition. 
 
After CNS injury, in order to stabilize the site of injury, a glial scar forms at the injury site 
and this leads to a physical and molecular barrier to axonal growth (Fitch et al. 2008). 
Chondroitin sulphate proteoglycans (CSPGs) are a major class of growth-inhibitory 
molecules associated with the glial scar extracellular matrix, and they are densely 
upregulated following injury to the CNS (Galtrey et al. 2008). The distribution of CSPGs 
within the glial scar closely correlates with the failure of axonal growth in the injured 
spinal cord in experimental studies. Treatment of the spinal cord with the bacterial 
enzyme chondroitinase ABC (ChABC) is the best established and most widely used 
mechanism through which CSPGs have been degraded in order to diminish their 
inhibitory properties (Bradbury et al. 2011). In a dorsal column crush animal model, 
ChABC treatment enhanced the sprouting of intact fibres from the ventral CST and 
increased innervation of denervated grey matter (Bradbury et al. 2002). Serotonergic 
fiber sprouting was also observed following ChABC treatment in rat (Garcia-Alias et al. 
2009) and cat (Tester et al. 2008) experimental studies. Taken together, mounting 
evidence suggests that removal of growth inhibitory factors plays a role in promoting 
axon plasticity after SCI. 
 
In addition to pharmacological intervention, activity-dependent approaches, such as 
physical rehabilitation, may contribute to functional recovery by enhancing the 
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rebuilding, strength, and selection of synapses. Recent studies have also focused on 
combinatorial therapies based on pharmacologically promoting structural plasticity 
combined with a rehabilitation program. The results revealed that this is a more effective 
strategy to enhance functional recovery compared to either pharmacological treatment 
or rehabilitative training alone (Ying et al. 2008; Garcia-Alias et al. 2009). 
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1.6 Benefits of rehabilitation 
A well–establish therapeutic approach to promote neuroplasticity and recovery following 
SCI is rehabilitative training (Beekhuizen 2005; Edgerton et al. 2006). The capacity for 
CNS reorganization is a well-documented property that may contribute to many 
examples of functional recovery. It is now widely accepted that rehabilitation training is 
the current successful treatment to promote neuroplasticity following SCI with/without 
administration of pharmacological agents. I summarize below some of the benefits 
gained from rehabilitation following SCI.  
1.6.1 Up-regulation of growth/plasticity associated factors 
Neurotrophic factors are a class of polypeptide growth factors that promote survival, 
growth and maintenance of neurons, and modulate synaptic strength to improve signal 
transduction. After SCI, the expression of neurotrophic factors is downregulated but it 
increases with training and voluntary locomotor programs (Dupont‐Versteegden et al. 
2004; Hutchinson et al. 2004; Ying et al. 2008). Exercise-induced increase in 
neurotrophic factors in the damaged spinal cord can promote regeneration of damaged 
axons, the plasticity of spinal cord circuity and improve functional locomotor recovery. 
For example, BDNF (Gomez-Pinilla et al. 2002; Boyce et al. 2007), NT3 (Grill et al. 
1997), and insulin-like growth factor 1 (Jung et al. 2014) have been shown to enhance 
survival of damaged neurons, modulate synaptic strength and contribute to the recovery 
of function following injury. Notably, the effects of activity-dependent rehabilitation are 
not limited to the region of the spinal cord most likely stimulated by training, but also 
increases some neurotrophic factors throughout the spinal cord (Cote et al. 2011). 
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1.6.2 Contribution to plasticity in lesioned and spared tracts 
Various studies have demonstrated that spontaneous sprouting of lesioned and spared 
descending axons is linked to functional recovery following SCI (Weidner et al. 2001; 
Bareyre et al. 2004). Recently, some studies have demonstrated that rehabilitative 
training in a reaching task increases spontaneous collateral sprouting of CST axons 
after CNS lesion (Girgis et al. 2007; Starkey et al. 2011). In addition to CST axonal 
sprouting, MiniMitter running wheel exercise can also induce increased serotonin fibre 
density in the lumbar spinal cord of mice after moderate contusion injury (Engesser-
Cesar et al. 2007). It has been suggested in SCI models that treadmill training activates 
cellular and molecular growth factors within the spinal cord (Shin et al. 2014). These 
plasticity-promoting factors might contribute to axonal sprouting and functional recovery 
following training. Another important issue that should be considered is that guidance of 
new sprouting fibres to appropriate post-synaptic cells represents a complex, delicate 
process, which is still poorly understood. Once new neuronal circuits have formed, the 
rehabilitation training may favour appropriate projections by modulating and stabilizing 
the neuronal pathways, thus boosting functional improvement. 
 
1.6.3 Change in neuronal properties can facilitate recovery 
It is well-known that SCI induces changes in motor neuron activity patterns due to the 
interruption of descending supraspinal and propriospinal pathways. Removal of 
descending presynaptic inhibition of group Ia axons may contribute to the decrease in 
reflex threshold and loss of habituation by motor neurons (Hochman et al. 1994). 
Recent data revealed that motor neurons can change their properties as a response to 
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SCI and rehabilitation. Passive cycling exercise can moderate the deleterious 
responses of motor neurons to SCI and promote structural and physiological plasticity in 
motor neurons below the lesion site (Beaumont et al. 2004). Exercise also modifies the 
activity of inhibitory transmitters after SCI. Levels of the inhibitory neurotransmitter, 
glycine, and GAD-67, a synthetic enzyme for GABA, are both increased at chronic time 
points after SCI (Tillakaratne et al. 2000; Khristy et al. 2009). This adaption in inhibitory 
tone may indicate a compensatory response to the loss of descending inhibition. 
However, both glycine and GAD-67 levels and the expression of GABAB receptors are 
restored to normal levels by treadmill training following spinal cord complete transection 
(de Leon et al. 1999). 
One electrophysiological study demonstrated that synaptic input and action potential 
after-hyperpolarization of motor neurons was amplified after treadmill stepping following 
SCI (Petruska et al. 2007). These changes in motor neuron properties following 
exercise in SCI could be caused by changes in ion channel activity (Gardiner et al. 
2006). Changes in neuronal excitability associated with training represent a promising 
target for restoring motor function following SCI. 
 
1.6.4 Training facilitates cortical reorganization 
The somatosensory cortex serves several key functions in the brain. Cortical map 
changes following SCI have been reported in patients and in animal models (Cohen et 
al. 1991; Bruehlmeier et al. 1998; Fouad et al. 2001; Mikulis et al. 2002). Following 
cervical SCI, expansion of motor maps can be promoted by forelimb reaching training 
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over several days (Girgis et al. 2007; Krajacic et al. 2009). The enhanced cortical maps 
modulated by rehabilitation correlate with increasing collateral sprouting of CST fibres 
and neurological recovery (Fouad et al. 2001). In addition to the motor system, recovery 
of tactile abilities has also been observed in rats receiving sensorimotor training. 
However, this recovery was not present in rats without training (Martinez et al. 2009). 
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1.7 Docosahexaenoic acid 
Fatty acids are carboxylic acids with a long unbranched carbon hydrogen tail of varying 
lengths, which is either saturated or unsaturated. Fatty acids that have carbon-carbon 
double bonds are known as unsaturated. Fatty acids without double bonds are known 
as saturated. PUFAs contain multiple double bonds and can be categorized by the 
position of the first double bond from the methyl end of the acyl chain. According to the 
international nomenclature, the position of the first double bond is given by the n-x (also 
-x or omega-x) notation, counting the number of carbon atoms from the methyl end. 
DHA contains 22 carbons and 6 double bonds, and the first double bond occurs at the 
third carbon atom from the methyl group. It therefore belongs to the class of omega-3 
fatty acids. 
 
Mammals are unable to synthesize double bonds between carbons 1 and 9 because 
they lack the necessary desaturase enzymes (Salem et al. 1989). The long chain 
PUFAs may be directly ingested from the diet or produced from their shorter chain 
precursors.  A major source of omega-3 PUFAs is cold-water oily fish. DHA is 
synthesized through desaturation and elongation reactions from a precursor, an 18-
carbon fatty acid, alpha-linolenic acid (ALA), which is available in the diet. Although 
neurons are major targets for DHA accumulation, they are unable to synthesize DHA. 
The conversion of ALA to DHA occurs primarily in the liver (Igarashi et al. 2007). After 
release from the intestine after a lipid-rich meal or from the liver, fatty acids circulate in 
the plasma loosely bound to albumin and cross plasma membranes via fatty acid 
transporters. 
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The omega-3 PUFA can directly diffuse into cells and also interact with fatty-acid-
transport proteins (FABPs). The intracellular transport of long-chain fatty acids involves 
binding to FABPs, which recent evidence suggests could be used as markers of organ 
injury (Michael-Titus et al. 2014). At least 9 members of FABPs have been identified and 
they have various roles (Furuhashi et al. 2008). Among these, brain FABP (B-FABP) is 
distinguished from other FABPs by its strong affinity for omega PUFAs, in particular 
DHA, which indicates that B-FABP may be intricately linked to the role of DHA in the 
nervous system (Xu et al. 1996; Balendiran et al. 2000). In recent studies, there has 
been increased interest in the neuroprotective benefits of PUFAs, especially omega-3 
PUFAs, which have shown significant therapeutic potential in neurology and in particular 
for neuroprotection (Lauritzen et al. 2000; Heller et al. 2006; Kidd 2007; Michael-Titus 
2007; Dyall et al. 2008). 
 
1.7.1 Molecular targets of DHA 
An extensive literature has demonstrated that omega-3 PUFAs have multiple actions. 
To explain the effects on DHA, a number of explanations have been formulated, ranging 
from unspecific effects on cell membrane fluidity to specific binding to protein targets. 
Dietary supplementation with DHA may affect intracellular and intercellular signalling as 
well as physical membrane properties (Farooqui et al. 2004; Fukaya et al. 2007). DHA 
can also modulate neurological function directly or indirectly at many different levels 
through various membrane proteins, such as enzymes, ion channels, nuclear receptors, 
and G-protein coupled receptors (Fig 1.3). A comprehensive list of the targets of DHA is 
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yet to be produced. However, there are several strong candidates that have been 
identified as possible targets involved in DHA effects. 
. 
1.7.1.1 Involvement of ion channels 
PUFAs have beneficial effects in both epilepsy and cardiac arrhythmia due to their 
effect on voltage-gated ion channels (Leaf et al. 2003; Taha et al. 2010). In neuronal 
tissue, a role for PUFA modulation of ion channels has been suggested in synaptic 
plasticity, development, and in the outcome of ischaemia, seizures, and perhaps other 
pathological conditions (Bazan 2006). DHA treatment could reduce the glutamate 
excitotoxity associated with SCI and TBI through modulation of voltage-gated ion 
channels. Both in vivo and in vitro studies also demonstrate that omega-3 PUFAs 
suppress neuronal excitability by inhibiting voltage-sensitive Na+ and Ca+ channels 
(Vreugdenhil et al. 1996; Voskuyl et al. 1998; Leaf et al. 1999), and by activation of the 
two-pore domain background K+ channel, TREK-1 (TWIK-related potassium channel-1) 
(Boland et al. 2008). 
 
1.7.1.2 Involvement of intracellular fatty acid-binding proteins 
Fatty acid-binding proteins (FABPs) are a multigene family of cytosolic proteins that are 
the counterpart to extracellular albumin, which can facilitate the transfer of fatty acids 
across extra- and intracellular membranes (Chmurzynska 2006). There are a total of 
nine FABPs, but only Heart-FABP (H-FABP), Epidermal-FABP (F-FABP), and Brain-
FABP (B-FABP) have been identified in the nervous system (Myers-Payne et al. 1996; 
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Owada et al. 1996). H-FABP expression increases in gray matter during development 
(Owada et al. 1996). The concentration is highest in the synaptosomal cytosol, which 
suggests H-FABP has an important function at the synapse (Pu et al. 1999). E-FABP is 
highly expressed during neurogenesis, neural migration and differentiation of neurons 
(Allen et al. 2000; Liu et al. 2000). B-FABP is expressed mainly in glial cells at early 
stages of brain development and its level decreases in neonatal and adult brain (Owada 
et al. 1996). B-FABP may be an important target to explore, since it has high affinity for 
DHA (Balendiran et al. 2000). 
 
1.7.1.3 Involvement of transcription factors  
DHA can also activate transcription factors, such as retinoid X receptors (RXRs), and 
peroxisome proliferator-activated receptors (PPARs), to alter gene expression. RXR is 
an obligatory component of various nuclear receptor heterodimers involving the retinoic 
acid receptor (RAR), the vitamin D receptor, the thyroid hormone receptor and PPARs 
(Calderon et al. 2007). It has been shown that DHA can bind to RXRs and influence 
RXR-mediated transcription in brain (de Urquiza et al. 2000; Lengqvist et al. 2004). 
RXRs are activated and expressed by microglia after contusion SCI (Schrage et al. 
2006). One of the major transcription factors responsible for the regulation of 
inflammatory cytokines is NFB. A previous study has shown that RXR inhibits NFB-
dependent gene expression and reduces interleukin-12 production in macrophages (Na 
et al. 1999). Thus, DHA may reduce the inflammatory response by modulating reactive 
microglia. 
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Omega-3 PUFAs can activate PPARs, which include three isotypes: PPAR, PPRA, 
and PPAR. Various experimental studies have shown that PPAR agonists exert 
neuroprotective effects through PPARactivation(Sundararajan et al. 2005; Zhao et al. 
2006; McTigue et al. 2007; Yi et al. 2008). An in vitro study suggests that EPA and DHA 
may reduce lipopolysaccharide-induced nuclear factor-kappaB (NF-B) activation and 
monocyte chemoattractant protein-1 (MCP-1) expression via activation of PPAR (Li et 
al. 2005). In addition, omega-3 PUFAs supplementation appeared to increase PPARs 
as well as  RXR expression in aged rats‘ brain compared to an aged untreated group 
(Dyall et al. 2010). The effect may be linked to the neurogenesis promoting effect of 
DHA seen in in vitro and in vivo studies (Kawakita et al. 2006). 
Activation of PPARs can also increase BDNF and NGF levels (Meng et al. 2011) and 
induce neuronal differentiation by modulating the BDNF/TrkB pathway (D'Angelo et al. 
2011). An increased BDNF level was also detected in TBI (Wu et al. 2004; Wu et al. 
2011) and cerebral ischaemia (Blondeau et al. 2009) animal models after omega-3 
PUFAs supplementation and was correlated with neurological functional recovery. 
These findings suggest that DHA can upregulate BDNF expression and promote 
neurogenesis through PPAR activation. 
1.7.1.4 Involvement of G-protein coupled surface receptors 
G-protein coupled receptors (GPRs) are known to play important physiological roles in 
response to fatty acids. GPR120 (Hirasawa et al. 2005) and GPR40 (Itoh et al. 2003) 
are both able to bind long-chain fatty acids and both activate intracellular signalling 
pathways. GPR120 is highly expressed in adipose tissue and proinflammatory 
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macrophages (Oh et al. 2010). By signalling through GPR120, DHA and EPA mediate 
potent anti-inflammatory responses and inhibit the TNF- signalling pathway, and this 
effect is abrogated by GPR120 knockdown (Oh et al. 2010). A recent study also 
reported that the anti-inflammatory effect of DHA may be related to cPLA2 activation via 
GPR120 (Liu et al. 2014). In addition, PUFAs also promote the activation of PI3K-Akt 
pathways via GPR120, leading to an anti-apoptotic effect (Katsuma et al. 2005). 
GPR40 is also a receptor for PUFA, and in addition to expression in the pancreas, its 
gene was reported to be expressed ubiquitously in the human brain (Briscoe et al. 
2003). GPR40 has been shown to be localized to -cells of the pancreas and to 
modulate insulin secretion in response to free fatty acids, but its role in the CNS is not 
well clarified. In GPR40 gene transfected rat neuronal stem cell cultures, one study 
demonstrated that DHA induced neurite growth and neuronal differentiation (Ma et al. 
2010). This suggests that PUFAs might act as extracellular signalling molecules at such 
membrane receptors to regulate neuronal function and promote neuronal differentiation 
(Yamashima 2008; Ma et al. 2010). 
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Figure 1-4 Cellular targets and metabolites of DHA 
DHA and its metabolites acts through various mechanisms: its incorporation into 
membranes can change the properties of membrane microdomains (lipid rafts and 
caveolae); it binds to membrane proteins, receptors and ion channels to activate 
neuroprotective and neuroplasticity promoting mechanisms; DHA metabolites (resolvins, 
docosatrienes, and neuroprotectins D1) also contribute to the anti-inflammatory 
response. Adapted from (Dyall et al. 2008; Michael-Titus et al. 2014). 
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1.7.2 DHA and neuronal function 
The CNS has the second highest concentration of lipids after adipose tissue, with a 
large proportion of brain lipids being comprised of PUFAs (Salem et al. 1989; Horrocks 
et al. 2004). PUFAs are major components of glial and neuronal membrane 
phospholipids, and play a pivotal part in brain membrane remodelling and synthesis, 
and signal transduction (Rapoport et al. 2007). Both omega-3 and omega-6 PUFAs are 
important components of cell membranes and are precursors to many other substances 
in the body such as those involved with regulating blood pressure and inflammatory 
responses. The major part of omega-3 PUFAs in the CNS is DHA, representing 10-20% 
of total fatty composition, whereas eicosapentaenoic acid (EPA) and arachidonic acid 
(AA) represent considerably less (Michael-Titus 2009). Normal CNS function and 
structure has been proposed to depend on an optimal balance between omega-3 and 
omega-6 PUFAs and if this balance is disturbed, it may lead to neurologic deficits 
(Noaghiul et al. 2003) and cognitive changes (Conquer et al. 2000). 
DHA levels in the brain are responsive to dietary intake of preformed DHA (Brenna et al. 
2007). During omega-3 PUFA dietary deficiency, the transfer of DHA out of the CNS 
across the blood brain barrier is reduced, while unesterified DHA is also rapidly recycled 
from brain phospholipids in order to maintain DHA levels (Contreras et al. 2000). 
 
1.7.3 DHA and neuroprotection 
The beneficial effect of omega-3 PUFAs following injury to the spinal cord was first 
documented by Lang-Lazdunski et al. in a rat model of transient spinal cord ischaemia 
(Lang-Lazdunski et al. 2003). Over the past 10 years, there has been increased interest 
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in the health benefits of PUFAs, with evidence emerging that omega-3 PUFAs have 
significant therapeutic potential in a variety of CNS disorders, including Zellweger 
syndrome, schizophrenia, depression, and Alzheimer‘s disease (Calon et al. 2007). In 
particular, a number of clinical and pre-clinical studies have reported neuroprotective 
effects of diets enriched in omega-3 PUFAs (Morris et al. 2003; Huang et al. 2007; 
Figueroa et al. 2013). 
 
1.7.3.1 Anti-inflammatory effect 
Inflammation is a natural defence response to trauma or microbial invasion. This 
phenomenon is designed to remove the inflammatory stimulus and rescue tissue from 
damage. However, an excessive inflammatory response can lead to local tissue 
damage and further remodelling, which may cause significant injury. Several studies 
have reported that the functional outcome after SCI is improved by therapies that 
reduce inflammation (Popovich et al. 1997; Kwon et al. 2004). PUFAs play an important 
role in the onset and resolution of inflammation. Omega-6 PUFAs, such as AA, 
contribute to the initiation of inflammation. The primary injury leads to excitotoxicity, 
which activates cytosolic phospholipase A2 (cPLA2) releasing AA and producing pro-
eicosanoids, leukotrienes, prostaglandins, and thromboxanes that mediate inflammation 
by enhancing vascular permeability, increasing local blood flow and infiltration (Profyris 
et al. 2004; Jones et al. 2005). Contrary to the omega-6 PUFAs, omega-3 fatty acids, 
such as DHA and EPA, have well-described anti-inflammatory effects (Mori et al. 2004). 
Several possible mechanisms have been proposed to explain the anti-inflammatory 
effects of omega-3 fatty acids. Omega-3 fatty acids play a role in substrate competition, 
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preventing AA conversion into proinflammatory eicosanoids such as prostaglandins 
(PGs) and leukotrienes (LTs). Omega-3 fatty acids can serve as an alternative substrate 
to produce less potent 5-series LTs and 3-series PGs and thromboxanes (Seki et al. 
2009). Recently, many studies have also demonstrated that the metabolites of omega-3 
fatty acids play a vital part in anti-inflammatory resolution. The resolving inflammatory 
exudates use omega-3 fatty acids to produce structurally distinct families of signalling 
molecules- resolvins, protectins and maresins, collectively termed specialized pro-
resolving mediators (SPMs) (Serhan 2014). Specific SPMs shorten the resolution 
interval by limiting neutrophil recruitment and stimulation of macrophage efferocytosis 
and tissue regeneration (Serhan et al. 2012). 
 
Omega-3 fatty acids also have potent anti-inflammatory effects on the human immune 
system. In vitro studies have shown that they can inhibit lymphocyte-endothelial cell 
adhesion to ameliorate the inflammatory response (Khalfoun et al. 1996), and suppress 
T-cell-mediated immune function (Wu et al. 1998). They can reduce inflammation by 
modulating the response of reactive microglia (Antonietta Ajmone‐Cat et al. 2012). 
1.7.3.2 Anti-oxidant effect 
Increase in superoxide and hydroxyl radicals has been well documented in spinal cord 
injuries (Liu et al. 1998; Bao et al. 2004; Liu et al. 2004). One major event leading to 
direct damage to neuronal and axonal membrane structure and function after SCI is 
lipid peroxidation (Hall et al. 2004). Furthermore, lipid oxidation can cause 
microvascular damage and secondary ischaemia, and potentially lead to protein 
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oxidation (Berlett et al. 1997) and extensive  tissue damage and neuron cell death (Xu 
et al. 2005). In a series of studies from our group, DHA treatment after thoracic SCI has 
been shown to significantly decrease oxidative stress, including lipid peroxidation, 
protein oxidation, and RNA/DNA oxidation (King et al. 2006; Huang et al. 2007). It is 
likely that the reduction of such damage by DHA plays a crucial role in its 
neuroprotective effects. In vitro studies have shown that DHA supplements can reduce 
oligodendrocyte injury by increasing neuronal glutathione activity and preventing 
hydrogen peroxide-induced cell death (Brand et al. 2008). Neurofilament proteins are 
vulnerable to oxidative stress, which results in alteration in their structure and the 
eventual collapse of the cytoskeleton (Gelinas et al. 2000). The anti-oxidant capacity of 
DHA may thus also ameliorate the neurofilament loss. 
 
1.7.3.3 Reducing glutamate excitotoxicity 
The release of glutamate after traumatic SCI leads to death of neurons and 
oligodendrocytes (Liu et al. 1999; Park et al. 2004). Work from other laboratories 
showed that DHA treatment can reduce glutamate-induced excitoxicity both in vivo 
(Hogyes et al. 2003) and in vitro (Wang et al. 2003). The underlying mechanism is 
possibly that DHA inhibits voltage-gated sodium and calcium ion currents, thus reducing 
the depolarization-induced glutamate efflux (Seebungkert et al. 2002) and N-methyl-D-
aspartate (NMDA) receptor activation (Nishikawa et al. 1994). In another possible 
mechanism, DHA could activate two-pore domain potassium channels, i.e. the Twik-
related potassium channel 1 (TREK-1) and the TWIK-related arachidonic acid 
stimulated potassium channel (TRAAK) (Kanellopoulos et al. 2000). TREK-1 is 
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expressed at both presynaptic and postsynaptic sites. In glutamate-containing neurons, 
opening of presynaptic TREK-1 channels will reduce glutamate release by closing 
voltage-dependent calcium channels. At the postsynaptic level, membrane 
hyperpolarization will decrease NMDA receptor activation and excitotoxicity in 
pathological conditions (Franks et al. 2004). 
 
1.7.4 DHA and neuroplasticity 
PUFAs are incorporated into membrane phospholipids, thus playing important structural 
roles, but they can also activate a variety of cell signaling pathways. Our investigation of 
DHA effects on neuroplasticity was prompted by observations indicating that DHA 
treatment influences brain plasticity and function. Some studies indicate that DHA 
provides support to learning and memory in animal models of Alzheimer‘s disease 
(Hashimoto et al. 2002; Lim et al. 2005) and brain injury (Wu et al. 2004). 
 
1.7.4.1 DHA enhances synaptic plasticity 
DHA has widespread effects on synaptic function, but the mechanism underlying the 
promotion of synaptic plasticity by DHA remains to be elucidated. However, these 
functions likely involve a complex interplay of synergistic effects on neuronal membrane 
structure and function. As mentioned previously, DHA is a key building block for 
synaptic membranes and significantly alters many basic membrane properties and 
consequently regulates neurotransmission and signal transduction (He et al. 2009). Oral 
chronic DHA intake has been shown to promote the synthesis of synaptic membranes, 
elevate the level of phosphatides and of specific presynaptic proteins, e.g. synapsin-1, 
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syntaxin-3, post-synaptic protein PSD-95 and cytoskeleton protein F-actin (Wurtman et 
al. 2006). A number of studies have shown that omega-3 PUFA can modulate 
neurotransmission. Omega-3 PUFA supplementation can increase dopamine level in rat 
frontal cortex (Chalon et al. 1998). In contrast, chronic omega-3 PUFA deficiency 
significantly decreases dopamine storage vesicles (Zimmer et al. 2000) and dopamine 
levels (Delion et al. 1996). Furthermore, an omega-3 PUFA deficient diet also alters 
serotonergic transmission (Kodas et al. 2004) and cholinergic transmission in the rat 
hippocampus (Aid et al. 2003). 
In SCI, few studies have discussed the effect of DHA on synaptic plasticity. In one study, 
dietary DHA acts synergistically with the effect of exercise on synaptic plasticity by 
increasing the mRNA levels of molecular markers of learning, i.e., BDNF, cAMP 
response element-binding protein (CREB), Ca2+/calmodulin-dependent protein kinase II 
(CaMKII) and syntaxin-3 (Joseph et al. 2012). Several studies have shown that BDNF 
modulates synaptic plasticity (Bolton et al. 2000; Hariri et al. 2003). BDNF-related 
mechanisms are another possible way in which DHA may promote synaptic plasticity 
following SCI. 
 
1.7.4.2 DHA promotes anatomical neuroplasticity 
Recent studies demonstrate that DHA can increase both maximum neurite length and 
the total number of neurites in embryonic hippocampal cell cultures (Calderon et al. 
2004), and even in mature neurons (Robson et al. 2010). Dietary supplementation with 
DHA following facial nerve injury appears to promote a pro-regenerative response 
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(Makwana et al. 2006). DHA treatment improves locomotor function and increases 
serotonin levels in lumbar spinal cord at 6 weeks following thoracic compression SCI 
(Ward et al. 2010). Topical DHA in combination with nerve growth factor can increase 
corneal nerve regeneration in rabbits (Esquenazi et al. 2005; Cortina et al. 2013). Such 
evidence supports the hypothesis that DHA has the ability to enhance axon growth. 
 
The molecular mechanism underlying the promoting effect of DHA on anatomical 
neuroplasticity remains unclear. DHA can influence cell function through multiple 
mechanisms, ranging from modulation of membrane properties to regulation of signal 
transduction and gene expression. Omega-3 PUFAs are known to act as ligands for the 
RXR and PPARγ. For instance, nerve growth factor (NGF)-induced neuronal 
differentiation is mediated through activation of PPARγ in a TrkA-dependent manner 
(Fuenzalida et al. 2005). PPARγ activation also increases NGF and BDNF levels after 
SCI (Meng et al. 2011). Furthermore, a role of retinoid signaling (likely to be modulated 
by DHA) in the regeneration of sensory neurons in the spinal cord has also been 
demonstrated (Wong et al. 2006). Syntaxin-3 is a plasma membrane-bound protein, 
which is found in neuronal growth cones and is susceptible to the influence of DHA on 
membrane expansion and neurite outgrowth (Darios et al. 2006). A recent report 
showed that the level of syntaxin-3 is upregulated after DHA treatment in TBI (Wu et al. 
2011). Thus, it is likely that DHA exerts its effect on neuroplasticity through multiple 
pathways. 
1.8 Aims 
DHA has promising potential in the treatment of SCI. The studies that follow are divided 
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into five parts 
a) To characterize a cervical SCI model  
b) To evaluate the neuroprotective effects of DHA in a cervical SCI animal model 
c) To assess the effects of DHA on neuroplasticity in the cervical SCI animal model 
d) To investigate the mechanism responsible for the effects of DHA on 
neuroplasticity 
e) To examine the synergistic effect of DHA treatment and a rehabilitation program 
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2 Material and Methods 
Experimental procedures in animals were performed in compliance with the Barts and 
the London, School of Medicine and Dentistry guidelines and were approved by the 
United Kingdom Home Office (Animal [Scientific Procedures] Act 1986). Surgery was 
carried out under anaesthesia and pain relief was provided appropriately during post-
operative care. 
 
2.1 Cervical hemisection SCI 
To perform the injury to the spinal cord, adult female Sprague-Dawley rats (weight 225-
249 g Charles River, Margate, UK) were deeply anaesthetized with 4% isoflurane 
(Merial, Essex, UK), as evidenced by lack of response to a nociceptive stimulus 
consisting of a paw pinch. The neck of the anaesthetized animals was shaved and 
disinfected with povidone iodine. A dorsal midline incision was made in the skin and 
superficial muscles of the neck region. Exposure of vertebral laminae C4, C5, and C6 
was made through blunt dissection. The spinal process and vertebral laminae of C4 and 
C5 were removed without applying pressure on the underlying spinal cord, under 
microscope control. After opening the dura, the left side of the cervical spinal cord was 
cut at the middle of C4 and C5 with a microblade. The microblade was inserted into the 
spinal cord at the midline until the ventral surface of the vertebral column was touched. 
The knife was then pulled across the spinal cord until it came out the lateral side. This 
incision was repeated once and the completeness of the lesion was verified 
microscopically. Sham animals only received laminectomy to expose the spinal cord, 
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leaving the spinal cord undisturbed. After complete coagulation, muscles were sutured 
layer by layer and skin layers were closed with subcutaneous suture with 4-O 
absorbable suture (VICRYL Rapide Suture W9930). After surgery, animals were given 
buprenorphine subcutaneously (0.02 mg/kg; Reckitt Benckiser, UK) and then were 
placed in warm cages to recover from anesthesia. 
 
2.2 Mouse pyramidotomy 
The pyramidotomy was performed by Dr. Ping K Yip. Right pyramidotomy was 
performed on adult female CD1 mice (weight 25-29 g Charles River, Margate, UK) (n = 
5-6 per group) using methods adapted from previous studies (Starkey et al. 2005; Yip et 
al. 2010). Mice were anaesthetised with a mixture of medetomidine (0.5 mg/kg) and 
ketamine (75 mg/kg) intraperitoneally. Surgical sterile procedures were adapted from 
previous studies (Thallmair et al. 1998; Starkey et al. 2005). Mice were prepared for 
surgery by shaving and disinfecting the ventral surface between the forelimbs and jaw. A 
ventral midline incision was made; the sterno-hyoid and sterno-thyroid muscles were 
lightly retracted. The trachea and oesophagus were carefully displaced. The 
ventrocaudal part of the bone was partially removed using forceps before the right 
pyramidal tract was incised with iridectomy scissors. The oesophagus, trachea and 
muscles were repositioned, and the skin sutured. Thirty minutes after pyramidotomy, 
animals received a tail vein injection of either vehicle (0.2% ethanol in saline) or DHA 
(500 nmol/kg) in a volume of 5 ml/kg. Post-operative care involved subcutaneous 
injection of analgesic (buprenorphine, 0.05 mg/kg) twice daily for 3 days following 
surgery. 
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2.3 Preparation and treatment of DHA for acute i.v. injection 
2.3.1 Preparation of DHA for acute i.v. injection 
1 M stock aliquots of free fatty acid (DHA; Sigma, Dorset, UK) were prepared in a 
polystyrene box under 100 % nitrogen and were made up in absolute ethanol. The 5 μl 
concentrated stock aliquots were then kept at -20℃ in light opaque, airtight glass 
containers (Agilent, Stockport, UK) to prevent oxidation. On the day of surgery, required 
concentration solutions of DHA were prepared in sterile saline (NaCl, 0.9% w/v) from 
the stock aliquot solutions of DHA. 
2.3.2 Acute administration of DHA in animals following surgical intervention 
Thirty minutes after hemisection in rats and pyramidotomy in mice, animals received a 
tail vein injection of either vehicle (0.2% ethanol in saline) or DHA (250 nmol/kg in rats, 
500 nmol/kg in mice) in a volume of 5 ml/kg. The i.v. tail vein injections were carried out 
by Dr. Meirion Davies and the author was blinded to the treatment group. The animals 
received postoperative care including subcutaneous injection of analgesics 
(buprenorphine, 0.02 mg/kg body weight) and normal saline (2 ml) for 3 days following 
surgery. 
2.4 Anterograde tracing 
To evaluate whether the treatments had promoted axonal sprouting, we performed 
anterograde tracing of the intact CST as previously described (Yip et al. 2010). One 
week after the hemisection injury and 4 weeks after pyramidotomy in mice, animals 
were anesthetized again with 4% isoflurane. Animals were placed in a stereotaxic frame 
and seven burr holes were made into the skull ipsilateral to the hemisection and 
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contralateral to the pyramidotomy. In cervical hemisected rats, burr holes were made at 
the following coordinates defined as anteroposterior (AP), mediolateral (ML) related to 
bregma: (i) AP: -1.5 mm, ML: 2.5 mm; (ii) AP: -0.5 mm, ML: 3.5 mm (iii) AP: - 0.5 mm, 
ML: 2.5 mm; (iv) AP: + 0.5 mm, ML: 3.5 mm; (v) AP: + 1.0 mm, ML: 1.5 mm; and (vi) AP: 
1.5 mm, ML: +2.5 mm; and (vii) AP: +2.0 mm, ML: 3.5 mm (Fig 2.1). In the 
pyramidotomy mice, the holes were made at the following coordinates: (i) AP: -1.0 mm, 
L: +0.5 mm; (ii) AP: -1.0 mm, L: +1.0 mm; (iii) AP: -0.5 mm, L: +1.0 mm; (iv) AP: -0.5 
mm, L: +0.5 mm; (v) AP: 0 mm, L: +1.0 mm; (vi) AP: +1.0 mm, L: +1.0 mm; (vii) AP: +1.5 
mm, L: +1.0 mm; (viii)  AP: +2.0 mm, L: +1.0 mm.  At each site, injections of biotinylated 
dextran amine (BDA; 10%; 10 000 MW, 1 l/site for rat and 0.2 l/site for mouse) were 
delivered using a glass micropipette attached to a Hamilton syringe via water-filled 
polyethene tubing. The micropipette was inserted below the skull surface (2 mm deep 
for rat and 1 mm for mouse) and BDA delivered at a rate of 0.2 l/min. Animals were 
subsequently maintained for 2 weeks before tissue was collected for histology. 
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Figure 2-1 The coordinates for the neuronal tracer injection on the rat skull 
The reference point is bregma, which is the anatomical point on the skull at which the 
coronal suture is intersected perpendicularly by the sagittal suture. 
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2.5 Tissue harvesting for immunohistochemical analysis 
2.5.1 Perfusion, fixation and embedding of spinal cord and brain tissue 
At the appropriate postsurgical interval, animals were deeply anesthetized with sodium 
phenobarbital (50 mg/kg, i.p.). Once the absence of corneal or forepaw reflexes was 
confirmed, a midline incision was performed along the chest and the animal was 
perfused through the ascending aorta with normal saline followed by 4% 
paraformaldehyde in 0.1 M phosphate buffer. The cervical spinal cord and brain was 
dissected out, postfixed in 4% paraformaldehyde for 2 hours, and cryoprotected in 20% 
sucrose in 0.1 M phosphate buffer overnight at 4°C. After embedding in OCT (Optimal 
Cutting Temperature compound) embedding medium (VWR, Lutterworth), tissue was 
frozen and stored at -80°C for subsequent processing for immunohistochemistry. 
2.5.2 Cryosectioning of rat spinal cord 
Serial horizontal cryostat spinal cord sections of 15 m thickness were cut from C3 to 
C7, which segment was identified by the dorsal ganglion root. All sections were 
collected onto Superfrost glass microscope slides (VWR, Lutterworth, UK). The slides 
were then stored at -20°C until required for immunohistochemistry. 
2.5.3 Cryosectioning of mice spinal cord 
The cervical region (C3-7) of the pyramidotomy mice was sectioned (15 m) in the 
transverse plane. 
2.5.4 Cryosectioning of rat brain  
To investigate the change in cortical neurons in the forelimb area of motor cortex after 
SCI, the rat brains were cut in a coronal manner from –0.5 to 5.5 mm rostral to bregma 
(Brus-Ramer et al. 2009). 
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2.6 Immunocytochemistry 
Selected slides of brain and spinal cord sections were removed from -20°C and the 
chosen slides were washed with gentle agitation in PBS (3 x 5 min). Then, the sections 
were incubated in 10% normal donkey or goat serum for 30 mins followed by an 
overnight incubation with primary antibodies (Table 2.1).The next day, sections were 
washed three times (5 min each) in PBS before being incubated for 2 h in the 
appropriate secondary antibodies conjugated to Alexa Fluor 488 or 594 (1:1000). After 
another three 5 min washes in PBS, sections were then counterstained with the 
fluorescent nuclear dye bis-benzimide (Hoechst 33342; 0.2 mg/100 ml PBS; Sigma, UK) 
for 5 min to facilitate detection of cell nuclei or in NeuroTrace® 435/455 Blue 
Fluorescent Nissl (1:100, Life Technologies) to stain neuronal cell bodies. Slides were 
mounted in ProLong® Gold antifade reagent. 
The tyramide signal amplification technique was carried out for the detection of BDA-
labelled corticospinal tract fibers and PTEN immunostaining in the cortex. Sections were 
washed three times (5 min each) in PBS and then incubated with 0.3% hydrogen 
peroxide for 30 min. After further 3x5 min washes with PBS, the sections were 
incubated in avidin-biotin-peroxidase complex (Vectastain ABC Elite Kit, Vector 
Laboratories) for 30 min at room temperature. Following 3x5 min washes in PBS, 
sections were incubated with biotinel tyramide (1:75, NEN Life Sciences) for 10 min. 
After a further 3x5 min washes in PBS, the sections were incubated with extra-avidin 
FITC (1:400) for 2 hours before the sections were further immunostained with another 
antibody for double-labelling or washed, mounted, and cover slipped. 
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Table 2.1 Primary antibodies used 
Primary antibody Abbreviation  Concentration 
and species 
Distributor Specificity 
Neuron-specific 
nuclear protein 
 
NeuN 1:1000  
Mouse 
Chemicon UK Mature neuronal cell bodies 
Adenomatous 
polyposis coli tumor 
suppressor protein 
 
APC 1:200 
Mouse  
Calbiochem Oligodendrocyte cell bodies 
Ionized calcium-
binding adapter 
molecule 
Iba-1 1:1000 
Rabbit 
Wako Ca
2+
-binding peptide 
produced by resting 
monocytes as well as 
activated microglial cells 
 
Neurofilament H 
phosphorylated  
 
SMI31 1:1000 
Mouse 
Sternberger, Phophorylated epitope in 
the neurofilament heavy 
subunit 
Serotonin 5-HT 1:3000 
Rabbit 
Immunostar Serotonin coupled to bovine 
serum albumin (BSA) with 
paraformaldehyde 
 
Anti-choline 
acetyltransferase  
 
ChAT 1:100 
Goat 
Chemicon Cholinergic neurons 
Synaptophysin SYP 1:1000 
Rabbit 
Cell Signaling 
Technology 
 
Synaptic boutons 
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Visual system 
homeobox 2 
Chx 10 1:100 
Sheep 
Abcam, 
 
V2a group interneurons 
expression of the 
transcription factor Chx10 
 
Phosphatase and 
tensin homologue 
deleted on 
chromosome ten 
PTEN 1:250 
Rabbit 
Cell Signaling 
Technology 
Endogenous levels of total 
PTEN protein in cells 
Protein kinase C 
gamma 
PKC 1:500 
Rabbit 
Santa Cruz 
Biotechnology,  
Intracellular signaling kinase 
found in axons of the 
corticospinal tract 
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2.7 In situ hybridization 
In situ hybridization (ISH) was performed on brain cortex sections as described 
previously (Lopez-Ramirez et al. 2014) except for minor changes. Sections were first 
washed in PBS for 5 minutes for 3 times prior to proteinase K treatment 2 g/ml at 37oC 
for 10 minutes, performed in water bath. Sections were then fixed again for 5 min in 4% 
PFA and dehydrated in 70%, 96% and 99.9% ethanol twice, for one minute each time. 
Double digoxigenin–labeled miRcuryLNA probe miR-21 oligonucleotide (5 nM; Exiqon, 
Vedbaek, Denmark) was hybridized with the sections for one hour at 53°C. After 
hybridization, the sections were washed in a series of 5 minutes saline-sodium citrate 
(SSC) washes at 53°C, consisting of 3 washes with 5x SSC, 2 times in 1x SSC  3 
washes in 0.2x SSC, and incubated for 15 minutes in a  blocking solution (0.05% Tween 
and 1% sheep serum) prior to incubation overnight in sheep anti-digoxigenin antibody 
conjugated to alkaline phosphatase (Roche), diluted to a concentration of 1:800 in 
dilution buffer (0.05% Tween,1% sheep serum and 1% bovine serum albumin). Next, 
the sections were washed with TBST 3 times, 5 min each, before incubation for 5 
minutes twice in alkaline development buffer (100 mM Tris HCl, PH 9.5; 100 mM NaCl; 
50 mM MgCl2; and 0.1% Tween-20), and then the sections were incubated with 
NBT/BCIP (5-Bromo-4-chloro-3-indolyl phosphate/Nitro blue tetrazolium) (1%; Roche) 
and levamisole (0.5%; Vector Laboratories, Peterborough, UK), at 30°C overnight. 
Finally, sections were washed in KTBST (50 mM Tris Hcl PH7.5, 150 mM NaCl, 20mM 
KCl, 0.5% Tween-20) for 5 minutes twice to stop the reaction, then washed with water 
one minute twice. The slides were dehydrated at room temperature overnight, then 
sections were mounted and coverslipped with mounting medium. 
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2.8 Western blotting 
Spinal cord tissue was separated into several segments, rostral and caudal to the lesion 
site. Each sample was homogenized in ice-cold lysis buffer (20 mM HEPE PH 7.4, 100 
mM NaCl, 100 mM NaF, 1 mM Na3VO4, 5 mM EDTA, 1X protein inhibitor, 1% nonidet P-
40). Lysates were left under rotation for 2 h at 4℃ before centrifugation (15000 g, 15 
min, 4℃) and collection of the supernatant. The protein concentration of lysates was 
estimated using a colorimetric protein assay according to the manufacturer‘s 
instructions (BCA protein assay (Pierce UK). 10 g of total protein from each sample 
was electrophoresed in loading buffer (60 mM TrisCl PH 6.8, 2% SDS, 1% beta-
mercaptoethanol, 5.6% glycerol, 0.02% bromophenol blue) across a 4.5% acrylamide 
stacking gel (20 min at 90 V) and 12% acrylamide resolution gel (90 min at 110 V). 
Proteins were transferred to a nitrocellulose membrane using a semi-dry transfer 
method (60 min, 120 V). Membranes were then blocked in skimmed milk (5%, 30 min) 
prior to incubation overnight with a primary antibody: rabbit synaptophysin (1:1000; cell 
signaling, Technology) and mouse anti- –III tubulin (1:1000; Promega). Membranes 
were washed and then incubated with secondary antibodies (donkey anti- rabbit IRDye 
800, goat anti-mouse IRDye 680, 2 hr; Licor Biosciences) and visualized using the 
Odyssey infrared imagining system (LiCor Biosciences). Integrated band intensities for 
synaptophysin and –III tubulin were quantified for each sample using Image J 
software. Densitometric values for synaptophysin were normalized against  –III tubulin 
for each sample. 
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2.9 Primary cell culture with DHA and sodium selenite treatment  
Adult female Sprague-Dawley rats (225–250 g) were killed according to UK Home 
Office regulations. The dorsal root ganglia (DRGs) were dissected and transferred to 
Ham‘s F12 medium (Gibco). DRGs were desheathed and trimmed, digested in 0.125% 
collagenase (Sigma) at 37° C for 2 h, and mechanically dissected by trituration with a 
P1000 Gilson pipette in 1 ml of modified Bottenstein and Sato‘s culture medium (BS) in 
Ham‘s F12. The cell suspension was centrifuged at 800 g for 6 min through a cushion of 
15% bovine serum albumin (BSA, Sigma). The dissociated neurons were diluted in 
modified BS culture medium to approximately 1,600 cells per ml. Cells (500 per well) 
were plated in 4-well plates (Labtek) that were precoated with laminin (0.1 g/ml 
Sigma). Cells were incubated at 37° C in a humidified atmosphere containing 5% CO2.  
For experiments, the next day (1 day in vitro (DIV)), DHA (1-10 M) or control media 
(BS media with 0.008% ethanol) were added to the DRG cultures. At 2 DIV, sodium 
selenite (10 M) was added to the cultures to induce PTEN expression (Berggren et al. 
2009; Luo et al. 2013). At DIV3, neurons were fixed for 20 min in 4% paraformaldehyde 
and permeabilized with methanol at –20°C for 5 min, washed with phosphate-buffered 
saline (PBS) and incubated at room temperature for 2 h with a combination of mouse -
III tubulin (1:1,000) with  rabbit PTEN (1:200, Cell Signaling Technology). Secondary 
antibody staining was performed with a mixture of Alexa Fluor 488 (1:1,000, Molecular 
Probes) and Alexa Fluor 594 (1:1,000, Molecular Probes) at room temperature for 45 
mins. After PBS washes, cells were mounted with FluorSave reagent (Calbiochem) and 
observed under a fluorescence microscope. 
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2.10 Image capture and analysis 
2.10.1 Image capture and data analysis for the DHA study in rats 
All analyses were performed blind. Regions from at least 3 sections per animal were 
used for quantification or measured and data expressed as means ± S.E.M. 
2.10.1.1 NeuN positive cells and APC positive cells 
To determine the number of spinal cord neurons and oligodendrocytes, sections were 
viewed on a Leica epifluorescence microscope using tetramethylrhodamine 
isothiocyanate (Y3) or fluorescein isothiocyanate filter blocks and photographed at 20X 
magnification. All NeuN and APC immunoreactive cells were also visualized using the 
filter for Hoechst, which showed labelled nuclei. To maintain consistency with previous 
work, measuring frames at specific locations were used (Fig 2.2). Quantitative analysis 
of the number of Hoechst-labelled NeuN cells was conducted by capturing an image of 
NeuN-labeling and Hoechst labeling at various levels rostral and caudal to the lesion 
site. All captured cells were then counted in a 500 m X 500 m measuring frame by 
using the Image J analysis programme (Image J 1.46u, National Institute of Health, 
USA). A similar analysis was conducted for APC-labelled cells, with the exception that 
areas chosen for APC were in the ventral white matter. 
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Figure 2-2 The template of neuronal cell counting 
(A) The presented image is a montage image of rat spinal cord with NeuN staining. (B) 
The diagram shows a horizontal section through the injury epicenter and the various 
measuring frames caudal and rostral to the lesion site used to analyse different 
biochemical markers. (C) NeuN immunoreactive neuronal cells are shown as seen in 
one frame. (D) The section also was double stained with Hoechst, labelling nuclei. (E) 
The number of Hoechst-labelled NeuN cells was assessed. 
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2.10.1.2 SMI31 neurofilament, serotonin fibers, pre-synaptic protein (synaptophysin) 
High power images (20X objective) were taken of specific areas. In the Image J analysis 
program, these images were converted to binary overlay and were counted 
automatically using the ―analyse particles‖ programme. The programme summarized the  
percentage area of 500 m x 500 m squares that are occupied by immunostaining 
structures. 
2.10.2 Image capture and data analysis for the DHA study in mice 
For the mouse pyramidotomy study, tissue sections were viewed on a Leica 
epifluroscence microscope using a 20x objective. The quantitative analysis of Chx10 
positive interneurons in all groups in spinal cord tissue was conducted by counting all 
labelled cells within the field of view in the areas of the intermediate column and ventral 
horn. In order to correlate with functional recovery, the number of Chx10 positive 
interneurons contacted by sprouting fibres was also identified and recorded. The 
histological assessment of BDA-labelled axons crossing the midline was done in the 
cervical spinal cord by a BSc student, Mr. Jae Won Lee under Dr. Ping K. Yip 
supervision. 
 
2.10.3 Image capture and data analysis for the DHA study in primary cell culture 
During the course of this study, slides were viewed and images captured using a Leica 
epifluorescence microscope (Wetzlar, Germany). Ten images from each cover slip were 
captured at 20X magnification using the Image J analysis program in the regions shown 
(Fig. 2.2). This quantification format enables a representation of the whole cover slip to 
be captured and analysed. The expression level of PTEN, the length of the neurites and 
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the number of neurites of individual DRG cells was measured by Image J software. 
Cultures for each group were performed in duplicate, and for each well 200-400 
neurons were quantified. Cultures were repeated four times.  
 
Figure 2-3 Capture and analysis of cell immunostaining intensity 
Ten images, denoted by numbers, were captured in the indicated regions to provide a 
representation of the cellular coverage of the whole cover slip. 
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2.11 Behavioural studies 
2.11.1 Open field locomotion  
Impairments in hindlimb and forelimb locomotor skills after cervical SCI were evaluated 
using the Basso, Beattie, Bresnahan (BBB) locomotor rating scale (Basso et al. 1995) 
and the forelimb locomotor scale (FLS) (Cao et al. 2008). Animals were allowed to 
acclimatize preoperatively to the testing environment in an open field, which was a 
circular plastic enclosure. Forelimb and hindlimb function were evaluated in the open 
field, which measured approximately 3 feet in diameter, and rats were observed for 4 
minute intervals. The open field test was conducted 1 day after surgery, then every day 
for 2 weeks. After 2 weeks, the test was performed every other day for another week. 
 
2.11.2 Staircase test 
The Montoya staircase test (Montoya et al. 1991) is a well-established measure of 
forepaw motor function in rats and has been demonstrated to be reproducible and 
sensitive to motor impairments. In our study, animals were trained on the Montoya 
staircase test daily for 14 days prior to SCI. We then performed the test every day for 
one week after injury and every other day from one week to three weeks post-injury. 
Two parameters were assessed in this task. One is the number of food pellets retrieved 
and eaten by animals (skilled limb control) and another one is the number of food 
pellets displaced or retrieved (general limb control). One food pellet was placed per 
step, and the number displaced and the number eaten was recorded. 
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Figure 2-4 Forepaw reaching following cervical hemisection injury 
A side view of a rat in the staircase apparatus. The left forearm is stretching to reach a 
food pellet in the fourth stair. 
 
2.11.3 Grid exploration test  
The grid-walk test focuses on voluntary aspects of limb movements (Metz et al. 2000). 
Deficits in descending motor control can be examined by assessing the ability of a rat to 
precisely control and place its hind paws on a horizontal, ladder-like grid. The animals 
are placed on the grid for 3 min and allowed to walk freely across the space. The wire 
mesh  is about 40 cm×60 cm containing 5 cm×5 cm mesh, raised 20 cm high. A video 
camera was located below the grid apparatus, with an angle of about 20-40 degrees. 
Behavior on the grid was recorded on video film. One misplacement was counted when 
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the limb protruded entirely through the grid and extended below the wire surface. All 
animals were required to receive the grid exploration test 3 times before surgery, to gain 
the baseline data and get used to the mesh grid. The post-surgery testing was 
performed weekly until the end of the study. 
 
Figure 2-5 forepaw slip demonstration during grip exploration test  
The picture demonstrates the left forepaw slip during the grid exploration test in rats 
following cervical hemisection. 
 
2.11.4 Footprint test 
To assess stepping patterns of forelimbs and hindlimbs after injury, animals were 
required to run along a paper-lined runway (120 cm long, 7 cm wide) to obtain a food 
treat in a darkened box at the end of the runway. The plantar surfaces of forelimbs and 
hindlimbs were brushed with red and black nontoxic ink. Footprint analysis was 
performed on the day prior to surgery and at postoperative days 2, 7, 14, 21. 
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Fig 2.6 Footprint test.  
The photograph demonstrates the rat running along the paper-lined runway to the 
darkened box. 
2.11.5 Task-specific rehabilitation 
Staircase training has been shown to improve food pellet grasping after cervical spinal 
cord (Garcia-Alias et al. 2009) and brain ischaemia lesions (Maldonado et al. 2008). 
Recovery of reaching and pellet retrieval is associated with plasticity of the corticospinal 
and rubrospinal tracts and motor cortex, and requires integration of segmental, 
intersegmental, and supraspinal input to propriospinal interneurons and motoneurons 
over many spinal levels (Whishaw et al. 1998; Stackhouse et al. 2008). 
 
For 2 weeks before injury, animals were trained to grasp and eat food pellets from the 
Montoya-type staircase device, the same as the one used for staircase rehabilitation. 2 
days after cervical spinal cord hemisection, the animals were started on task-specific 
rehabilitation. One food pellet was put on the right side wells (non-lesion side), and a 
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variety of food pellets were put on the left side so the animals were encouraged to grasp 
the food pellets with their injured forepaw. The training was performed for 30 min twice 
daily. 
 
2.12 Statistical analysis 
The behavioural assessment and histological analysis were performed blind. All 
statistical analyses were performed using GraphPad Prism Version 6 (Gradpad software 
Inc., San Diego, CA, USA). The data were presented as means and standard error of 
the means. One-way or two-way repeated measures ANOVA was used to compare 
experimental groups, with Tukey‘s post-hoc comparisons. Differences were considered 
significant when p< 0.05. 
 
  
91 
 
3 Characterization of cervical hemisection SCI 
3.1 Introduction 
The majority of SCI occurs at cervical level (Jackson et al. 2004) and most of these 
injuries are ‗incomplete‘ (Raineteau et al. 2001). To establish a clinically relevant 
cervical spinal cord animal model, hemisection of the cervical spinal cord was applied to 
our animals. By disrupting both ascending and descending pathways on one side, 
spinal hemisection provides an interesting model to study plastic changes that may 
differentially affect the somatosensory and motor cortical representations, as well as 
their potential implications for behavioural recovery.  
 
3.1.1 Models of cervical SCI 
Patrick D Wall in a personal communication to the International Spinal Research Trust 
(Ramer et al. 2000), has stated four characteristics that are required for an optimal 
model of SCI. These are as follows: 
1. The extent of the lesion should be precisely defined. If there is doubt about the 
extent of a lesion or whether axons have been spared, then the interpretation of 
regeneration can be misleading. 
2. A histological method should be available to detect the growth of axons through the 
lesion. In order to visualize specific pathways and allow the comparison of different 
pathways following treatment, anterograde and retrograde tracers and biomarkers 
should be applied to the animal models. 
3. An electrophysiological method should be available capable of detecting functional 
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synaptic transmission beyond the lesion. Synaptic connection examination will be 
essential to determine the function of regenerating axons. 
4. A behavioral measure should be available, capable of detecting restoration of 
known circuits. The behavioral tests are necessary to assess whether functional 
recovery has been achieved. 
In addition to these characteristics, the animal model should reproduce as closely as 
possible the anatomical and physiological changes that occur in human SCI. 
 
The first significant attempt to produce a clinically relevant model of SCI was that of 
Allen (Allen 1911). In this paradigm, a defined weight is dropped from a known height 
onto the dorsal surface of the exposed thoracic spinal cord. However, the first cervical 
SCI was described in 1992 (Anderson et al. 1992), and established the feasibility of a 
C4—C5 spinal cord contusion injury model in the rat. The study was focused on the 
degree and persistence of forelimb behavioral deficits following cervical spinal cord 
contusion injury. In 1993, Schrimsher and Reier (Schrimsher et al. 1993) developed a 
partial section of the spinal cord, to establish the role of various long-tract spinal 
pathways in forelimb motor control. Recently, there has been an increasing interest in 
the development and characterization of rodent cervical SCI (Dai et al. 2009; Martinez 
et al. 2009; Dunham et al. 2010), largely due to the high clinical relevance and great 
potential to evaluate the neuroprotection or neuroplasticity that involved both gray and 
white matter following injury. Compared with the often used mid-thoracic SCI, return of 
segmental function is easier to detect and analyze in cervical injury models (Anderson 
et al. 2007). In addition, cervical spinal injury models offer another advantage, 
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evaluating the function of paw and digits that are directly controlled by cortical input 
(Whishaw, Pellis et al. 1993). 
 
Many studies use the thoracic SCI model and evaluate locomotion, which is one of the 
most crucial neurological functions. However, most locomotor function is regulated by 
central pattern generating locomotor networks in the lumbar spinal cord that are 
triggered by activity in the reticulospinal tract (Rossignol et al. 1996). In human beings, 
supraspinal input plays an essential role in locomotor control, in particular from the CST 
for fine motion. Animal models which can assess conduction and control from 
supraspinal neurons may therefore be more clinically relevant. A recent questionnaire 
was raised to survey the opinion of clinical and scientific members of the SCI 
community. Ninety-four percent voted that the cervical models were more relevant than 
thoracic models, and only 6% voted that the two were equally relevant, after some 
discussion concerning a therapy being administered to cervical SCI patients (Kwon et 
al. 2011). 
  
3.1.2 Different types of cervical SCI animal models 
In recent years, considerable concern has arisen over the application of cervical SCI 
animal models in SCI research. Table 1 lists published rodent cervical SCI studies. 
Three common approaches (section-based injury, contusion injury, and clip 
compression) are used as experimental models that aim to mimic the type of cervical 
SCI that is seen clinically. The most common model is the section-based injury, in which 
specific axon pathways or specific areas of the cord are damaged in order to study the 
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response to injury of that particular region. Some studies have employed the lateral 
hemisection (half the cord) model, to investigate the effects of various treatments in 
promoting axon regeneration and neuroplasticity (References 3,6,9-12, 15, 18-19, 23, 
26-27, 29, 33-34, 36-37, 40, 44-45,47 in Table 1). The second most common approach 
is to use a weight drop method or computed impaction system, which models contusion 
injury (References 1, 4, 7, 13, 16, 20, 24, 28, 32, 37-38, 41-42, 47 in Table 1). 
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Table 3.1 Rodent cervical SCI animal models 
 Source of Paper Injury 
level 
Species Injury type  Purpose of study 
1 (Schrimsher et al. 
1992) 
C4/5 Rat Contusion Characterize animal model 
2 (Schrimsher et al. 
1993) 
C4 Rat 
Female 
Partial section Characterize animal model 
3 (Ye et al. 1997) C2/3 Rat Lateral hemisection  Neuroregeneration agent evaluation 
(neurotrophic factor) 
4 (el-Bohy et al. 
1998) 
C2 & 
C4/C5 
Rat 
Female 
Contusion Respiratory function following SCI 
5 (Ballermann et al. 
2001) 
C1 Rat 
Female 
Partial section Sensory assessment following SCI 
6 (Golder et al. 
2001) 
C2 Rat 
Female  
Lateral hemisection Respiratory function following SCI 
7 (Soblosky et al. 
2001) 
C4-5 Rat 
Female 
Contusion Characterize animal model 
8 (Casha et al. 
2001) 
C7 Rat 
Female  
Clip compression  Pathological change following SCI 
9 (Webb et al. 
2002) 
C3 Rat  
Female 
Lateral hemisection Behavioral compensation following 
SCI 
10 (Anderson 2004) C5-T1 Mice 
Female  
Lateral hemisection Characterize animal model 
11 (Vinit et al. 2005) C2 Rat 
Female 
Lateral hemisection Pathological change following SCI 
12 (Anderson et al. 
2005) 
C5 Rat 
Female 
Lateral hemisection Characterize animal model 
13 (Pearse et al. 
2005) 
C5 Rat 
Female  
Contusion 
 
Characterize animal model 
14 (Onifer et al. 
2005) 
C4 Rat Partial section    Characterize animal model 
15 (Fujiki et al. 2005) C2 Rat 
Female 
Lateral hemisection Neuronal pathway reorganization 
16 (Gensel et al. 
2006) 
C5 Rat 
Female 
Contusion Characterize animal model 
17 (Massey et al. C6/7 Rat Partial section Neuroplasticity-promoting agents 
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2006) Male evaluation 
(ChABC) 
18 (Vinit et al. 2006) C2/3 Rat 
Male 
Lateral hemisection Respiratory function following SCI 
19 (Anderson et al. 
2007) 
C5 Rat 
Female 
Lateral hemisection Characterize animal model 
20 (Onifer et al. 
2007) 
C5/6 Rat Bilateral contusion Electrophysiology change following 
SCI 
21 (Cao et al. 2008) C4 Rat Partial  
section 
Neuroplasticity-promoting agents 
evaluation 
(NEP1-40) 
22 (Stackhouse et al. 
2008) 
C3-4 Rat 
Female 
Partial section Neurological deficit assessment 
following SCI 
23 (Ying et al. 2008) C4 Rat male Lateral hemisection Neuroplasticity-promoting therapy 
evaluation 
(BDNF + exercise) 
24 (Anderson et al. 
2009) 
C5-8 Rat 
Female 
Bilateral  
contusion 
Characterize animal model 
25 (Garcia-Alias et 
al. 2009) 
C4 Rat Partial section Neuroplasticity-promoting therapy 
evaluation 
(ChABC + Rehabilitative training) 
26 (Martinez et al. 
2009) 
C4 Rat 
Male 
Lateral hemisection Characterize animal model 
27 (Martinez et al. 
2009) 
C4-5 Rat 
Male 
Lateral hemisection Activity based therapy evaluation 
28 (Beaumont et al. 
2009) 
C4/5 Rat 
Female 
Bilateral  
contusion 
Neuroprotective agent evaluation  
(Rolipram) 
29 (Strong et al. 
2009) 
C4 Rat 
Female 
Lateral hemisection Forelimb control following SCI 
30 (Krajacic et al. 
2010) 
C2/3 Rat 
Female 
Partial section Activity based therapy evaluation 
31 (Harel et al. 2010) C3/4 Mice Partial section Neuroplasticity-promoting therapy 
(Nogo deletion) 
32 (Dunham et al. 
2010) 
C5 Rat 
Male 
Unilateral 
Contusion 
Characterize animal model 
33 (Martinez et al. 
2010) 
C4/5 Rat 
Male 
Lateral hemisection Cortical reorganization following SCI 
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34 (White et al. 
2010) 
C2 Rat 
Female 
Lateral hemisection Respiratory outcome following cell 
transplantation 
35 (Lee et al. 2010) C5 Rat Unilateral 
contusion 
Neuroprotection agent evaluation 
(simvastatin and minocycline) 
35 (Filli et al. 2011) C4/5 Rat 
Female 
Lateral hemisection Neuronal pathway reorganization  
36 (Dai et al. 2011) C4/5  Rat 
Female 
Lateral hemisection Activity based therapy evaluation 
37 (Lane et al. 2011) C3/4 Rat 
Female 
Bilateral Contusion Respiratory function following SCI 
38 2012 
Simard(Simard et 
al. 2012) 
C7 Rat 
Female 
Unilateral 
Contusion 
Neuroprotection agent evaluation 
(glibenclamide and riluzole) 
39 (Khaing et al. 
2012) 
C3-4 Rat 
female 
Lateral  
hemisection 
Forelimb function assessment 
following SCI 
40 (Nguyen et al. 
2012) 
C7-T1 Rat 
Female 
clip compression Neuroprotection agent evaluation 
(IgG) 
41 (Walker et al. 
2012) 
C5 Rat 
female 
Unilateral 
contusion 
Neuroprotection agent evaluation 
(Bisperoxovanadium) 
42 (Cote et al. 2012) C5 Rat 
Female 
Unilateral 
Contusion 
Neuronal pathway reorganization 
following SCI 
43 (Lopez-Dolado et 
al. 2013) 
C6 Rat 
Male 
Lateral  
hemisection 
Neuroanatomical change following 
SCI 
44 (Fouad et al. 
2013) 
C5/6 Rat 
Female 
Lateral hemisection Neuroplasticity-promoting therapy 
(BDNF,NT3 expression cell graft) 
45 (Weishaupt et al. 
2013) 
C3/4 Rat 
Female 
Partial 
section 
Neuroplasticity-promoting therapy 
(BDNF, NT3, + Rehabilitative training) 
46 (Kolar et al. 2014) C3/4 Rat 
Female 
Lateral hemisection Stem cell  therapy evaluation  
(adipose-derived stem cells) 
 
47 (Singh et al. 
2014) 
C5 Rat Unilateral 
contusion 
Forelimb function assessment 
following SCI 
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3.1.3 The choice of the level of cervical lesion  
In an animal model of cervical SCI, it is important to define a rationale for the choice of a 
particular injury level. For example, for a lesion at the C4-5 level of the cervical spinal 
cord:  
1. C4 and C5 are the most common levels for cervical injuries in patients. 
2. The cervical cord innervates the deltoids (C4), biceps (C4-5), wrist extensors (C6), 
triceps (C7), wrist flexors (C8), and hand muscles (C8-T1). In interpreting the 
consequences of cervical injury, it is important to note that lesions at C5 are upper 
motor neuron lesions with respect to the muscles of the forearm (McKenna et al. 
2000). 
3. The animal model can be used to mimic the dysfunction of upper limbs in patients 
after cervical SCI. 
4. The C4 (the phrenic nerve system) also innervates the diaphragm. Cervical lesions 
above the C4-5 level may affect respiration, which would introduce further 
complications.  
 
3.2 Aims 
Building an effective experimental animal model is important to understand the 
pathophysiology after SCI and to develop and validate further therapeutic strategies. 
Our group has successfully studied rodent compression and hemisection models of 
thoracic SCI (Huang et al. 2007; Huang et al. 2007; Lim et al. 2013). These have 
allowed us to study in detail the pathogenesis of primary and secondary SCI, and to 
investigate the effects of various therapeutic agents. Our hypothesis is that a cervical 
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hemisection animal model can increase our basic understanding of mechanisms 
involved in cervical SCI and recovery. The present study was aimed at characterizing a 
reliable and reproducible method of producing experimental cervical hemisection SCI in 
the rat and investigating the effects of a cervical spinal hemisection on sensorimotor 
performance in relation to the histological changes in the cervical spinal cord. In 
addition, this model forms the basis for further studies in this thesis, evaluating the 
neuroprotective and plasticity-promoting effects of DHA. 
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3.3 Results 
The work presented here demonstrates the development of a rat cervical hemisection 
SCI by behavioural observation, assessed by locomotor score (FLS and BBB), Montoya 
staircase test, grid exploration test, and foot print analysis. Three weeks after injury, we 
employed immunohistochemical techniques to examine the histological changes 
following cervical hemisection.  
 
3.3.1 Effect of cervical hemisection SCI on neurons 
Three weeks after surgery, we used mouse neuron specific nuclear protein (NeuN) to 
examine neuronal survival. In laminectomy controls, more NeuN-labelled neurons were 
present in the spinal cord than in the hemisection animals (Fig 3.1.A,B). In the cervical 
spinal cord hemisection group, a loss of NeuN immunoreactivity was noted in the 
vicinity of the spinal cord lesion site (Fig 3.1.C,D). Quantitative analysis confirmed that 
significantly lower numbers of NeuN-labelled cells were found in spinal cord tissue 3 
weeks after left cervical spinal cord hemisection injury than in sham operation controls. 
In the sham animal group, the number of neuronal cells per 0.25 mm2 in cervical spinal 
cord 250 m caudal (74.5±5.8 v.s 18.8±6.9, p<0.05) and rostral (68±9.8 v.s 8.5±3.5, 
p<0.05) to the lesion site is significant higher than the hemisection group (Fig 3.1.E). 
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Figure 3-1 NeuN staining and quantification of neuronal cells in cervical SCI and 
sham operation animals 
The representative images in A-D were taken through the spinal cord rostral (A,C) and 
caudal (B,D) to the lesion. The images (A,B) from the sham surgery group revealed 
numerous NeuN-labelled cells. The number of NeuN-labelled cells was diminished in 
the spinal cord 250 m rostral (C) and 250 m caudal (D) to the lesion site in the 
hemisection group. Stars denote lesion site. Quantitative analysis of NeuN 
immunostaining (E) revealed that there was a significant loss of NeuN in the epicenter 
region (*P<0.05). Results represent mean ±SEM; n=4 animals in each group. Scale bar 
=100 m. 
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3.3.2 Effect of cervical hemisection SCI on oligodendrocytes  
Mouse adenomatous polyposis coli (APC) tumor suppression protein was used to 
examine the survival of oligodendrocytes following SCI. In the spinal cord of control rats, 
APC-labelled oligodendrocytes were present throughout the white matter in the spinal 
cord. (Fig 3.2.A,B). In contrast to sham operation animals, there was a dramatic loss of 
APC-labelled cells in the cervical hemisection group ( (Fig 3.2.C,D). The analysis of 
APC labelling showed a similar effect to that for NeuN labelling. Quantitative analysis 
confirmed a significant decrease in APC-labelled oligodendrocytes in the epicenter 
region as compared to the sham surgery group (49.5 ± 6.5 v.s 20.5 ± 5.5 per 0.25 mm2, 
p<0.05) (Fig 3.2.E).  
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Figure 3-2 APC staining and quantification of oligodendrocytes in cervical SCI 
and sham operation animals 
Representative immunohistochemical labelling of APC oligodendrocytes, 250 m rostral 
(A, C) and 250 m caudal (B, D) to the lesion site. In the sham operation group, APC 
immunoreactive cells are present throughout the white mater of the spinal cord (A, B). 
After cervical hemisection (C, D), a loss of APC labelled cells was seen in the epicentre. 
Quantification revealed a significant loss of APC immunoreactive cells in the epicentre 
white matter region (* p<0.05). Results represent mean ± SEM; n=4 animals in each 
group. Scale bar =100 m. 
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3.3.3 Effect of cervical hemisection SCI on microglia/macrophages  
Rabbit ionized calcium-binding adapter molecule-1(Iba-1) was used to evaluate the 
changes in microglia following SCI. Immunohistochemical examination showed that Iba-
1 protein is expressed by quiescent as well as activated microglia (Ito et al. 1998). In the 
control group, the resting microglia were characteristically small cells with long and 
ramified processes (Fig 3.3.A, A‘). In the hemisection group, microglia were transformed 
into an activated form and appeared as hypertrophied and bushy cells (Fig 3.3 C, C‘). 
The data showed heavily stained microglia in the epicenter area compared to the 
shame operated rats (7.2 ± 2.1 vs. 1.05 ± 0.2, p<0.05), and this increase was apparent 
as far as 2-3 mm from the lesion site (Fig 3.3E).  
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Figure 3-3. Iba-1 staining and quantification of activated microglia in cervical SCI 
and sham operation animals  
Representative images taken from the spinal tissue caudal and rostral to the lesion site 
show that small resting microglial cells with ramified thin processes were observed in 
the control group (A,B). Microglia/macrophage activation occurs at 3 weeks after 
cervical hemisection, with large, rounded Iba-1 labelled cells (C,D). Quantitative 
analysis showed significant Iba-1 labelling in the epicentre region of cervical 
hemisection group compared to the sham operation group (* p<0.05). Results represent 
mean ± SEM; n=4 animals in each group. Scale bar =100 m. 
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3.3.4 Effect of cervical hemisection SCI on phosphorylated neurofilament 
SCI has been reported to result in a significant loss of neurofilaments (Kanellopoulos et 
al. 2000). In this experiment, the effect of injury on the phosphorylated neurofilament in 
the cervical spinal cord was examined by using mouse monoclonal antibody (clone SMI-
31) in the white matter. In the sham surgery group, SMI-positive axons appeared as 
numerous, linear and intense staining in the white matter of the spinal cord rostral and 
caudal to lesion site (Fig 3.4.A,B). In the cervical hemisection group, there appeared to 
be fewer SMI-31 positive axons in the spinal cord caudal to the lesion compared to the 
control rats (Fig 3.4.C,D). The analysis revealed a substantial loss of immunoreactivity 
in the epicenter region (2.8 ± 0.4 vs. 3.9 ± 0.4, p<0.05) and caudal part (2.9 ± 0.3 vs. 4.9 
± 1.2, p<0.05) of the cervical spinal cord following injury (Fig 3.4E). 
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Figure 3-4 SMI-31 staining and quantification of phosphorylated neurofilament in 
cervical SCI and sham operation animals. 
Representative images were taken from the spinal cord rostral (A,C) and caudal (B,D) 
to the lesion site. In the control group, the SMI-31 labelled axons were arranged in a 
regular manner. In the hemisection group (C,D), the spinal cord below the lesion site 
showed less SMI31 immunoreactivity than the control group. There was an overall loss 
of SMI staining in the cervical spinal cord following cervical hemisection compared to 
the sham (E) (* p<0.05). Result represent mean ± SEM; n=4 animals in each group. 
Scale bar =100 m. 
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3.3.5 Effect of cervical hemisection SCI on serotonin fibres 
To assess the depletion of bulbospinal monoaminergic projections after cervical 
unilateral hemisection, immunohistochemical staining for serotonin was performed at 
different spinal levels of the animals 1 week and 3 weeks after SCI. The serotonin fibre 
intensity significantly increased in the vicinity of the lesion site rostral to the lesion 
compared to the sham group at 1 week and 3 week after SCI (1 week 3.6 ± 0.4, 3 
weeks 5.1 ± 1.1 vs. sham 1.4 ± 0.3, p<0.05 Fig 3.5B). One week after cervical 
hemisection, an increase in serotonin fibres rostral, and a decrease caudal to the injury 
site in the cervical spinal cord was seen. However, the number of serotonin fibres 
caudal to the lesion site returned to baseline levels by 3 weeks post-injury (Fig 3.5). 
These data suggest that serotonin fibre sprouting occurs in the absence of any 
treatment. 
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Figure 3-5 Serotonin levels change in the cervical spinal cord rostral to the lesion 
site 
Representative sections (A) showing serotonin axons at the lesion site 3 weeks after 
cervical hemisection. The boxed areas are shown at higher magnification. Scale bar 
100 m. Quantification (B) revealed serotonin fibres in the rostral part of the lesion site 
were significantly increased at 1 week (red squares) and 3 weeks (blue circles) 
compared to the sham operated group after lateral cervical hemisection. Results 
represent mean ± SEM; n=4 animals per group. However, in the caudal region, 1 week 
post injury staining appears below the level of the sham operated group. 3 weeks post 
injury staining is similar to the sham operated group. N = 4 animals per group. # P<0.05 
1 week hemisection vs. sham group. * P<0.05 3 weeks hemisection vs. the sham group. 
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3.3.6 Effect of cervical hemisection SCI on locomotor function 
Based on the FLS, the left forelimb function in the hemisection group was severely 
impaired then improved gradually over a period of 2 weeks following injury (from score 4 
to 15). BBB scoring of the hindlimb showed that recovery in the hemisection group 
developed gradually over 2 weeks following injury (from score 13 to 18, Fig 3.6). The 
effect of cervical SCI on hindlimb locomotion was not as severe as on forelimb 
locomotion. 
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Figure 3-6 Effect of cervical hemisection SCI on locomotor function 
Open-field locomotor ability was assessed using the BBB score for hindlimb locomotion. 
The FLS score was used for forelimb locomotion. A significant difference was observed 
between the sham and hemisection groups after cervical hemisection (* p<0.05). 
Results represent mean ± SEM; n=4 animals per group. 
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3.3.7 Effect of cervical hemisection SCI on skilled forelimb function 
We used the Montoya staircase test to assess skilled forelimb function. The Montoya 
staircase test allows assessment of extension and grasping ability independently for 
each forelimb. For the left forelimb, the staircase study revealed statistically significant 
differences between the hemisection and sham operation group after surgery (Fig 3.7), 
for the whole duration of the study. 
 
3.3.8 Effect of cervical hemisection SCI on skilled locomotor function  
The grid exploration test was utilized to evaluate the effect of cervical hemisection SCI 
on skilled locomotor behaviour. The grid exploration test focuses on skilled aspects of 
limb movements. The animals were placed on the grid for 3 min and allowed to walk 
freely across the space. After surgery, a significant increase in the misplacement of the 
paw was observed in the hemisection group following surgery. In contrast, there was no 
difference in the sham operation group (Fig 3.8). 
 
3.3.9 Effect of cervical hemisection SCI on stepping patterns 
To assess stepping patterns of the forelimbs and hindlimbs after injury, animals were 
required to run along a paper-lined runway to obtain a food treat in a darkened box at 
the end of the runway. Three different parameters (stride length, stride width, and base 
of support) were measured. There was a significant decrease in stride length (13.2 ± 1.9 
vs.17.5 ±0.5, p<0.05) at 2 weeks, with partial recovery by 3 weeks. Left paw stride width 
decreased gradually after hemisection injury, reaching significance at 3 weeks. The 
base of support increased at 2 weeks after injury, but recovered by 3 weeks (Fig 3.9). 
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Figure 3-7 Effect of cervical hemisection SCI on skilled forelimb function 
Skilled forelimb function was assessed by the Montoya staircase test. (A) The 
quantification of food pellets displaced on the lesion side revealed a significant loss of 
the ability to move food pellets after injury and showed little recovery after 3 weeks. (B) 
The quantification of food pellets eaten using the left forelimb revealed a loss of the 
ability to retrieve and consume pellets immediately after surgery, and this did not 
recovery by the end of the experiment.(** p<0.01). Results represent mean ± SEM; n=4 
animals in each group. 
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Figure 3-8 Effect of cervical hemisection SCI on skilled forelimb and hindlimb 
function. 
Skilled locomotor function was assessed with the grid exploration test. Three tests were 
performed before surgery to obtain the baseline data of the grid exploration test. The 
test was performed at 3 days, 7 days, and 14 days after surgery. After cervical 
hemisection, the rats made more footslips compared to the sham group in both the left 
forelimb (A) and hindlimb (B) when walking on the grid. The results revealed highly 
significant differences between sham and hemisection groups over the study period (* 
p<0.05). Results represent mean ± SEM; n=4 animals in each group. 
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Figure 3-9 Effect of cervical hemisection SCI on stepping patterns 
(A) Representative images of the walking track performance in the sham operation 
group. (B) Measurements were taken from the footprints (C). The stride length 
significantly decreased after 2 weeks following SCI compared with the pre-injury stride 
length. (D) Left forelimb paw width decreased after cervical hemisection. The difference 
reached significance 3 weeks after SCI. 
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3.4 Discussion 
3.4.1 Cervical hemisection SCI animal model 
Approximately half of human traumatic SCI occur at cervical segments, causing 
incomplete lesions in about 70% of cases (Lopez-Dolado et al. 2013). However, most 
experimental models of SCI have examined thoracic SCI. Histological, behavioural and 
therapeutic findings in the thoracic SCI model may not be readily applicable to cervical 
level because of spinal cord diameter differences (Ko et al. 2004), white/gray matter 
distribution (Wrathall et al. 1995), and the relative dedication of the cord segments to 
specific ascending and descending systems and specific termination sites (Nathan et al. 
1996; Pearse et al. 2005). 
 
Recently, a number of models of cervical SCI have been reported, in which the spinal 
cord is injured by complete transection, hemisection, contusion, compression, or crush. 
Different animal models are designed for various study purposes. Complete transection 
is useful for studying axonal regeneration, while hemisection is optimal for axonal 
plasticity (Kwon et al. 2002). Furthermore, the hemisection animal model provides a 
comparison between the injured and non-injury sides in the same animal. For the 
animal‘s welfare, given that hemisection results in a less severe injury than complete 
transection or bilateral injury, postoperative mortality is lower in hemisection compared 
with complete injury (Kwon et al. 2002; Anderson et al. 2009). Actually, close to two-
thirds of all reported human SCI are partial lesions, with the majority occurring in the 
cervical spinal cord (NSCISC, 2010). In view of clinical translation, the hemisection 
(partial injury) animal model is closest to the patient injury condition, especially a sharp, 
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penetrating SCI. In addition, one ultimate aim of our research is to explore plasticity 
changes after SCI. For this reason the hemisection model is very suitable for our study. 
 
3.4.2 Locomotor function recovery after cervical hemisection 
In our study, locomotor function recovered gradually after 2-3 weeks according to the 
BBB score and the FLS score. The substantial spontaneous recovery of locomotor 
function over the first month followed by continued improvement has been reported 
(Webb et al. 2002; Martinez et al. 2009). Recently, a relation between spontaneous 
locomotor function recovery after SCI and plasticity in spinal neuronal circuits has been 
generally recognized (Bareyre et al. 2004; Ballermann et al. 2006; Barriere et al. 2008). 
However, it remains uncertain as to which aspects of plasticity contribute to functional 
recovery. There are several suggested mechanisms including axonal sprouting (Bareyre 
et al. 2004; Ballermann et al. 2006), intrinsic re-organization of intraspinal circuits 
(Barriere et al. 2008) and changes in neurotransmitter systems that facilitate functional 
recovery, such as glutamate (Giroux et al. 2003), and serotonin (Saruhashi et al. 1996; 
Schmidt et al. 2000). 
 
3.4.3 Skilled movement recovery after cervical hemisection 
Compared to locomotor function recovery, skilled forelimb functions (i.e. staircase test 
performance) did not recover spontaneously even after 3 weeks. A complete 
hemisection at C4-5 level interrupts descending motor pathways, including the dorsal 
CST in the dorsal column and the dorsolateral CST (Casale et al. 1988; Rouiller et al. 
1991), which are important for distal flexor function. In addition to gripping ability, food 
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pellet retrieval requires postural adjustments, forearm extension, grasping with the 
digits, and supination and flexion to bring the food to the mouth. This kind of function 
requires fine, skilled movement of the fingers and the behaviour is quite similar to 
humans (Whishaw et al. 1992). Complete hemisection at C5 cervical level causes a loss 
of gripping ability in the ipsilateral forepaw in rats, and the impairment is permanent 
(Anderson et al. 2005; Anderson et al. 2007). Another interpretation is that the 
hemisection lesion creates a disruption to the rubrospinal tract, which results in impaired 
movement of the distal forelimbs and significant deficit in digit flexion (Schrimsher et al. 
1993). In addition to the lesion of descending fibres resulting in impairment of food 
retrieval, one study found that the sensory input conveyed by the dorsal columns is 
important for both proximal and distal limb movements used for skilled reaching 
(McKenna et al. 1999). Further work has demonstrated that rats with unilateral cervical 
dorsal column lack the ability to discriminate surfaces of different textures (Ballermann 
et al. 2001). Skilled forelimb behaviours require the integration of both sensory and 
motor systems. Because of this complexity, skilled movement can be used as a 
sensitive indicator of the therapeutic effects of novel therapies. 
 
3.4.4 Histology findings after cervical hemisection SCI 
In my animal model, it is likely that the cervical hemisection SCI leads to neuronal, 
oligodendrocyte, and phosphorylated neurofilament loss at the lesion site. Most 
neuronal loss is considered to be the result of necrosis caused by the original injury 
(Wrathall 1992). However, a number of other studies have shown the occurrence of 
neuronal apoptosis after SCI (Bareyre et al. 2003). Secondary injury following the 
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primary insult such as inflammation, ischaemia, glutamate-induced toxicity, and free 
radical production, could contribute to neuronal loss. Some studies suggested that loss 
of NeuN immunoreactivity after CNS injury does not indicate neuronal cell loss but 
rather suppression of the antigen in intact neurons (McPhail et al. 2004; Unal-Cevik et 
al. 2004). However, one study demonstrated the loss of neurons in ventral horn after 
SCI with toluidine blue, which is compatible with the pattern of NeuN expression, 
suggesting that NeuN loss does represent actual neuronal loss following SCI (Huang et 
al. 2007). 
Oligodendrocytes are the cells responsible for the myelination of axons in CNS, and 
remyelination of injured axons. APC is a marker that has been identified as a useful 
oligodendrocyte marker. APC clearly labels the oligodendrocyte cell body, but not 
processes or myelin sheaths (Bhat et al. 1996). In comparison with myelin protein 
antibodies, the ability of APC to label the oligodendrocyte cell bodies without labelling 
processes or myelin offers unique advantages for the study of oligodendrocytes. We 
found loss in the number of oligodendrocytes after cervical SCI compared to the sham 
operation group. These findings are consistent with other SCI studies (Liu et al. 1997).  
To investigate axonal pathology, a neurofilament maker (SMI 31) was examined in my 
animal model. Our data revealed a decrease in the phosphorylated component of 
neurofilament 3 weeks following SCI, especially in the epicenter region and caudal to 
the lesion site. This finding is consistent with reports on a decrease in phosphorylated 
and non-phosphorylated neurofilament protein following SCI (Kanellopoulos et al. 2000; 
Ward et al. 2010). The primary function of neurofilament is to maintain the axonal 
caliber. Destruction of this protein will lead to a dramatic decrease in the caliber of 
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spinal cord axons and reduce their conduction velocity (Liu et al. 2004).  
3.4.5 Serotonin changes associated with SCI 
Serotonin may have a biphasic influence on spinal cord recovery after trauma. A 
microdialysis study has demonstrated that large amounts of serotonin are released 
acutely in the injured spinal cord (Sorkin et al. 1991). Serotonin is released from the 
neural tissue at the injury side and is transiently taken up by platelets (Saruhashi et al. 
1991). It has been proposed that the release of serotonin in the acute stage of SCI 
contributes to local adverse effects such as the traumatic decline in blood flow and the 
oedema in injured cords (Sharma et al. 1990). 
It has been reported that rapidly diminished spinal levels of serotonin occur ipsilateral to 
spinal lesion following thoracic SCI, with levels of serotonin returning by 4 weeks after 
injury in the lumbar region (Saruhashi et al. 1996; Hains et al. 2002; Saruhashi et al. 
2009). These dynamic changes can be used as an indicator of injury severity (Faden et 
al. 1988) and provide a substrate for changes in somatosensory and locomotor 
behaviours. There are two considerations which could contribute to the recovery of 
serotonin levels after SCI.  Although most serotonin pathways descend ipsilaterally, it 
would appear in some immunohistochemical studies that serotonin fibres cross in the 
region of the central canal (Hadjiconstantinou et al. 1984; Saruhashi et al. 1996). 
Secondly, Newton and Hamill report some serotonin neurons found in lamina VII and X 
of the thoracolumbar and sacral spinal cord of the adult rat (Newton et al. 1988). Such 
intraspinal serotonin neurons may be a source of fibres that reinnervate the spinal cord. 
In cervical SCI animal models, there is limited data about the changes that occur in 
serotonin levels at the lesion site and how they correlate to behavioural recovery. In my 
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animal model, the serotonin level was markedly increased in the cervical spinal cord 
rostral to the lesion site even 3 weeks after injury. It is postulated that serotonin 
contributes to neuroplasticity at the lesion site and accumulates in the descending 
bulbospinal serotonergic pathways that are cut by the cervical hemisection. In contrast, 
the serotonin level in the spinal cord caudal to lesion site showed no obvious difference 
from the control group.  
 
3.5 Summary 
 A cervical spinal cord hemisection injury model has been successfully developed in 
the rat, which revealed a strong correlation between histological finding and 
neurological recovery.  
 The behavioural tests showed substantial spontaneous recovery of crude forelimb 
function, but a long-lasting deficit in fine forelimb function. 
 Neuronal and oligodendrocyte loss after cervical hemisection injury was observed, 
which offers an opportunity for neuroprotective intervention.  
 Microglia/macrophage activation was observed after injury. These findings are 
consistent with other SCI animal models. 
 A substantial loss of phosphorylated neurofilament was observed 3 weeks after 
SCI. 
 Hemisection led to neuroplastic changes in the cervical spinal cord, including 
increased expression of serotonin fibres at the lesion site. 
 In conclusion, our animal model is a reliable animal model to assess the 
pathophysiological mechanisms of cervical SCI and can be used to investigate 
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neuroprotection and neuroplasticity in subsequent work. 
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4 Neuroprotective effect of DHA treatment in 
cervical hemisection SCI 
4.1 Introduction 
4.1.1 Neurological benefits of DHA 
The first study with DHA treatment in traumatic CNS injury used a model of thoracic 
hemisection SCI in adult rats (King et al. 2006). Evidence of neuroprotective potential 
has been provided involving a variety of mechanisms, including anti-inflammatory 
effects through inhibition of the production of proinflammatory cytokines (Endres et al. 
1996),  antioxidant effects (Sarsilmaz et al. 2003), and apoptosis prevention (Martin et 
al. 2002). Both neurons and oligodendrocytes are highly vulnerable to cell death 
following SCI (Bunge et al. 1993). Work in our laboratory has shown that omega-3 
PUFAs have potent neuroprotective effects. In the first of our studies, an intravenous 
bolus of DHA was given 250 nmol/kg 30 min after thoracic hemisection injury (King et al. 
2006). The results showed that DHA can decrease the neuronal cell and 
oligodendrocyte loss, and reduce apoptosis following injury. Then, we studied a more 
severe SCI type, compression injury, in rat thoracic spinal cord (Huang et al. 2007). 
Similar to what was seen in hemisection injury, the DHA treatment reduced neuronal cell 
loss and oligodendrocyte loss. Furthermore, the administration of DHA after injury also 
reduced the activation of microglia and macrophages, which suggested that DHA can 
suppress the inflammatory response. Concerning the axonal injury, we found that DHA 
can decrease the number of injured axons labelled with -APP, which is anterogradely 
transported under normal conditions, but abnormally accumulates in axons following 
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injury (Huang et al. 2007). These histological findings were supported by the improved 
recovery of locomotor function after DHA treatment. In addition, the neuroprotective 
effect of acute DHA treatment (500 nmol/kg) was also demonstrated in another species, 
the mouse, following compression injury (Lim et al. 2013). Following mouse 
compression injury, we found that DHA also reduced neuronal, oligodendrocyte and 
neurofilament loss and suppressed macrophage/microglial activation in both the grey 
and white matter. The promising neuroprotective effects of DHA were also demonstrated 
in other laboratories. Pretreatment with DHA of rats subjected to thoracic contusion SCI 
increases the preservation of axons and survival of   neuronal cells and 
oligodendrocytes (Figueroa et al. 2012). Dietary omega-3 PUFA prophylaxis also 
accelerates bladder recovery, improves locomotor function and ameliorates sensory 
dysfunction (Figueroa et al. 2013). 
 
4.1.2 DHA treatment in cervical SCI 
The neuroprotection effect of DHA was well demonstrated in thoracic SCI rodent animal 
models. However, the majority of reported human injuries occur at cervical level. There 
are several anatomical differences between the thoracic spinal cord and cervical spinal 
cord, such as differences in spinal cord diameter, white/grey matter distribution, the 
degree of vascularization, and the targets of innervation (Pearse et al. 2005). The 
therapeutic effect of DHA in thoracic SCI may not be applicable to cervical SCI. Before 
DHA is tested in clinical trials, it should be validated in a wide range of preclinical SCI 
models, including a cervical SCI model.  
Furthermore, rats do not use their hindlimbs as skillfully as their forelimbs, nor can use 
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of their hindlimb paw and digit be as carefully evaluated as the forelimb paws and digits. 
Compared to thoracic SCI, recovery from forelimb dysfunction offers more general and 
skilled motor movements by which to better assess the efficacy of potential therapies, 
especially mild degrees of improvement (Soblosky et al. 2001).  
 
4.2 Aims 
Confirmation of efficacy in more than one species or model is one of the criteria for 
consolidation of the translational value of a treatment in SCI. Our hypothesis in this 
chapter is that DHA can improve neurological function recovery and histological 
preservation in cervical hemisection animal model. Therefore, the present study was 
designed to further investigate the effects of DHA using a cervical hemisection SCI 
model. The therapeutic effect of DHA was assessed by histological analysis and 
behavioural tests. 
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4.3 Results 
4.3.1 DHA treatment increased neuronal cell survival after spinal cord 
hemisection injury 
Examination of NeuN labelling at 21 days post-injury revealed that rats that received 
DHA treatment after injury had substantially more labelled cells both rostral and caudal 
to the lesion site (Figure 4.1). The quantitative analysis of NeuN positive cells confirmed 
the significant differences; rats in the DHA treatment group had more NeuN labelled 
cells in the region within 1250 μm caudal and rostral to the lesion site (71.3 ± 7.4 
vs.44.3 ± 6.7 caudal to the lesion site, 58.2 ± 5.8 vs. 39.7 ± 11 1250 μm rostral to the 
lesion site, p<0.05 Fig 4.1). There was no statistically significant difference in NeuN-
labelled cells in the more caudal part of the spinal cord between the two groups. The 
results suggest that DHA has a neuroprotective effect in the vicinity of the lesion site. 
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Figure 4-1 Effect of the acute administration of DHA on NeuN staining after rat 
cervical hemisection 
Images show representative neuronal (NeuN) labelling in the cervical spinal cord in the 
vehicle and DHA treatment groups. Scale bar =100 m. Quantification revealed there 
was a significant difference in the epicentre region (*P<0.05). Results represent mean ±
SEM; n=6 animals in each group.  
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4.3.2 DHA treatment has a modest effect on oligodendrocyte survival after spinal 
cord hemisection injury 
In the epicentre of spinal cord lesion, APC-labelled oligodendrocytes were lost in both 
groups. From the images captured from the vicinity of the spinal cord lesion, there 
appeared to be slightly more APC-labelled oligodendrocytes in the DHA treated group 
(Fig. 4.2). Regarding the quantification of APC-labelled oligodendrocytes in the 
perilesional area, there was no significant difference between DHA and the vehicle 
group (Fig 4.2). 
 
4.3.3 DHA treatment ameliorates neurofilament loss 
SMI31 was used to detect phosphorylated neurofilament. At 3 weeks after cervical 
hemisection, rats that received acute DHA administration 30 min after injury had 
substantially more SMI-31 labelled axons in the spinal cord caudal to the lesion site (Fig 
4.3). The quantification of SMI31 positive neurofilament revealed no difference in the 
vicinity of the lesion site (5.9 ± 1.1 vs. 5.1± 0.8 in the lesion site). However, in the spinal 
cord 3000 m below the lesion site, the immunoreactivity of SMI31 in white matter in the 
DHA group was 2 times more than in the vehicle group (9.3 ± 2.0 vs. 4.9 ± 0.8 p< 0.05). 
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Figure 4-2 Effect of the acute administration of DHA on APC staining after rat 
cervical hemisection. 
Images show representative APC labelled oligodendrocytes in the white matter of the 
vehicle and DHA groups. Scale bar = 100 m. Quantification of APC labelled cells 
revealed more oligodendrocyte survival in the epicentre region of the DHA group. 
However, the difference was not significant (p>0.05). Results represent mean ±SEM; 
n=6 animals in each group. 
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Figure 4-3 Effect of the acute administration of DHA on SMI-31 labelling of axons 
after rat cervical hemisection. 
Representative images showed SMI-31 labelled axons at various levels caudal and 
rostral to the lesion site in vehicle and DHA-treated groups. Scale bar=100 m 
Quantification revealed significant differences in the amount of SMI-31 labelled axons 
below the level of 3,000 m caudal to the lesion site between the two groups. Results 
show the mean ± SEM of n=6 animals in each group. 
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4.3.4 DHA treatment decreases microglial staining 
Iba-1 is an antibody commonly used to identify resting and activated microglia in rat 
spinal cord tissue. The micrographs revealed a substantial increase in the size and 
number of Iba-1 cells in both groups (Fig 4.4). Overall, the microglial cell staining was 
higher in the vehicle group than the DHA treatment group, with a significant difference at 
the epicentre (7.6 ± 0.9 vs. 5.7 ± 1.3, p< 0.05). 
 
4.3.5 DHA treatment decreases the lesion size 
GFAP labelling at the spinal cord hemisection site in both groups revealed the lesion 
epicentre as an area devoid of GFAP staining (Fig 4.5). The lesion extended from the 
midline to the lateral edge of the spinal cord. Quantitative analysis showed that the DHA 
treatment reduced the lesion size by 50% compared to the vehicle group, but the 
difference did not reach statistical significance. 
  
132 
 
 
 
Figure 4-4 Effect of the acute administration of DHA on activated microglia after 
rat cervical hemisection SCI.  
Images show Iba-1 immunoreactive cells at various levels rostral and caudal to the 
lesion site in vehicle and DHA-treated groups. Scale bar=100 m. Quantification 
revealed there was a significant difference in the epicentre region (*P<0.05). In the DHA 
treatment group, the Iba-1 immunostaining was lower than in the vehicle group. Results 
represent mean ±SEM; n=6 animals in each group. 
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Figure 4-5 Effect of DHA treatment on lesion size 
(A) GFAP stained spinal cord sections from vehicle and DHA treated rats show a 
difference in lesion size and morphology. In DHA treated rats, the lesion margin was 
well defined compared to vehicle group. Scale bar = 100 m (B) Quantification revealed 
DHA decreased the lesion size, but there was no significant difference (p=0.133 >0.05) 
vs. vehicle treated rats. Results represent mean ±SEM; n=6 animals in each group. 
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4.3.6 DHA treatment improves locomotor behaviour recovery 
To determine the general ability of the animals to use their forelimbs and hindlimbs, all 
animals were tested in the open field test 1 day after cervical spinal cord hemisection. 
The animals treated with DHA had the best locomotor outcome overall (Fig 4.6). The 
ANOVA analysis revealed that there was a significant treatment effect within the first 
week after cervical hemisection, especially significant on days 1, 2, and 3 on BBB 
scores, and days 1 and 2 on FLS scores. In general, all animals recovered gross 
hindlimb and forelimb motor function within 2 weeks with and without treatment, which is 
comparable with other studies (Wang et al. 2011; Khaing et al. 2012). However, the 
quantitative data revealed a trend showing that rats treated with DHA had higher scores 
in FLS and BBB than the vehicle control group, and maintained their improvement until 
the end of the study. 
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Figure 4-6 The effect of treatment with DHA on locomotor recovery after cervical 
hemisection SCI 
Statistical analysis showed that DHA treated animals had significantly higher scores on 
ratings of hindlimb locomotor use in the open field BBB test than the vehicle group 
during the first, second, and third day after surgery. The FLS revealed a significant 
difference during the first and second day after surgery. Results represent mean ±SEM; 
n=6 animals in each group. 
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4.3.7 DHA treatment improved skilled forelimb function 
To assess skilled forelimb motor function, the dexterity of the affected forepaw was 
examined using the staircase test. All animals received training on the staircase task 
before injury, and only animals that performed successfully on the staircase (successful 
retrieval of 6 out of 7 food pellets) were included in the study. We used two parameters 
to assess the forepaw function: the number of food pellets eaten and the number of 
pellets that were displaced but not eaten by rats.  
Concerning the number of pellets retrieved, one day after SCI injury, all rats 
demonstrated a marked drop in grasping performance and in the number of food pellets 
retrieved. After one week post injury, food pellets were displaced but not eaten in the 
DHA treatment group (Fig. 4.7). Two weeks later, significantly more food pellets were 
eaten by the DHA treated rats compared to the vehicle control group (0.88 ± 0.6 vs. 0 ± 
0, p<0.05 Fig. 4.7). Grasping performance gradually improved in the DHA-treatment 
group, and this was significant after 20 days post-injury. On the last testing day, the 
animals treated with DHA seemed to still follow a trajectory of improvement. 
4.3.8 DHA treatment improved skilled locomotion  
During the 3 week period after cervical hemisection, the grid exploration test was used 
to assess skilled locomotor function. In the grid exploration test, all the animals 
gradually recovered forelimb placement 1 week, 2 weeks, and 3 weeks following SCI. A 
significant difference was observed in limb misplacement between the DHA treated 
group and the vehicle group (Fig. 4.8). The animals with DHA treatment exhibited 
significantly fewer misplacements than the vehicle group in both forelimb and hindlimb 
at 1, 2 and 3 weeks post-injury. 
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Figure 4-7 Effect of DHA treatment on skilled forelimb function. 
Skilled forelimb function was assessed by the Montoya staircase test. (A) All animals 
lost the ability to retrieve the food pellet after cervical hemisection. The animals treated 
with DHA gradually recover food retrieval ability. A significant difference was observed 
between the groups. (B) Displacement indicates that the rat had the ability to reach the 
food pellet, but failed to put the food pellet into their mouth. Quantitative analysis shows 
that the animals in DHA treatment group have more ability to displace the food pellet. * 
P<0.05, ** P<0.01, *** P<0.001 DHA vs. vehicle group. Results represent mean ±SEM; 
n=8 animals in each group. 
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Figure 4-8 Effect of cervical hemisection SCI on skilled locomotor movement 
Skilled locomotion was evaluated by grid exploration test 1, 2 and 3 weeks after cervical 
hemisection. After injury, the animals treated with DHA made significantly fewer forelimb 
and hindlimb mistakes compared to animals receiving saline injection. Quantification of 
left forelimb and hindlimb misplacement shows the number of misplacements is 
significantly higher in the vehicle group than in the DHA treatment group (* P<0.05). 
Results represent mean ±SEM; n=6 animals in each group. 
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4.3.9 DHA treatment dose not promote functional recovery when administrated 
in the subacute phase of SCI 
To investigate the effect of DHA on skilled forelimb function in the subacute stage 
following SCI, DHA was administered via tail vein injection 3 weeks following cervical 
spinal cord hemisection. Skilled forelimb and hindlimb function was assessed by the 
Montoya staircase test and the grid exploration test. In the Montoya staircase test, all 
rats lost the ability to retrieve the food pellets after cervical SCI. Sixty-two days after 
SCI, the DHA-treated group still cannot regain the ability to eat or displace more food 
pellets than the vehicle group (Fig 4.9). In the grid exploration test, the results showed 
no significant difference in misplacements made (left forelimb and hindlimb) between 
the two groups, before and after DHA injection (Fig 4.10). Therefore, there is no 
therapeutic effect of the DHA treatment delivered at the subacute stage in cervical SCI. 
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Figure 4-9 Delayed DHA treatment does not promote improved forelimb skilled 
functional recovery 
 (A,B) In the Montoya staircase test, all injured animals lost the ability to displace (gross 
motor function) and eat (fine motor function) the food pellet after cervical lateral 
hemisection, from 2 days post injury. The animals treated with either vehicle (blue 
square) or DHA (red circle) at 3 weeks post injury did not significantly recover food 
retrieval ability in comparison to uninjured sham operated animals. Results represent 
mean ±SEM; n=5-6 animals in each group. 
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Figure 4-10 Delayed DHA treatment does not improve skilled locomotor recovery 
DHA treatment was given 3 weeks after cervical spinal hemisection. In the grid 
exploration test, there are no significant differences in left forelimb (A) and hindlimb (B) 
misplacements between the vehicle and DHA-treated group during the period of 
behavioural assessment. Results represent mean ±SEM; n=6 animals in each group. 
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4.4 Discussion 
Previous work in our laboratory has shown the neuroprotective effect of DHA treatment 
in a thoracic SCI animal model (King et al. 2006; Huang et al. 2007; Lim et al. 2013). 
This study demonstrates for the first time that DHA has a neuroprotective effect in a 
cervical SCI animal model. In the histology results, we showed that DHA treatment 30 
min after hemisection leads to a decreased lesion size, an increased neuronal cell 
number, and reduced microglial cell activation. In behavioural assessment, locomotor 
function and skilled forelimb movement significantly improved after DHA treatment. 
 
4.4.1 Doses, timing and administration route of DHA after cervical SCI 
For the purpose of clinical translation, a rapid delivery of neuroprotective agents is 
required after injury. Acute intravenous administration is adequate for this setting. The 
chosen timing and dose of DHA administration was based on previous studies from our 
laboratory showing functional improvements after SCI (King et al. 2006; Huang et al. 
2007). The acute administration of DHA at a dose of 250 nmol/kg given 30 min after 
injury improves neurological function in a thoracic hemisection SCI. In a pilot study, no 
clear dose-dependent effect was seen with the bolus of DHA post-SCI, and no overt 
toxicity appeared up to DHA 2500 nmol/kg injected 1 hour after SCI (Huang et al. 2007). 
However, the beneficial effects of DHA were lost if the administration of intravenous 
DHA was delayed from 30 min to 3 hours after thoracic hemisection (Huang et al. 2007) 
or 3 weeks in my animal model (Fig 4.9). This suggests that a bolus administration of 
DHA only works during an early critical time window. The possible underlying 
mechanism will be discussed in Chapter 6. 
143 
 
4.4.2 Histological changes after DHA treatment 
The lesion size after cervical hemisection SCI was reduced after DHA treatment. The 
reduction in lesion size is likely to be partly because of decreased cell death, consistent 
with our finding of more survival of neuronal cells and oligodendrocytes in the 
perilesional area following DHA treatment. Cell death after SCI involves both necrosis 
and apoptosis. Some studies have demonstrated that DHA reduces apoptosis after SCI 
(Lang-Lazdunski et al. 2003; King et al. 2006). Two main apoptosis signaling pathways 
have been described following SCI. One pathway is initiated by mitochondrial 
dysfunction, which is caused by ATP depletion, hypoxia or oxidative stress. Cytochrome 
c is released from mitochondria and activate caspase-9 pathway (Saikumar et al. 1998). 
The intrinsic pathway is mainly regulated by Bcl-2 and Bax, which are anti- and 
proapoptotic proteins, respectively (Saikumar et al. 1998). Of note, DHA can be  
catabolized to produce neuroprotective catabolites such as neuroprotectin D1 (Bazan 
2005). DHA or neuroprotectin D1 can increase neuronal cell survival by upregulating the 
Bcl-2 family of antiapoptotic proteins, and downregulating caspase-3 and caspase-9, 
apoptotic proteins (Lukiw et al. 2008; Paterniti et al. 2014). Another well-established 
apoptosis pathway involves signaling by the TNF receptor family, including TNFR1, Fas 
ligand and p75. When these receptors are ligated, they recruit and proteolytically 
activate the initiator caspase-8 (Ashkenazi et al. 1998), which produces apoptotic cell 
death. These death receptors are upregulated in neurons, microglia, and 
oligodendrocytes after injury such as SCI (Li et al. 2000; Casha et al. 2001; Beattie et 
al. 2002). Several studies have demonstrated that DHA treatment can modulate the 
expression of TNF receptors, which may contribute to the regulation of cell apoptosis 
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(Moghaddami et al. 2007; Ebert et al. 2009; Paterniti et al. 2014). It can be 
hypothesized that DHA is able to attenuate apoptotic cell death through the intrinsic 
pathway. 
 
From the current experimental data, we have found that DHA suppresses microglial 
activation after SCI. Macrophages express multiple phenotypes, with corresponding 
functions in tissue repair or damage (David et al. 2011). Activated microglia in the 
injured spinal cord produce various pro-inflammatory cytokines, proteases and other 
factors that are cytotoxic. Microglia express mRNA for IL-1after SCI (Pineau et al. 
2007). Intrathecal infusion of IL-1 receptor antagonist for 72 hours after SCI in rats 
markedly reduced apoptosis related to injury (Nesic et al. 2001). Furthermore, anti-
inflammatory treatment with minocycline or FK506 reduced the microglial activation and 
lesion size after injury, and contributed to functional recovery (Stirling et al. 2004; 
Lopez-Vales et al. 2005). The detrimental effects of microglia may be explained by the 
fact that microglial activation is linked to increased expression of the inducible isoform of 
nitric oxide synthase (iNOS). Microglia can kill neurons through formation of superoxide 
and nitric oxide (Kaushal et al. 2007). It has been shown that DHA is an endogenous 
ligand for RXR (de Urquiza et al. 2000) and PPARs (Grygiel-Gorniak 2014). After SCI, 
activated microglia express the retinoic acid receptor (Mey et al. 2005). RXR agonist (9-
cis-retinoic acid) has been shown to suppress the lipopolysaccharide-triggered 
inflammatory response of microglia and astrocytes in vitro (Xu et al. 2006). In addition, 
PPARγ activation can also induce apoptosis of activated macrophages (Chinetti et al. 
1998) and reduce the differentiation of monocytes into macrophages (Combs et al. 
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2000). Thus, DHA may alleviate the inflammatory response by modulating the response 
of reactive microglia. 
 
Neurofilament is present in neuronal cell bodies and axons in both phosphorylated and 
non-phosphorylated forms (Pant et al. 2000; Liu et al. 2004). Its phosphorylation state 
plays a crucial role in the regulation of its function and is vital in its degradation following 
CNS injury. A subunit of Phosphorylated neurofilament has used to evaluate the severity 
of SCI in patients (Hayakawa et al. 2012). In order to examine axonal pathology, a 
neurofilament marker was used (SMI31) to evaluate phosphorylated neurofilament 
expression following injury. In our previous study, DHA administration can significantly 
reduce the loss of non-phosphorylated neurofilament after compression SCI (Ward et al. 
2010; Lim et al. 2013). In agreement with our previous observations, we showed here 
that a significant decrease in neurofilament occurred after cervical hemisection (chapter 
3), and the loss of neurofilament was significantly reduced after DHA treatment in the 
cervical spinal cord caudal to the lesion site. 
 
At the lesion site, although a neuroprotective effect of DHA on neuronal cells was 
observed, there appeared to be no obvious increase in the number of oligodendrocytes 
and SMI-31 positive neurofilaments in rats treated with DHA. These findings are 
different from observations in the thoracic SCI animal model. The reason for this 
discrepancy is not clear but may be due to the severity and extent of lesion 
(compression injury vs. hemisection injury). Our lesion size made by hemisection is 
smaller than the lesions made by compression or contusion injury. If the severity of the 
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primary injury is limited, this diminishes the extent of secondary injury in SCI. Another 
possible explanation is that dephosphorylated neurofilament, which was evaluated in 
our previous studies, is more vulnerable to injury-induced proteolysis than the 
phosphorylated form (Schumacher et al. 2000). DHA may exert more neuroprotection 
on dephosphorylated neurofilament compared to phosphorylated neurofilament.  
 
Concerning protection of oligodendrocytes, an in vitro study demonstrated that DHA is 
necessary to protect oligodendrocytes against hydrogen peroxide-induced cell death, 
and neuronal glutathione activity is increased by supplementation with DHA (Brand et 
al. 2008). DHA treatment significantly increased oligodendrocytes survival in thoracic 
SCI models (Huang et al. 2007; Lim et al. 2013). However, it appears that DHA had a 
limited neuroprotective effect on oligodendrocytes in my animal model. One factor that 
should be taken into consideration is the anatomical variance between cervical spinal 
cord and thoracic spinal cord. The ratio between gray matter and white matter is higher 
in cervical spinal cord. This means that fewer oligodendrocytes were involved per 
cervical spinal cord cross section compared to the thoracic spinal cord, which could 
result in no significant effect of DHA due to the lower number of oligodendrocytes. 
 
4.4.3 Behavioural recovery after DHA treatment 
Accurate behavioral assessment is an important part of developing SCI repair 
strategies. Open field tests are user-friendly and widely used. In thoracic SCI, DHA 
treatment has been shown to improve locomotor function recovery in rodent animal 
models (Huang et al. 2007; Lim et al. 2013). In our open field tests, the rats treated with 
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DHA showed significant improvement within one week. However, the recovery of 
vehicle-treated rats was very comparable to that in rats with DHA treatment one week 
after cervical SCI. This result is different from the finding in thoracic SCI animals, in 
which DHA can improve hindlimb locomotor function at the end point of the experiment. 
The development of the BBB scoring system has enabled researchers to efficiently and 
reproducibly evaluate the locomotor abilities of thoracic spinal cord injured rats (Basso 
et al. 1996). One study reported that a hemisection of the rat spinal cord at thoracic 
level affected the hind limbs more severely than a cervical hemisection (Webb et al. 
2002). The cervical hemisection resulted in the same BBB score as sham animals 40 
days following injury. However, the BBB scores showed a significant difference between 
a thoracic hemisection group and the sham group. When a quantitative and more 
stringent analysis was used, significant alterations in the gait of rats with either a 
cervical or a thoracic hemisection were observed for up to 6 weeks post-surgery. This 
may result from the difficulty of detecting quantitative differences in a relatively non-
challenging locomotor task and because the animals recover a substantial amount of 
their locomotor abilities following unilateral cervical hemisection. We also should keep in 
mind the fact that the methods used for evaluating thoracic spinal cord injured animals 
may not be optimal for cervical spinal injured animals.  
 
It is not clear what the underlying changes are that produce this pattern of recovery. The 
recovery of locomotor ability may be due to spared pathways originating from 
supraspinal and propriospinal structures which can play an active role in the recovery 
process, and also in restoring some voluntary control (Rossignol et al. 2011). Another 
148 
 
possible mechanism contributing to functional recovery is the formation of new circuits. 
The new circuits could result from new anatomical connections (new circuits) or from 
enhanced connectivity (enhancing existing circuits). A more detailed discussion of this 
topic will be given in Chapter 5. 
 
An attempt was made to analyze functional recovery in more detail. We employed the 
Montoya staircase test and grid exploration test to examine the skilled forelimb and 
hindlimb function on the lesion side. Notably, our results demonstrate that DHA is able 
to enhance skilled functional recovery. In the staircase test, in order to fully demonstrate 
voluntary forelimb functionality and dexterity, animals were required to grasp food 
pellets to eat. Improvement in both food pellets displaced and pellets eaten revealed a 
significant difference between the vehicle and DHA-treated groups at the end point of 
the test. In the grid exploration test, a significant difference in limb misplacement was 
observed in the control group compared with the DHA treated group throughout the 
behavioural testing period. As opposed to the relatively stereotyped locomotor 
movement, skilled locomotion requires (1) the ability to rapidly adjust muscle length and 
tension, (2) a high degree of intra- and interlimb coordination, and (3) the ability to 
voluntarily and rapidly adjust portions of the step cycle (Webb et al. 2005).  
In summary, DHA treatment can significantly improve functional recovery on skilled 
tasks. 
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4.4.4 Correlation between functional outcome and histological assessment after 
SCI  
Several studies have demonstrated a strong correlation between locomotor function and 
the amount of spared grey and white matter following thoracic SCI (Joshi et al. 2002; 
Kurita et al. 2005). In our study, we assessed the locomotion recovery after cervical SCI 
by using the FLS score, which has recently been shown to correlate with the extent of 
spared tissue at the epicenter of the lesion following cervical SCI (Singh et al. 2014). 
Our FLS score results demonstrating that DHA treated animals achieve better results 
than the vehicle group may be due to DHA producing a reduced lesion size and more 
neuronal cells survival. Furthermore, during the locomotor test, the neurons at C4-5 
level are responsible for the ―forelimb duty factor‖, which represents the percentage of 
the total step cycle that was in stance phase (calculated as stance time / cycle time). 
C4/C5 right hemisection SCI rats have significantly different forelimb stride lengths and 
locomotor step cycle (Neckel et al. 2013). To address this issue in our animal model, 
further studies on detailed gait parameters would be valuable. 
 
Another interesting histological finding after cervical hemisection is the substantially 
increased SMI-31 positive axons in the spinal cord caudal to the lesion site. This result 
implies that there is more neurofilament below the lesion site. Several studies have 
demonstrated that the recovery of skilled movement is positively related to the amount 
of axonal innervation, especially by the CST (Metz et al. 2002; Bareyre et al. 2004). The 
increase in axons in the DHA group suggests that DHA can either prevent progress of 
demyelination or promote axonal sprouting from the contralateral side. This possibility 
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will be explored further in the next chapter.  Regarding the correlation between the 
number of SMI31 positive neurofilaments and the recovery of skilled forelimb task, there 
is no significant difference (see appendix, Figure 1). 
 
Compared with the sham operation group, our immunohistochemical study showed that 
hemisection reduced 5-HT fiber intensity in ipsilateral spinal cord caudal to the lesion 
site. However, hemisection also resulted in an extraordinary increase in the 5-HT 
intensity rostral to the lesion one week after hemisection. 3 weeks after hemisection, 
serotonin immunoreactivity recovered to baseline levels in the caudal part of the spinal 
cord. A significant elevation in serotonin fibres still was found in the spinal cord rostral to 
the lesion site. The finding of a recovery in serotonin intensity caudal to lesion site is 
supported by previous investigations in thoracic spinal cord hemisection animal models 
(Saruhashi et al. 1996; Hains et al. 2002; Saruhashi et al. 2009) 
 
4.5 Summary 
 Our observations provide evidence that acute DHA administration has therapeutic 
potential in cervical SCI 
 Acute DHA treatment increased the number of neuronal cells and axons in the 
spinal cord following cervical hemisection injury 
 Acute DHA treatment reduced the microglial response after SCI 
 Behavioural tests showed significantly improved skilled forelimb movement with 
DHA treatment 
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5 Effect of DHA treatment on neuroplasticity in rat 
cervical hemisection and mouse pyramidotomy 
SCI models 
5.1 Introduction 
It is now well established that the central nervous system is capable of substantial 
reorganization in cases of incomplete SCI, as cortical, subcortical and much of the local 
spinal cord circuitry remains intact and partially interconnected through spared axonal 
pathways (Raineteau et al. 2001). In view of such a potential for neuroplasticity, a 
variety of techniques employing pharmacological (Bradbury et al. 2002; Vavrek et al. 
2006) or sensorimotor stimulation (Hoffman et al. 2007) have been developed to 
promote functional recovery. 
DHA has been shown to induce significant functional improvements following spinal 
cord injury (SCI) (King et al. 2006; Huang et al. 2007; Figueroa et al. 2013; Lim et al. 
2013). The studies with omega-3 fatty acids in CNS traumatic injury have focused 
mainly on their neuroprotective potential. However, the beneficial effects of DHA after 
central neurological injury could also be related to promoting neuroplasticity. Several 
studies have demonstrated that DHA increases maximum neurite length and the total 
number of neurites in embryonic hippocampal and cortical neurone cultures (Calderon 
et al. 2004; Cao et al. 2005), as well as in primary sensory neurons (Robson et al. 2010). 
In animal studies, oral DHA has been shown to promote the synthesis of components of 
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synaptic membranes and specific presynaptic and postsynaptic proteins (Wurtman et al. 
2006) and improve brain learning involving synaptic plasticity (Wu et al. 2008). In my 
animals with acute DHA administration, it remains to be established whether the 
neurological functional recovery is due to neuroprotection only or also reflects increased 
axonal plasticity or synaptogenesis following DHA treatment. 
In this study, the neuroplasticity effects of DHA after cervical hemisection are examined 
in more detail. Furthermore, in order to determine whether DHA can promote axonal 
sprouting in another animal species and model, we carried out pyramidotomy in mice to 
explore this possibility. There are several advantages to using pyramidotomy to 
examine structural plasticity. Compared to spinal cord lesion, a lesion of the pyramidal 
tract in the brainstem is more likely to spare other spinal tracts and spinal neuronal 
structures. In this model, we can investigate the axonal growth and the neurological 
functional recovery in response to a complete unilateral CST lesion. Without spinal cord 
tissue damage, we can avoid the confounding neuroprotection effects of DHA treatment.  
Any recovery of motor function following pyramidotomy is therefore likely mainly to be 
due to neuroplasticity. 
5.2 Aims 
The hypothesis in this chapter is that DHA can improve neurological recovery by 
promoting axonal sprouting and synaptic function. The aim of the study presented in this 
chapter was to assess the neuroplasticity effect of an acute i.v. administration of DHA in 
(1) rat cervical hemisection and (2) mouse pyramidotomy. In both models, we studied 
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the effect of DHA treatment on skilled motor function and also on tissue neuroplasticity 
markers. 
5.3 Results 
5.3.1 DHA treatment increases synaptic terminals in the spinal cord caudal to 
lesion site after SCI 
Synaptophysin, a synaptic vesicle protein in presynaptic axons, represents a reliable 
marker for the quantification of synapses in CNS tissue (Calhoun et al. 1996) and has 
been used previously as a marker to show modification in neuronal circuitry (Mitsui et al. 
2005). Synaptophysin is known to play an essential role in activity-dependent synapse 
formation (Spiwoks-Becker et al. 2001; Tarsa et al. 2002). Synaptophysin 
immunoreactive boutons provide an efficient way to visualize synaptic profiles within the 
CNS, and synaptophysin immunostaining has been used widely to estimate an increase 
or decrease in synaptic contacts at light microscopic level (Toggas et al. 1996; Jeffrey et 
al. 2000; Zang et al. 2005). Synaptic terminals were examined by synaptophysin 
immunostaining 3 weeks after SCI. In the cervical spinal cord caudal to the lesion site, 
synaptophysin immunoreactive terminals were significantly increased in the DHA 
treatment group compared to the vehicle group ( at 1250 m caudal to lesion site (Fig 
5.1). We also used Western blotting to quantify the synaptophysin protein levels in the 
cervical spinal cord 3 weeks following injury in order to verify our immunostaining 
findings (Fig 5.2). 
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Figure 5-1 Effect of DHA treatment on synaptic terminals after cervical 
hemisection in the rat  
Photomicrographs showing immunocytochemical labeling of synaptophysin in different 
regions of longitudinal sections of the cervical segment of the spinal cord following 
hemisection. Scale bar =100 m. Analysis of synaptophysin immunoreactivity revealed 
significantly more synaptic terminals in the DHA treated group (red circles) and sham 
operated group (green triangles) compared to the vehicle treated group (blue squares) 
caudal to the lesion site. * P<0.05 DHA vs. vehicle group, † P<0.05 sham vs. vehicle 
group. # P<0.05 sham vs. DHA group. Results represent mean ±SEM. n=6 animals per 
group. 
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Figure 5-2 DHA increases synaptophysin in the spinal cord caudal to the lesion 
site. 
Western blot analysis using 3-tubulin as standard control showed that DHA increases 
synaptophysin protein in the spinal cord 0-3 mm, 3-6 mm caudal to the lesion site. R3 
represents 6-9 mm rostral to lesion site. R2 represents 3-6 mm rostral to lesion site. R1 
represents 0-3 mm rostral to lesion site. C1 represents 0-3 mm caudal to lesion site. C2 
represents 3-6 mm caudal to lesion site. C3 represents 6-9 mm caudal to lesion site. 
Results represent mean ±SEM; n=2 animals in each group. 
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5.3.2 DHA increases synaptic boutons contacting motor neurons in the cervical 
spinal cord 
Goat anti-Choline Acetyltransferase (ChAT) antibody was used to localize the motor 
neurons in ventral horn 5 mm caudal to lesion site that affect forelimb motor function 
after SCI. Further analysis revealed that DHA treatment increased the amount of 
synaptophysin protein in boutons around motor neurons in the cervical spinal cord 
ventral horn 2mm caudal to lesion site after hemisection (Fig 5.3), which could correlate 
with neurological functional recovery.  
 
Figure 5-3 Effect of DHA on synaptic boutons contacting motor neurons 
(A,B) Images showing the difference in the density of contacts between synaptophysin 
terminals and ChAT motor neurons in DHA and vehicle groups. Scale bar =100 m (C) 
Quantitative analysis confirmed the increase in density of synaptophysin contacts on 
ventral horn motor neurons in DHA treated rats. * P<0.05 DHA vs. vehicle group. 
Results represent mean ±SEM; n=6 animals in each group. 
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5.3.3 DHA treatment increases serotonin fibres ipsilateral to the lesion  
The spinal serotonergic pathway plays an essential role in modulating and triggering 
neuronal activity in the spinal cord (Ciranna 2006; Jordan et al. 2008). Quantification of 
cervical spinal cord serotonin immunoreactivity in the DHA treatment group and the 
vehicle group 21 days following cervical hemisection is shown (Fig 5.4). A dramatic 
increase in serotonin axons was observed in the spinal cord rostral to the lesion site in 
both groups. There was a significant difference between the two groups caudally. In the 
DHA treatment group, serotonin axons were more abundant than in the control group in 
the caudal part of the spinal cord. 
 
5.3.4 DHA increases serotonin contacts with motor neurons 
In addition to measuring the global immunoreactivity through the whole cervical spinal 
cord in longitudinal sections, I also assessed the density of 5-HT containing terminals 
contacting individual motor neurons, in order to provide more information on a specific 
site related to motor function recovery. 
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Figure 5-4 Effect of DHA treatment on serotonin terminals 
Photomicrographs of serotonin immunofluorescence in representative sections of a 
vehicle and DHA treatment group. Compared to the vehicle group, a higher staining 
intensity was observed. The area occupied by serotonin axons was quantified in both 
groups. Scale bar =100 m. The data revealed that serotonin fibres both rostral and 
caudal to the lesion site were significantly increased in the DHA treatment group 
compared to the vehicle group (*P<0.05). * P<0.05 DHA vs. vehicle group, † P<0.05 
sham vs. vehicle group. # P<0.05 sham vs. DHA group. Results represent mean ±SEM. 
n=6 animals per group. 
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Figure 5-5 DHA enhances serotonin fibres surrounding motoneurons  
(A,B) Images show the difference in density of contacts between serotonin (5-HT) 
immunopositive terminals (green) and choline acetyltransferase immunopositive motor 
neurons (red) in DHA- and vehicle-treated groups. Scale bar =100 m. (C) Quantitative 
analysis confirmed the increase in density of serotonin contacts on ventral horn motor 
neurons in DHA treated rats (red bar) compared to vehicle treated animals (blue bar). * 
P<0.05 DHA vs. the vehicle group. Results represent mean ±SEM. n=6 animals per 
group 
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5.3.5 DHA treatment increases sprouting of CST axons at a lesion site 
BDA was unilaterally injected into the ipsilateral hemisphere to anterogradely label 
intact CST axons and collaterals in rats following cervical spinal hemisection (Fig.5.6). 
Sprouting fibres in the grey matter on the lesioned side could be detected by 
immunofluorescence. DHA treated animals had increased CST collateral sprouting on 
the lesion side, which was significantly higher at the spinal cord level 1 mm caudal to 
the lesion site. In contrast, the vehicle group had only a few BDA-labelled CST axons in 
the grey matter of the lesioned side (Fig. 5.6). DHA treated animals also had increased 
CST axons on the unlesioned side (Fig. 5.6). 
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Figure 5-6 Effect of DHA treatment on corticospinal axons sprouting in cervical 
hemisection rats. 
(A,B) Photomicrographs of horizontal sections 1500 m caudal to the lesion site reveal 
more sprouting of CST axons across the midline to the lesion side in the DHA treatment 
group. Scale bare =100 m. (C,D) Quantification of labelled CST fibres after spinal cord 
lesion showed a significant increase in the spinal cord caudal and rostral to the lesion 
site on the lesion side (C) and increase in the spinal cord rostral to the lesioned site on 
unlesioned site (D). * P<0.05, ** p< 0.01 DHA vs. the vehicle group. Results represent 
mean ±SEM. n=5-6 animals per group 
163 
 
 
5.3.6 Effect of DHA in unilateral pyramidotomy 
In order to determinate whether DHA can promote axonal sprouting in another animal 
species and model, BDA was injected into the contralateral hemisphere in mice 
receiving a right unilateral pyramidotomy (Fig.5.7). Adult mice with a unilateral 
pyramidotomy were injected with a single bolus of DHA (500 nmol/kg) or vehicle (saline 
with 0.2% ethanol) 30 min after injury. A higher dose of 500 nmol/kg was used in mice 
compared to 250 nmol/kg used in rats based on our previous published data due to 
species and metabolic differences (Lim et al. 2013). 
5.3.7 DHA treatment increases sprouting axons  
BDA was injected in the sensory-motor cortex ipsilateral to lesion site four weeks 
following pyramidotomy. A significant increase in the number of sprouting axons was 
detected in the DHA treatment group compared to the vehicle group (Fig. 5.8) 
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Figure 5-7 Pyramidotomy in mice 
(A) Ventral view of the brainstem of mice following pyramidotomy, showing a unilateral 
lesion of the CST running in the medullary pyramids. The arrow indicates the 
transection site in the right pyramidal tract. (B) Loss of PKCγ immunostaining in the 
main portion of the tract in the dorsal funiculus of the cervical spinal cord confirms lesion 
of the CST. Scale bare =100 m. (C) The intensity of PKCγ immunostaining of the 
bilateral CST in the cervical spinal cord revealed a significant decrease on the lesion 
side (left) after pyramidotomy compared to the sham operation group. However, there 
was no significant difference in PKCγ staining between the DHA and vehicle group. 
Results represent mean ±SEM; n=6 animals in each group. 
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Figure 5-8 DHA treatment increases CST axonal sprouting in mice following 
pyramidotomy 
Transverse sections of the cervical spinal cord reveal CST fibres sprouting from the 
contralateral side after pyramidotomy in both the vehicle (B) and DHA (C) treated 
groups. Scale bar =100 m. (A) Quantitative analysis of midline crossing fibres showed 
that the DHA-treated group had significantly more midline crossing fibres in the CST-
denervated side of the cervical spinal cord compared to vehicle and sham groups. 
Results represent mean ±SEM; n=4-5 animals in each group. 
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5.3.8 DHA treatment improved skilled locomotor activity 
In addition to the analysis of CST sprouting fibres, a behavioural test was performed to 
determinate if the increased sprouting fibres are associated with functional recovery. 
During the 4-week period after CST injury, the grid exploration test was used to assess 
sensorimotor function in vehicle and DHA treated mice. No difference was detected 
between the groups in forelimb grid exploration in the first week (Fig. 5.9 A). The poor 
performance of the affected forelimb is likely due to failure of CST re-innervation in both 
groups. However, 2 weeks after injury, DHA-treated mice had fewer misplacements 
compared with the vehicle group. A significant difference between the two groups was 
found 3 weeks after injury. In the hindlimb grid exploration test (Fig. 5.9 B), fewer 
misplacements were observed in the DHA treated group compared with the vehicle 
group throughout the behavioural testing period.  
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Figure 5-9 Effect of DHA on behavioural recovery in mice following pyramidotomy 
(A) Mice failed to accurately grasp the rungs of the grid with the left (lesioned CST) 
forepaw following pyramidotomy in both groups in the first week. However, the DHA 
treated mice made significant fewer errors 3 weeks following pyramidotomy. (* P< 0.05) 
(B) Quantification reveals that DHA treated mice made fewer footslip errors with their 
left hindpaw than vehicle group animals throughout the testing period. Results represent 
mean ±SEM. n=5 animals per group. 
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5.3.9 Sprouting CST axons contact interneurons  
A major question raised by the findings that DHA promoted sprouting of CST fibres is 
the functional relevance of these anatomical changes. According to a previous study, 
sprouting CST fibres may contact propriospinal interneurons following SCI. These new 
contacts are maintained on propriospinal interneurons that project past the lesion and 
form a circuit that allows transmission of descending signals below the lesion (Bareyre 
et al. 2004; Flynn et al. 2011). Recently, a group of ventrally located neurons was 
designated V2a interneurons. This group of interneurons play a key role in maintaining 
locomotor rhythmicity and in ensuring appropriate left–right alternation and firing of 
ipsilateral motor neurons during locomotion (Cowley et al. 2008; Dougherty et al. 2010). 
The V2a interneurons constitute a subpopulation of the V2 class and express Chx10. 
The Chx10 neurons are exclusively glutamatergic and project ipsilaterally (Al-Mosawie 
et al. 2007). However, previous studies did not provide any information about the 
relationship between the innervation of the Chx10 population and the recovery of skilled 
locomotor function after SCI. Using immunohistochemistry, V2a interneurons in the 
spinal cord could be identified using a Chx10 antibody (Fig 5.10). Double 
immunolabelling revealed that sprouting CST fibres appeared to contact V2a 
interneurons. Confocal analysis of selected sections confirmed that some CST fibres 
made contacts with Chx10 immunoreactive cell bodies, revealed using blue fluorescent 
Nissl staining (Fig 5.11). 
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Figure 5-10 V2a interneurons express the transcription factor Chx10. 
(A) A transverse section of mouse cervical spinal cord showing Chx10 positive cells 
located in lamina X. Chx10 immunoreactivity is present in the nuclei of V2a-derived 
interneurons (arrows in the inset). (B) Blue Nissl staining labelled all neurons in the 
spinal cord. (C-D) With BDA labelling, some Chx10 cells were seen to be contacted by 
CST axons (arrows). 
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Figure 5-11 Confocal images of mouse cervical spinal cord transverse sections 
Representative images showing examples of BDA-labelled CST collaterals (green) in 
the vicinity of blue fluorescent Nissl stained cells (Neurotrace 435/455), some of which 
are V2a interneurons identified by immunostaining for Chx10 (red). The dashed boxes 
in panels A are shown at higher magnification in B and C, which reveal contacts (arrows) 
between BDA-labelled collaterals and Chx10 interneurons (asterisks). (A) A Z-stack 
comprising 10x 0.66 µm optical images. (B) A Z-stack, comprising 25 x 0.72 µm optical 
images) and (C) a single 0.72 µm optical image. 
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5.3.10 DHA treatment increased the number of interneurons contacted by 
sprouting CST fibres 
In order to identify possible targets of the CST sprouting and circuitry that could 
contribute to locomotion recovery, we carried out specific staining for V2a interneurons, 
which are responsible for locomotion control and coordination in mice (Al-Mosawie et al. 
2007; Dougherty et al. 2010). Immunostaining of Chx10 labelled V2a interneurons in 
spinal cord transverse sections revealed that BDA-labelled sprouting CST fibres contact 
more V2a interneurons in the DHA treatment group than in saline controls (Fig.5.12 A). 
In addition, we also examined the correlation between the number of Chx10 cells 
contacted by CST axons and forelimb misplacement. We found that higher numbers of 
Chx10 cells contacted by CST axons correlated with less forelimb misplacement (Fig 
5.12 B). 
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Figure 5-12 DHA treatment increases the number of interneurons contacted by 
sprouting CST axons 
 (A) Analysis revealed a significant increase in the number of Chx10 interneurons 
contacted by BDA-labelled CST collaterals following DHA treatment (red bar) compared 
to vehicle treatment (blue bar). (B) A strong negative correlation was observed between 
the numbers of Chx10 interneurons with BDA-labelled CST contacts and the numbers 
of forelimb misplacements. Data was taken from DHA treated (red circles) and vehicle 
treated animals (blue squares). *** P<0.001 DHA vs. vehicle group. Results represent 
mean ±SEM; n=5-6 animals in each group 
  
173 
 
5.4 Discussion 
To date, several DHA studies in different SCI models have shown significant 
neurological recovery which appears to be due to a neuroprotective effect (King et al. 
2006; Huang et al. 2007; Lim et al. 2013; Paterniti et al. 2014). However, the effect of 
DHA on neuroplasticity has not been investigated in SCI. This present study 
demonstrates that DHA can induce neuroplasticity after SCI by promoting sprouting of 
axons. Functional and anatomical plasticity was demonstrated by the behavioural and 
histological assessment in two different rodent species and models. Furthermore, 
studies of cervical hemisection show that DHA not only induces axonal sprouting but 
also exerts a positive effect on synaptogenesis after SCI. 
5.4.1 DHA enhances synaptogenesis 
In the current study, we address the question whether the acute administration of DHA 
can enhance synaptogenesis following CNS injury. In the cervical hemisection animal 
model, our results indicate that the level of synaptophysin increased in the spinal cord 
ventral horn caudal to the injury site in the DHA group. The elevation in synaptophysin 
levels implies that upregulation of synaptic function occurs after treatment, which is 
related to functional improvement. This finding is consisted with other experimental 
studies. In rats and mice, individual differences in spatial learning capacity are 
correlated with the level of synaptophysin expression in the hippocampus (Smith et al. 
2000; Frick et al. 2003). In another experimental study, the neurological performance in 
rats receiving motor training is proportional to the extent of synaptophysin in thalamus 
(Ding et al. 2002). In the spinal ventral horn, the changes in synaptophysin expression 
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could modulate motor function in a mouse model of amyotrophic lateral sclerosis (ALS) 
(Zang et al. 2005) and in a traumatic SCI animal model (Macias et al. 2009). 
In an effort to gain more insight into synapse formation on appropriate caudal targets, 
such as the motor neurons that are responsible for specific forelimb movements, 
synaptophysin expression surrounding motor neurons was measured. The data 
revealed that synaptophsin was significantly augmented in the region of motor neurons.  
Our findings are similar to other animal models treated with DHA. Oral DHA has also 
been shown to promote the synthesis of synaptic membranes and specific presynaptic 
proteins (synapsin-1 and syntaxin-3) and postsynaptic proteins (postsynaptic density 
protein 95) (Wurtman et al. 2006; Cansev et al. 2007). Upregulation of these synaptic 
proteins after dietary consumption of DHA is also linked to improvement in brain 
learning (Wu et al. 2008) and spinal cord sensorimotor learning following SCI (Joseph et 
al. 2012).  
Previous studies demonstrated that synaptophysin immunoreactivity is reduced in the 
spinal cord caudal to the lesion site after spinal cord hemisection or transection 
(Nacimiento et al. 1995; Macias et al. 2009; Lopez-Dolado et al. 2013), which is 
compatible with our results. In our study, the global synaptophysin expression 
decreased below the lesion site. However, the synaptophysin immunoreactivity in the 
DHA treated group was significantly higher than in the vehicle group. We also quantified 
the synaptophysin boutons contacting motor neurons in the cervical spinal cord and this 
demonstrated an enhancement of synaptic input to motor neurons after DHA treatment. 
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This study thus provides some insight into changes in synaptic input to motor neurons 
that affect forelimb motor function after cervical spinal hemisection. 
The enhanced synaptic input to motor neurons treated with DHA suggests an essential 
role of DHA in promoting synapse formation and/or pre-synaptic neurotransmitter 
release. The observed increases in pre-synaptic proteins may involve activation of 
transcriptional factors following injury. DHA has been shown to be an endogenous 
ligand for retinoid X receptor (de Urquiza et al. 2000). SCI is associated with changes in 
retinoid signalling (Schrage et al. 2006), which is involved in the control of synaptic 
plasticity, cytoskeleton, signal transduction and ion channel formation during 
neurodevelopment (Maden 2002; Lane et al. 2005). One possible mechanism is that 
DHA binding to retinoid X receptor enhances its transcriptional activity, which 
upregulates synaptic activity.  
In the CNS, neurotransmitter release is activated by pairing a synaptic vesicle-SNARE 
(soluble N-ethylmaleimide-sensitive fusion (NSF) protein attachment protein receptor) 
complex with its target traffic-SNARE on the intracellular surface of the plasma 
membrane (Jahn et al. 2006). Concerning changes in synaptic transmission following 
DHA treatment, DHA can influence SNARE protein expression or ternary complexes, 
and increase co-localization and interaction of SNAP-25 and syntaxin-3, and upregulate 
synaptic membrane biogenesis (Darios et al. 2006; Pongrac et al. 2007; Mazelova et al. 
2009). A set of experimental data demonstrates that DHA can induce modifications in 
several synaptic neurotransmission systems. DHA can promote glutamatergic synaptic 
activity by increasing glutamate receptor subunits (NMDA receptor subunit 2B (NR2B) 
and glutamate receptor 1 (GluR1)) in hippocampal neurons (Kim et al. 2011). 
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Conversely, deficiency of DHA results in decreases in glutamate receptor units (GluR1, 
GluR2, NR1, NR2A, and NR2B), which leads to impairment in long-term potentiation in 
the hippocampus (Cao et al. 2009). Omega-3 PUFA deficiency can also alter 
monoamine systems. Omega-3 PUFA deficiency results in changes in the vesicular 
pool of serotonin as well as dopamine, leading to irreversible alteration in specific brain 
functions (Chalon 2006). Mice on a DHA deficient diet show augmented amphetamine-
induced locomotor sensitization, associated with an alteration in the mesolimbic 
dopamine pathway (McNamara et al. 2008). DHA deficiency also causes a 10% 
cholinergic transmitter reduction in muscarinic receptor binding, although 
acetylcholinesterase activity and the vesicular acetylcholine transporter were not 
affected (Aid et al. 2003). 
 
5.4.2 DHA induced axon plasticity 
SCI causes an immediate paralysis of muscles innervated by motor neurons caudal to 
the lesion site. This insult is partly due to loss of cortical axons that control voluntary 
limb movements, using glutamate (Jordan et al. 2008). Another cause is the loss of 
brainstem-derived axons that provide motor neurons with a source of neuromodulators, 
particularly serotonin (Rekling et al. 2000; Jacobs et al. 2002). It is known that gross 
motor recovery depends on various sensory-motor tracts sprouting or regenerating 
(Bareyre et al. 2004; Bradbury et al. 2006). This axonal growth may involve spared 
axons, collateral sprouting, and/or changes in local spinal circuitry (Bradbury et al. 
2006). In this chapter, we evaluated two different descending axonal systems (the 
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serotonergic system and the CST pathway) to determine if DHA has an effect on 
promoting axon sprouting which could be responsible for functional recovery. 
5.4.2.1 The serotonergic system 
Serotonergic pathways arise from medullary raphe nuclei, then they mainly pass 
through the ventrolateral funiculus and ventral funiculus and terminate within the ventral 
horn, innervating motor neurons and interneurons (Sharma et al. 1997; Gerin et al. 
2010). Previous studies demonstrated that rapidly diminished spinal levels of serotonin 
occur ipsilateral to spinal lesion following thoracic SCI, with levels of serotonin returning 
by 4 weeks after injury in the lumbar region (Saruhashi et al. 1996; Hains et al. 2002; 
Saruhashi et al. 2009). It has been reported that increased sprouting of serotonergic 
fibres in the injured spinal cord leads to improved recovery of locomotion (Li et al. 2005). 
In our study, DHA treatment also remarkably enhanced axonal sprouting in the spinal 
serotonergic pathway, which plays an essential role in modulating and triggering 
neuronal activity in the spinal cord (Ciranna 2006; Jordan et al. 2008). 
We evaluated 5-HT immunoreactive axons by two methods. The first method was to 
measure the global immunoreactivity through the whole cervical spinal cord in 
longitudinal sections. Several SCI studies have demonstrated that locomotor activity is 
modulated and triggered by serotonin and serotonin precursors or agonists, and that 
enhanced motor performance can result from stimulation of serotonin receptor subtypes 
(Cowley et al. 1994; Kiehn et al. 1996; Ung et al. 2008). To address this problem, we 
assessed the density of 5-HT containing terminals contacting individual motor neurons 
in the ventral horn, to provide more information on a specific site related to motor 
function recovery. With respect to the changes in the expression of serotonin, it is 
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notable that the serotonin level not only increased in the perilesional area in the DHA 
treatment group, especially in the spinal cord caudal to the lesion site. We also found 
the level of serotonin contacting motoneurons significantly increased. The present 
results of the serotonergic innervation of the ventral grey matter suggest that DHA 
stimulates axonal plasticity within the spinal neuronal network, which may eventually 
result in enhanced locomotor performance.  
Previous studies have shown that DHA supplementation influences serotonin level and 
serotonin receptors in the CNS. A positive association has been reported between the 
amount of dietary DHA and brain 5-HT in piglets (de la Presa Owens et al. 1999). 
Conversely, rats with a chronic omega-3 polyunsaturated fatty acid dietary deficiency 
have a low response to fenfluramine-induced 5-HT stimulation (Kodas et al. 2004). In 
addition, omega-3 polyunsaturated fatty acid supplementation reverses the stress-
induced reduction in serotonin levels (Vancassel et al. 2008). Recently, one study 
showed that a high-saturated-fat diet increases 5-HT1A and 5-HT2A receptor binding 
densities in the brain, which leads to cognitive dysfunction in rats. DHA supplementation 
can reverse changes in 5-HT receptors and thus attenuate such alteration (Yu et al. 
2013). In our data, the acute administration of DHA appears to upregulate 5-HT fibres 
following SCI, which may contribute to motor function recovery. 
5.4.2.2 Corticospinal tract axons 
The CST is a major descending pathway contributing to the control of voluntary 
movement in mammals. About 95% of all corticospinal axons in rat are located in the 
ventral aspect of the dorsal columns and about 3–5% in the medial aspect of the ventral 
columns (Brosamle et al. 1997). Limited spontaneous sprouting of lesioned CST fibers 
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has been reported at the site of a spinal cord lesion in adult rats (Aoki et al. 1986; Li et 
al. 1994; Weidner et al. 2001). One study confirmed that the spontaneous sprouting of 
CST fibres contributes to locomotor recovery, by carrying out electrophysiological 
assessment (Bareyre et al. 2004). 
In our cervical hemisection animal model, DHA treatment significantly increased the 
axonal density in the main CST projections contralateral to the hemisection lesion, as 
well as causing sprouting of CST fibres within the grey matter in the ipsilateral regions 
rostral and caudal to the lesion site. This finding of an increase in axonal density in the 
main CST and collateral sprouting fibres may be related to the ability of DHA to promote 
axonal plasticity. In our behavioural assessments, we obtained evidence for a functional 
role of this DHA-promoted CST sprouting by demonstrating a precise and positive 
correlation with improved food pellet grasping, a task known to be associated with CST 
function (Kanagal et al. 2009). 
Our findings are in agreement with previous study results, which have shown that skilled 
movement recovery is closely linked to CST sprouting. To investigate the axonal 
sprouting after injury with/without treatment, several animal models have been used to 
discover the underlying mechanism, such as bilateral dorsal column crush, bilateral 
dorso-lateral column ablation, partial and complete pyramdiotomy. The lesion created 
by cervical hemisection included a substantial extent of grey matter. The lesion area 
included premotor interneurons, propriospinal neurons and possibly, motor neurons that 
form the segmental circuitry underlying forelimb movement. In order to put our focus on 
DHA promoting collateral CST sprouting, unilateral pyramidotomy was employed to 
address this issue. The pyramidotomy lesion model in mice together with behavioural 
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tests is a valuable tool for assessing therapeutic strategies to promote CST plasticity 
(Starkey et al. 2005). 
In the unilateral pyramidotomy model, the behavioural data showed that mice treated 
with DHA made significantly fewer forepaw misplacement 3 weeks after pyramidal tract 
lesion. The analysis of sprouting CST fibers from the contralateral side shows a robust 
increase after DHA treatment. Furthermore, the extent of the pyramidotomy lesion was 
determined using immunostaining for PKC in cervical spinal cord. The lack of effect of 
DHA on PKC immunostaining in the CST indicates that there was no neuroprotection 
of CST axons. Therefore the prominent effect of DHA on the sprouting response of CST 
axons after pyramidotomy suggests that DHA can promote skilled movement recovery, 
without a parallel neuroprotection effect. These data provide promising support for 
neuroplasticity playing a key role in the therapeutic effect of DHA.  
However, not all anatomical plasticity is beneficial. From previous investigation, it is 
known that aberrant neuronal circuits can activate inappropriate combinations of 
sensorimotor networks during gait execution (Beauparlant et al. 2013). Functional 
recovery should be built on the basis of direct compensatory plasticity. Previous studies 
demonstrated that sprouting can result in indirect reconnection of the lesioned axons to 
caudal targets via propriospinal interneurons (Bareyre et al. 2004; Vavrek et al. 2006). 
The spinal cord contains many types of interneurons that can be assigned into different 
categories depending on anatomical, physiological and molecular criteria (Flynn et al. 
2011). The C3-C4 propriospinal system has been shown to comprise a population of 
propriospinal neurons located in upper cervical segments. Its role is to transmit CST 
input, as well as convergent input from other descending pathways (rubro-, tecto-, and 
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reticulo-spinal tracts) to motorneurons in segments C6 to T1 that innervate the forelimb 
(Illert et al. 1981; Alstermark et al. 1984). 
In mice, propriospinal neurons include a genetically accessible subpopulation of cervical 
V2a interneurons (Lee et al. 2001; Al-Mosawie et al. 2007). A recent study has 
demonstrated that this type of interneuron located in cervical spinal cord is responsible 
for skilled forelimb movements (Azim et al. 2014). In our study, we utilized the Chx10 
transcription factor to localize V2a interneurons. Contact between CST axons and V2a 
interneurons was confirmed using the confocal microscope. This analysis revealed that 
DHA can promote sprouting CST axons to contact V2a interneurons. Our work further 
shows that during CST remodelling not only the number of CST collaterals but also the 
number of targeted interneurons contacted by CST axons is affected, which is positively 
associated with functional recovery. 
5.5 Summary 
 We demonstrate a neuroplasticity promoting effect of DHA in two different animal 
models. 
 DHA can enhance the number of synaptic contacts on motor neurons, which may 
contribute to functional recovery. 
 Two different types of axons (serotonin axons and CST axons) were significantly 
increased in the spinal cord rostral and caudal to the lesion site after DHA 
treatment. 
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 In a mouse pyramidotomy model, DHA treatment promoted skilled locomotor 
functional recovery and immunochemical staining revealed that sprouting CST 
fibres contact Chx10 positive interneurons, which correlated positively with 
functional recovery. 
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6 The role of PTEN in neuroplasticity modulation 
after DHA treatment 
6.1 Introduction 
Utilizing two different CNS injury animal models, we have demonstrated that acute DHA 
administered as an intravenous bolus 30 min after injury promotes neuroplasticity 
(chapter 5). While this effect of acute intravenous injection of DHA was supported by 
data in the previous chapters, there is a need to characterize the underlying 
mechanisms responsible for neuroplasticity following DHA treatment in SCI. Studies 
aimed at understanding basic mechanisms of neuronal growth and plasticity are vital in 
order to develop successful treatments for SCI. Therefore, in this chapter we decided to 
explore the underlying mechanism involved in DHA promoting anatomical 
neuroplasticity. In my previous experimental data, delayed (3 weeks post injury) 
treatment of DHA seemed to have no neuroplasticity promoting effect. The 
neuroplasticity promoting effect of DHA may thus be only evident at the acute stage. 
 
Several studies have demonstrated that DHA has the ability to modulate gene 
expression in vivo and in vitro (Kitajka et al. 2002; Vedin et al. 2012). Owing to the 
limited time duration of DHA administration after SCI to promote neuroplasticity, it is 
reasonable to propose that DHA may exert the capacity to modulate gene expression in 
the early few hours following injury. In several studies, gene expression changes after 
SCI were analysed using DNA microarrays within a few hours after injury (Carmel et al. 
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2001; Bareyre et al. 2002; Nesic et al. 2002; Di Giovanni et al. 2003). A very high 
expression at the epicenter occurred for genes involved in cell damage and death, such 
as NF-B, c-jun and suppressor of cytokine signaling 3 (SOCS-3) (Carmel et al. 2001; 
Song et al. 2001; Di Giovanni et al. 2003). Significantly, transcriptional upregulation of 
inflammation-related markers was also identified at early time points. The level of pro-
inflammatory cytokines (IL-1 and IL-6) and interleukin receptors was elevated threefold 
(Carmel et al. 2001; Nesic et al. 2002; Di Giovanni et al. 2003). Another group of genes 
comprised ion channels (e.g. K
+
, Na
+
, and Ca
2+
 channels) and transporters, which are 
downregulated one hour after the injury (Carmel et al. 2001; Song et al. 2001; Di 
Giovanni et al. 2003). Injury of the spinal cord also induces the expression of 
neuroplasticity genes, such as Janus-activated kinase (JAK), signal transducer and 
activator of transcription (STAT) family, and insulin-like growth factor (IGF-1) one hour 
after injury (Nesic et al. 2002). These finding represent an early attempt of the spinal 
cord towards repair and regeneration.  
 
Currently, there is a lack of direct evidence about gene expression modulated after DHA 
treatment in SCI models. However, alteration of gene expression following SCI is likely 
accompanied by the post-transcriptional regulation of these modified gene networks 
(Nieto-Diaz et al. 2014). miRNAs have recently attracted much attention because of 
their ability to inhibit mRNA translation, which plays a vital part in post-transcriptional 
regulation (Pillai 2005). miR-21 has been documented to be an essential factor in 
multiple biological and pathological processes, including cell proliferation, anti-apoptosis, 
and inflammation (Krichevsky et al. 2009). The role of miR-21 in CNS injury is not well 
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documented. A number of studies have identified an increase in the expression level of 
miR-21 in the hippocampus and injured cerebral cortex from 6 h to 72 h following TBI in 
rats (Lei et al. 2009; Redell et al. 2009; Redell et al. 2011). The expression of miR-21 is 
also significantly upregulated following traumatic SCI (Hu et al. 2013; Nieto-Diaz et al. 
2014).  
Phosphatase and tensin homolog (PTEN), an important target of miR-21, could change 
the serine/threonine protein kinase Akt phosphorylation status and regulate downstream 
Akt signalling pathway (Chang et al. 2007). Recently, several studies have 
demonstrated that downregulation of PTEN function or expression promotes axon 
regeneration and neuroprotection following CNS trauma (Zhang et al. 2007; Park et al. 
2008; Liu et al. 2010; Walker et al. 2012). PTEN is a phosphatidylinositol (3,4,5)-
trisphosphate (PIP3) 3-phosphatase, which means it reverses the action of 
phosphatidylinositol 3-kinase (PI3K) by dephosphorylating PIP3 to PI-4,5-P2 (Cantley et 
al. 1999). By countering the actions of PI3K, it reduces activation of Akt and prevents all 
of the downstream signalling events that are controlled by Akt. Inactivation of PTEN 
leads to accumulation of PIP3 and the activation of Akt.  
Previous data have shown that DHA can activate Akt and protect neuronal cells from 
apoptosis (Akbar et al. 2002; Akbar et al. 2005; Wu et al. 2008; Figueroa et al. 2012). 
However, the underlying mechanism that activates the Akt signalling pathway still needs 
further delineation. Work from other labs has shown that PTEN protein expression 
peaks 24 h post-injury, and the level decreases between 24 and 48 hours following 
trauma (Ding et al. 2013; Hu et al. 2013). In this study, we tried to determinate if acute 
administration of DHA can upregulate miR-21 and decrease PTEN expression one day 
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following cervical spinal injury, and whether this correlates with the promotion of axonal 
sprouting. 
 
6.2 Aims 
In this chapter, our hypothesis is that DHA can initiate a neuroplasticity-promoting effect 
at a very early stage through miR-21 and PTEN pathways. The aims of this study were 
to determine whether DHA can induce miR-21 and suppress PTEN expression following 
cervical hemisection, and to gain more insight into the mechanism of DHA-induced 
promotion of plasticity (Fig 6.1). In an in vivo study, we examined PTEN and miR-21 
expression in pyramidal neurons located in layer V of the rat cortex one day following 
cervical hemisection. In an in vitro study, using a PTEN activator (sodium selenite), we 
have addressed the following questions: first, we tested whether DHA can promote 
neurite outgrowth in DRG cell culture; second, we examined if DHA could suppress 
PTEN expression activated by sodium selenite in cell culture and hence promote neurite 
outgrowth.  
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Figure 6-1 Schematic of the hypothesis that DHA upregulates miR-21 which 
affects the PTEN/mTOR signalling pathway 
DHA upregulates miR-21, which inhibits PTEN and therefore activates PI3K/Akt 
signalling and the mTOR pathway. This process has benefits on cell survival and 
regeneration. PI3K = Phosphatidylinositol 3-kinase; PTEN = Phosphatase and tensin 
homolog; mTOR = mammalian target of rapamycin; (adapted from Liu, Detloff, et al 
2012) 
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6.3 Results 
6.3.1 Cervical spinal cord injury increases the expression of miR-21  
To elucidate the effect of cervical SCI and DHA treatment on miR-21 and PTEN 
expression in pyramidal neurons in cerebral cortex in the acute stage, cervical 
hemisection was performed in rats. The rats were separated into two groups. Thirty 
minutes after surgery, one group received DHA administration and the other group 
received saline injection. One day after left cervical hemisection, the rats were perfused, 
and tissue was collected for histological analysis. The CST tract originates from 
pyramidal cells in layer V of the cerebral cortex. The expression of miR-21 in cortical 
neurons was measured by in situ hybridization. Compared to the left cortex, the miR-21 
expression of pyramidal cells was upregulated in the right side cortex after left cervical 
hemisection in both groups. It is notable that there was a significant upregulation in the 
vehicle group (Fig 6.1). 
6.3.2 DHA induces miR-21 expression in pyramidal cells 
To investigate if DHA can induce miR-21, we measured the expression of miR-21 in 
pyramidal cells of the unlesioned cortex, which is related to CST sprouting. In coronal 
sections, we discovered that the expression level of miR-21 in pyramidal neurons was 
significantly different between the two groups. At 1 day after SCI and DHA treatment, 
the miR-21 expression was substantially increased (Fig 6.2).  
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Figure 6-2 Cervical hemisection increases miR-21 expression in cortical neurons 
The representative images show miR-21 staining in pyramidal cells in layer V in the 
cortex, in the vehicle group (A,B) and in the DHA treatment group (C,D). Compared to 
the left brain cortex, the quantitative analysis revealed that the expression of miR-21 in 
the right cerebral cortex was upregulated after left cervical hemisection in the vehicle 
group (C) and in the DHA group (D). Scale bar = 100 m. A significant difference was 
noted between each hemisphere in the vehicle group. * P<0.05. Results represent 
mean ±SEM. n=4 animals per group.  
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Figure 6-3 DHA treatment increases the expression of miR-21 one day after 
cervical hemisection 
(A, B) Low magnification of the unlesioned cerebral cortex labelled for miR-21 
expression in left cervical hemisected rats at 1 day post injury. (C,D) Higher 
magnification of the dashed boxes in panels. (E) Quantification of miR-21 expression 
revealed a significant increase after DHA treatment (* P<0.05). Results represent mean 
±SEM. n=4 animals per group  
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6.3.3 DHA treatment decreases PTEN expression in pyramidal cells in motor 
cortex 
In order to assess the effects of the acute bolus DHA treatment on uninjured layer V 
projection neurons, the PTEN expression in pyramidal cells in motor cortex at bregma 
+0.14 mm was analyzed one day after cervical SCI. We found that PTEN expression in 
pyramidal cells was significantly upregulated after cervical hemisection in vehicle group 
compared to naïve animals. However, the expression of PTEN significantly decreased 
after DHA treatment compared to the vehicle group (56.5 ± 4.9 vs. 37.8 ± 2.8, p<0.05 
Fig 6.3).  
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Figure 6-4 DHA suppresses PTEN expression in pyramidal cells 
(A,B) Low magnification images of the cerebral cortex labelled for PTEN 
immunoreactivity in cervical lateral hemisected rats at 1 day post injury. (C-F) Higher 
magnification of the dashed boxes in panels A and B showing that PTEN 
immunoreactivity is co-localised with NeuN immunopositive neurons in the cerebral 
cortex. DHA-treated animals have reduced PTEN immunostaining compared to vehicle 
treated animals. (G,H) Low expression of PTEN immunoreactivity was observed in 
naïve animals. (I) Quantitative analysis revealed a significant increase in PTEN 
immunostaining in the cerebral cortex ipsilateral to the lesion side at one day after 
cervical SCI in vehicle group.* P<0.05. Results represent mean ±SEM. n=4 animals per 
group. DHA treatment (red bar) significantly reduces the PTEN immunostaining levels 
when compared to the vehicle treatment (blue bar). 
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6.3.4 DHA treatment decrease PTEN expression of raphe nucleus neurons in the 
brainstem 
The origin of serotonin projections is in the raphe nuclei in the brainstem. One group of 
cells (nucleus raphe magnus) is responsible for major spinal cord serotonin projections. 
In a previous chapter, our data showed the DHA treatment can boost serotonin fiber 
sprouting following SCI. Therefore, we also determined if DHA can suppress PTEN 
expression in nucleus raphe magnus, which may promote serotonin fibre sprouting. The 
response of nucleus raphe magnus following SCI was assessed by NeuN and PTEN 
immunolabelling of the brain stem.(-8.0 mm vs. bregma) (Abrams et al. 2004) (Fig 6.4). 
One day after cervical spinal cord hemisection, the PTEN immunoreactivity was 
decreased in the DHA treatment group in comparison with the vehicle group (Fig 6.5). 
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Figure 6-5 PTEN and 5-HT immunoreactivity in the brain stem raphe nuclei 
(A,B) Low magnification of the raphe nuclei immunostained for PTEN and 5-HT in 
cervical hemisected rats at 1 day post injury. (C,D) Higher magnification of the dashed 
boxes in panels A & B, showing PTEN and 5-HT immunoreactivity.  
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Figure 6-6 DHA treatment induces a small decrease in PTEN expression in 
nucleus raphe magnus 
(A,B) Images of PTEN immunostaining in nucleus raphe magnus. Scale bar =100 m. 
(C) The quantification showed that DHA induces a trend towards a decrease in PTEN 
immunoreactivity compared to vehicle group. Results represent mean ±SEM. n=4 
animals per group.  
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6.3.5 DHA enhances neurite outgrowth in DRG cell culture 
To evaluate the effect of DHA on neurite sprouting, we examined the growth of DRG 
cell cultures 3 days following DHA treatment. We compared the effect of different 
concentrations of DHA on neurite outgrowth. The number of neurites and the average 
neurite length were significantly increased by 3 M DHA compared to the control group 
(Fig 6.7). DHA also increased the maximum neurite length at all the concentrations 
tested. 
 
 
Figure 6-7 DHA promotes DRG cell neurite outgrowth 
(A,B) Quantification showed that DHA treatment significantly increases the number of 
neurites and average neurite length at a dose of 3 M DHA. (C) All concentrations of 
DHA tested increase the longest neurite length.* P<0.05. Results represent mean ±SEM 
n=3 independent experiments.  
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6.3.6 DHA treatment decreases PTEN expression in DRG cell culture. 
DRG neurons were cultured as previously described. The next day (1 day in vitro (DIV)), 
DHA (1-10 M) or control media (BS media with 0.008% ethanol) were added to the 
DRG cultures. At 2 DIV, sodium selenite (10 M) was added to the cultures to induce 
PTEN expression. At 3 DIV, the DRG were fixed with 4% paraformaldehyde and 
underwent immunocytochemistry. Figure 6.7 shows the induction of PTEN following 
treatment with sodium selenite. DHA (1 M) appeared to reduce PTEN expression. This 
was confirmed by the quantitative analysis, which showed that DHA reduced PTEN 
expression, in parallel with its neurite growth promoting effect (Fig 6.7). 
 
198 
 
  
Figure 6-8 DHA treatment reduces PTEN expression and enhances neurite growth 
(A,B) In adult DRG neuronal cultures treated with 10 M sodium selenite, 1 M DHA 
promotes neurite outgrowth. (C,D) There appeared to be reduced PTEN expression 
after 1 M DHA treatment, which occurred in parallel with the effect on neurite growth. 
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Figure 6-9 DHA treatment reduces PTEN expression and enhances neurite growth 
(A) Quantification showed that sodium selenite significantly increased PTEN expression 
compared to control. DHA significantly decreased the PTEN immunoreactivity at 1 M.  
(B,C) DHA promotes neurite outgrowth, assessed by average neurite length and neurite 
number at 10 M sodium selenite. * P<0.05. Results represent mean ±SEM. n=4 
independent experiments. 
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6.4 Discussion 
6.4.1 Mechanisms underlying the effect of DHA on neuroplasticity 
There are likely to be several mechanisms underlying the effects of DHA on 
neuroplasticity. DHA has widespread effects on synaptic function. The exact details 
remain unknown, but are likely to involve complex interactions of synergistic effects on 
neuronal membrane structure, function, and gene expression. In studies on rodent brain, 
DHA supplementation increased CaMKII and CREB levels and BDNF secretion to 
strengthen synaptic plasticity for spatial learning memory formation (Tanabe et al. 2004; 
Cao et al. 2009). The BDNF system seems crucial for mediating the action of DHA in 
the brain, as a diet deficient in DHA has been shown to reduce the activation of TrkB 
receptors (Bhatia et al. 2011). Studies show that the receptor GPR40 is activated by 
PUFAs (Briscoe et al. 2003; Ma et al. 2007), and a role for GPR40 signalling pathways 
in adult neurogenesis and the effect of DHA has been proposed (Yamashima 2008). 
Recent studies have shown that DHA can activate syntaxin 3. Syntaxin 3 is positioned 
in the presynaptic plasma membrane to detect local changes in PUFA (Darios et al. 
2006) and plays a crucial role in the docking and fusion of vesicles during synaptic 
transmission (McMahon et al. 1995). It also promotes neurite outgrowth by membrane 
expansion at growth cones (Darios et al. 2006). In one study, DHA treatment also led to 
an increase in the level of GAP-43 in cortical neuronal culture (Cao et al. 2005). GAP-43 
is a protein associated with growth cone formation, which can be used as a marker of 
axonal growth.  
However, the mechanisms mentioned above cannot fully explain my previous data on 
DHA delayed treatment data or some observations in our group‘s previous study 
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(Huang et al. 2007). Thus, the promising functional recovery promoted by DHA was 
diminished when the single bolus DHA treatment was delayed for 3 weeks or even 3 
hours after injury. Therefore, some mechanism promoting axonal sprouting and 
modulated by DHA is involved only at a very early stage after SCI. 
6.4.2 DHA induces miR-21 expression following cervical SCI 
MicroRNAs (miRNAs) are highly expressed in mammalian CNS, including in the spinal 
cord (Krichevsky 2007; Bak et al. 2008) and are integral to many biological processes. 
miRNAs inhibit translation of mRNAs by leading an inhibitory protein complex, the RNA-
induced silencing complex, to the mRNA via complementarity to its 3‘- untranslated 
region (3‘UTR). This limits the gene function, even though transcription of the gene may 
not be stopped (Pillai 2005). Studies published recently have shown that miR-21 is 
globally upregulated in response to brain injury (Lei et al. 2009; Buller et al. 2010) ,SCI 
(Strickland et al. 2011; Bhalala et al. 2012; Liu et al. 2012; Hu et al. 2013) and 
peripheral nerve injury (Strickland et al. 2011; Yu et al. 2011; Sakai et al. 2013). The 
data on miR-21 suggests that the upregulation of miR-21 attenuates neuronal apoptosis 
(Buller et al. 2010; Ge et al. 2014) and promotes neuroplasticity after injury, by different 
signalling pathways (Strickland et al. 2011). 
In our in situ hybridization analysis, the expression of miR-21 in the cortex contralateral 
to the lesion side was augmented compared to the ipsilateral side, after cervical 
hemisection. This significant upregulation was possibly linked to the degeneration of 
CST neurons following cervical lesions (Hains et al. 2003; Ghosh et al. 2012) or an 
attempt by the lesioned cell to regenerate. Furthermore, the rats treated with DHA 
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showed a higher labelling of miR-21 in cortical pyramidal cells. It seems that the 
expression of miR-21 was boosted bilaterally in the cortex by DHA treatment.  
 
6.4.3 DHA suppress PTEN expression: in vivo study 
The manipulation of the level of miR21 has recently been shown to affect functional 
recovery in animal models of CNS injury by modulation of PTEN expression. In a 
contusion SCI animal model, knockdown of miR-21 by antagomir-21 led to increased 
PTEN expression and attenuated neurological functional recovery (Hu et al. 2013). On 
the other hand, intraventricular infusion of agomir21 in rats receiving traumatic brain 
injury conferred a better neurological outcome, by inhibition of the expression of PTEN 
and Akt signalling activation (Ge et al. 2014). These findings suggest that upregulation 
of miR-21 after DHA treatment may lead to PTEN suppression. 
A number of studies have demonstrated that a reduction in phosphatase activity and 
PTEN is involved in axonal regeneration and synaptic plasticity (Liu et al. 2010; Ding et 
al. 2013). PTEN is expressed in adult CNS neurons (Cai et al. 2009; Liu et al. 2010) and 
is essential for processes related to cellular proliferation and neuronal growth regulation 
(Dahia 2000; Kwon et al. 2001). 
PTEN is a PIP3 3-phosphatase, which means it reverses the action of PI3K by 
dephosphorylating PIP3 to PI-4,5-P2 (Cantley et al. 1999). By countering the actions of 
PI3K, it reduces activation of Akt and prevents the downstream signalling events that 
are controlled by Akt. As a result, inactivation of PTEN leads to accumulation of PIP3 
and the activation of Akt. The PI3K/Akt signalling pathway regulates crucial biological 
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processes, including proliferation, growth, migration, metabolism, and neuronal and 
synaptic plasticity. 
PTEN is an early expressed molecule which peaks at 1 day and decreases at 3 days 
post injury in various rat CNS injury models (Ding et al. 2013; Hu et al. 2013). PTEN 
over-expression is a possible mechanism to inhibit neuronal regrowth after CNS injury. 
In our study, the data suggested that DHA can suppress PTEN expression, with a 
significant decrease in pyramidal neurons in the primary motor cortex region. This 
finding supports our data showing that DHA can facilitate CST sprouting after cervical 
hemisection. However, we only found a trend towards decrease in nucleus raphe 
magnus in the brain stem one day after injury, even though DHA boosts the sprouting of 
serotonin fibres in the cervical spinal cord following cervical hemisection. A possible 
reason is that the raphe nuclei are distributed near the midline of the brainstem, along 
its entire rostro-caudal extent (Hornung 2003). The serotonin projection to the spinal 
cord mainly originates in the raphe magnus nucleus and terminates in the dorsal horn. 
PTEN expression in nucleus raphe magnus is easy to identify because of the cell 
cluster located in the midline. However it is not possible to identify the particular 
neurons that project to the lesion site. To elucidate this issue, retrograde tracing of 
serotonin projections fibres may be needed. 
6.4.4 DHA suppresses PTEN expression in vitro  
To investigate the mechanism of PTEN suppression after DHA treatment, we made use 
of primary cultures of DRG cells. Firstly, we tried to determine the optimal concentration 
of DHA needed to promote axonal growth. It has been shown that DHA influences the 
response of neuron growth not only in immature embryonic cell culture (Calderon et al. 
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2004) but also in mature cell culture (Robson et al. 2010). Our data revealed that DHA 
can increase the number of neurites and the length of neurites at a concentration of 3 
M DHA. Several mechanisms could underlie the neurite promoting effect. In previous 
studies, DHA has been shown to upregulate the level of growth associated protein-43 
(GAP-43) in cortical neurone cultures (Cao et al. 2005). GAP-43 is a protein associated 
with growth cone formation. Growth cones are rich in phospholipases which release 
PUFA from membranes, supporting the importance of these compounds in membrane 
remodelling and neurite growth (Robson et al. 2010).  
In order to investigate if DHA can suppress PTEN expression, we utilized sodium 
selenite to induce PTEN expression (Berggren et al. 2009; Luo et al. 2013) in DRG cell 
cultures. The analysis of PTEN immunostaining after sodium selenite incubation 
revealed a significant increase in the level of PTEN expression in DRG cells and a 
decrease in the neurite length and number. After incubation with DHA, we saw that the 
immunoreactivity of PTEN was significantly reduced, and the number and length of 
neurites was significantly increased by DHA. Our result implies that inhibition of PTEN 
expression promotes neurite growth in DRG cell culture. This interpretation is consistent 
with other study results, which demonstrate that inhibition of PTEN in DRG cell culture 
promotes neurite outgrowth (Christie et al. 2010).  
From our in vivo and in vitro data, we found therefore that PTEN suppression is 
associated with the elevation of miR-21 after DHA treatment. This data is similar with 
another study result. In cortical neuron cultures, a study has demonstrated that miR-21 
can inhibit the expression of PTEN through Akt/PI3 pathway after scratch injury (Han et 
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al. 2014). This may be one potential mechanism which explains why acute DHA 
treatment can promote axonal sprouting after cervical SCI. 
 
6.5 Summary 
 In an in vivo study, increased miR-21 expression was observed in CST neurons 
after cervical SCI and DHA treatment. 
 Acute administration of DHA inhibits PTEN expression in pyramidal cells and 
nucleus raphe magnus one day after cervical hemisection. 
 In DRG cell culture, DHA increases the number of neurites and the length of 
neurites. 
 In DRG cell cultures, DHA decreases induced PTEN expression and enhances 
neurite outgrowth 
 The in vivo and in vitro results provide evidence that DHA can upregulate miR-21 
and inhibit PTEN expression after cervical hemisection, which may contribute to 
neuroplasticity.  
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7 Effect of combined DHA treatment and 
rehabilitation training in cervical SCI 
7.1 Introduction 
SCI results from an external force to the spinal cord causing transient or permanent 
neurological dysfunction of motor, sensory, and autonomic systems at and below the 
lesion site. Gradual recovery of neurological function does occur in the first year 
following incomplete SCI (Burns et al. 1997; Scivoletto et al. 2009). Rehabilitation 
therapies, such as intensive repetitive training (Beekhuizen et al. 2005) and locomotor 
training (Behrman et al. 2006) have shown great potential to promote functional 
recovery in patients. Such training appears to amplify the spontaneous axonal 
sprouting, cortical map reorganization and growth-associated protein up-regulation that 
develop following SCI. 
As the effect of rehabilitation training is modest, it appears desirable to combine 
pharmacological treatments which promote plasticity with training in order to maximize 
the plasticity effect. There is a need to develop novel single and/or combined treatments 
aimed at promoting neuroplasticity events following SCI and thus enhance functional 
recovery. From the results of chapter 5 and chapter 6, the neuroplasticity promoting 
effect of DHA appears promising. Moreover, acute DHA treatment with task-specific 
rehabilitation had not been investigated in a rodent model of cervical SCI. In this 
chapter, the effect of voluntary task-specific training (Montoya staircase) and of DHA, 
either alone or in combination, on neurological functional recovery was examined in a 
rat model of cervical hemisection. 
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7.1.1 Task-specific training  
Recently, several experimental studies have demonstrated that specific task training 
enhances forepaw reaching and grasping ability following different partial lesions of 
cervical spinal cord and pyramidal tracts (Girgis et al. 2007; Krajacic et al. 2010; Starkey 
et al. 2011). Recovery of forepaw function has been linked to plasticity in various 
descending systems, including the CST and the rubrospinal tract (Krajacic et al. 2010). 
However, the training benefits vary depending on the lesion type. Rats with a lesion 
involving the dorsal column that received training, showed significantly greater 
improvement compared to untrained animals. However, rats with a lateral funiculus 
lesion did not show any training effect (Krajacic et al. 2010). To our knowledge, there is 
no literature to discuss the benefit of specific task training in a cervical hemisection 
animal model. In order to design effective and relevant neuroplasticity promoting 
strategies, we need to explore the therapeutic effect of training in a range of animal 
models. 
 
7.1.2 Combined therapy 
In the past, different therapeutic strategies have addressed one particular target, such 
as neuroprotection, neuroregeneration, or neurorehabilitation. However, many recent 
studies indicate that a greater effect may be achieved when a combination of 
interventions is implemented. For example, in a thoracic SCI animal model, treadmill 
training combined with OEG cell transplantation (Kubasak et al. 2008) and radiation 
therapy (Ichiyama et al. 2009) demonstrated significant improvement compared to 
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individual therapy. A number of studies also showed that voluntary forepaw motor 
rehabilitation shows a strong synergistic effect when given together with CSPG 
digestion (Garcia-Alias et al. 2009; Ichiyama et al. 2011) or neurotrophic factor 
treatment (Weishaupt et al. 2013) in a cervical SCI model. 
 
Although combined therapy following SCI benefits neurological recovery in most 
studies, undesired effects of training are also reported in a few studies. Combined with 
Nogo neutralization in partially lesioned rats, intensive training appears to interfere with 
functional recovery, suggesting competition between mechanisms when both strategies 
are applied together (Maier et al. 2009).  Another report showed that animals receiving 
either step training or neurotrophins alone improved to a similar locomotor performance, 
while the combined therapy did not lead to significant recovery  compared to the 
individual interventions (Boyce et al. 2007). It is postulated that step training exerts 
much of its effect through neurotrophins, so there is little synergistic effect when the two 
interventions are combined. 
Recently, data from another laboratory revealed that a combination of exercise and 
dietary DHA promoted a significant enhancement in cognition in naïve animals or after 
TBI compared to either intervention alone (Wu et al. 2008; Wu et al. 2013). These 
results appear to be related to a synergistic effect of combined therapy via a BDNF-
mediated mechanism and an increase in the level of GAP43 and syntaxin-3 in the 
hippocampus (Chytrova et al. 2010).  It therefore seems logical to examine the 
synergistic effect of DHA treatment along with a rehabilitation program in our cervical 
SCI animal model. 
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7.2 Aim  
In previous chapters, we demonstrated that acute DHA administration enhances 
neuroplasticity in our cervical hemisection animal model. In this chapter, the hypothesis 
is that combined DHA and rehabilitation treatment can achieve better neuroplasticity-
promoting effects. We applied task-specific training in our animal model to examine the 
rehabilitation effect on neurological functional recovery. In addition, we sought to test 
whether promoting spinal cord plasticity with combined rehabilitation and DHA therapy 
maximizes functional recovery. 
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7.3 Results 
7.3.1 Rehabilitation promotes forelimb skilled motor recovery following cervical 
hemisection 
One objective of this chapter was to examine whether task-specific training on the 
Montoya staircase in rats receiving cervical hemisection could improve functional 
recovery. Therefore, two groups of rats underwent 3 weeks rehabilitation starting 2 days 
after cervical hemisection. In one group, rats received DHA 250 nmol/kg 30 min after 
cervical hemisection, and in the other group rats received a saline injection as in my 
previous study design. After 3 weeks of behavioural testing, the animals were sacrificed 
and spinal cord tissue was harvested for further histological examination. 
 
Compared to our previous animal Montoya staircase data, our results show that in rats 
receiving cervical hemisection with/without DHA treatment, 3 weeks rehabilitative 
training increased the neurological functional recovery (Fig 7.1). In the saline vehicle 
group, trained rats significantly grasped more food pellets 10 days after cervical 
hemisection. A similar trend was seen when the number of food pellets eaten by trained 
rats with DHA treatment was quantified. Interestingly, the training did not increase the 
ability of rats receiving DHA treatment to displace more food pellets. It appears that 
training increases the accuracy and success of food retrieval 12 days following cervical 
hemisection. 
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Figure 7-1 Effect of rehabilitation training on skilled forelimb function 
After SCI, all rats lost grasping ability in the Montoya staircase test. Starting from 10 
days, rats receiving rehabilitation training began to displace and retrieve significantly 
more pellets in the vehicle group (A,B). In the DHA treatment group, rats receiving 
rehabilitation training displaced more food pellets compared to untrained rats overall. 
However, there was no significant difference between these two groups. 12 days after 
lesion, the rats grasped more food pellets compared to the untrained rats (C,D). (* 
P<0.05,** p<0.01, *** p<0.001). Result represent mean ± SEM; n=8-10 animals in each 
group. 
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7.3.2 Combined therapy induced greater skilled forelimb functional recovery 
than single treatment 
Concerning food pellets eaten, at the time point of 3 weeks after cervical hemisection, 
those animals receiving combined therapy were performing significantly better than the 
other three groups, receiving DHA treatment alone, rehabilitation training alone, or the  
control group (Fig 7.2). This shows that rehabilitation or DHA treatment alone enabled 
animals to eat more food pellets compared to vehicle group during test, but the 
combination of DHA and rehabilitation enabled animals to grasp and eat more food 
pellets than each treatment alone. 
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Figure 7-2 Effect of combined therapy on skilled forelimb function 
For the first 48 hours after surgery, no rats showed any ability to retrieve food pellets. At 
6 days post-injury, DHA-treated rats receiving training had begun to outperform the 
other groups. Animals receiving DHA treatment with task-specific rehabilitation began a 
gradual recovery, which started to diverge from the DHA or rehabilitation only groups 
around 2 weeks after cervical hemisection. (* represents DHA + Reh vs Veh, # 
represent DHA+Reh vs DHA, + represents DHA + Reh vs Veh + Reh, * P< 0.05, ** P< 
0.01, *** P<0.001, # P<0.05, ## P<0.01, + P<0.05, ++P<0.01) Result represent mean ± 
SEM; n=8-10 animals in each group. 
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7.3.3 Rehabilitation training has no effect on skilled locomotion recovery  
The grid exploration is also designed to assess fine motor control of the forelimb, 
including wrist and paw, but it is essential to consider that walking over rungs is still a 
fundamentally different motor skill than reaching for pellets. Animals were placed on the 
grid one, two and three weeks post-operatively, to assess the misplaced steps made by 
the injured left forelimb. After injury, overall the rats receiving rehabilitation training 
without treatment had fewer misplacements compared to the control group during 3 
weeks. However, there was no significant difference between animals receiving 
rehabilitation training or not. In the DHA treatment groups, no obvious difference was 
found during this skilled locomotion test, with or without rehabilitation. 
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Figure 7-3 Effect of combinatorial treatment on non-trained skilled movement. 
In the vehicle group, overall, the rats receiving rehabilitative training exhibited fewer 
forelimb misplacements during the test period. However, no significant improvement in 
this test was found vs. the control vehicle. In the DHA treatment groups, the number of 
forelimb misplacements decreased week by week. The performance in the grid 
exploration test showed no obvious effect of rehabilitation training in combination with 
DHA. Overall, the rats receiving DHA treatment made fewer misplacements. Results 
represent mean ± SEM; n=6 animals in each group. (* represents DHA + Reh vs Veh, # 
represent DHA + Reh vs Veh +Reh * P< 0.05, ** P< 0.01, # P<0.05) 
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7.3.4 Combined therapy promotes axonal sprouting 
7.3.4.1 Corticospinal axons 
The anatomical changes in the contralateral spared CST were studied following 
ipsilateral BDA injection into the forepaw representation area of the sensorimotor cortex. 
We quantified contralateral CST sprouting across the midline above and below the 
lesion site. In the vehicle group, the rehabilitation training promoted significant CST fibre 
sprouting above and below the lesion site (Fig 7.4). In the DHA treatment group, there 
was a similar pattern of CST fibre sprouting. Both groups receiving rehabilitation training 
regardless of DHA treatment showed increased axon sprouting across the midline 
compared to the vehicle group. 
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Figure 7-4 The effect of rehabilitation training on CST axon sprouting 
The CST sprouting fibres in the spinal cord rostral and caudal to the lesion site were 
quantified. (A) The data revealed large numbers of sprouting axonal fibres in rats 
receiving rehabilitative training in the vehicle group (* p<0.05). (B) In the DHA treatment 
group, overall the training enhanced the sprouting of CST axonal fibres moderately. 
There was no significant difference in CST sprouting between the two DHA treated 
groups. (C) The data for all the four groups demonstrates a trend toward DHA-treated 
rats with rehabilitative training having more CST sprouting than the other groups. 
(*P<0.05, DHA + Reh v.s Veh). Results represent mean ± SEM; n=3-6 animals in each 
group. 
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7.3.4.2 Combined therapy and serotonergic fibre sprouting 
The sprouting of other CNS axons was also examined to reveal whether or not 
sprouting was restricted to corticospinal fibres. Utilizing 5-HT immunohistochemical 
staining, serotonergic axons were identified. To investigate the sprouting axon fibres 
below the lesion, the number of serotonin fibres was quantified 5 mm caudal to the 
lesion site. The quantification showed that animals that received combined therapy had 
significantly more axons caudal to the lesion, indicating a greater increase in the 
sprouting of serotonergic axons after combined treatment (Fig 7.5). 
219 
 
 
Figure 7-5 Effect of combined therapy on serotonin fibres 
Representative images of 5-HT labelling in the dorsal horns 5 mm caudal to the injury 
site in rats receiving DHA and saline treatment with/without rehabilitation training. Scale 
bar =100 m. The quantification showed that combined therapy significantly increased 
the density of serotonin fibres (* p<0.05). Result represent mean ± SEM; n=5 animals in 
each group.  
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7.3.5 The effect of combined therapy on synaptogenesis   
Synaptic terminals around motor neurons were identified by the level of synaptophysin. 
Synaptophysin is downregulated after SCI (see chapter 5). Given that DHA promoted 
synaptic plasticity after SCI, we asked whether combined therapy could also maximize 
the expression of synaptophysin. As shown in Fig. 7.6, using the immunochemical 
staining method, we observed the expression of synaptophysin around ventral horn 
neurons located in spinal cord 5 mm caudal to the lesion site. In saline and DHA-treated 
groups, the rehabilitation training increased the level of synaptophysin; however there 
appeared to be no significant synergistic effect. Overall, the combined therapy led to the 
highest level of synaptophysin surrounding motor neurons (Fig 7.6). 
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Figure 7-6 Effect of combination treatment on synaptogenesis 
Representative images in the cervical ventral horn taken 5 mm caudal to the epicenter, 
in DHA and vehicle treatment rats, with/without rehabilitative training. Sections were 
immunostained with synaptophysin at 3 weeks after SCI. Quantitative analysis revealed 
a significant increase in the DHA treatment group receiving training versus vehicle 
group with/without training (* p<0.05). Result represent mean ± SEM; n=5 animals in 
each group. Scale bar =100 m. 
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7.4 Discussion 
The results presented here show that the neuroplasticity following cervical hemisection, 
in terms of both functional neurological manifestations and histological outcome, is 
significantly improved after combined therapy compared to single treatment. Specific 
forelimb task behavioural assessments showed better functional recovery in rats 
receiving intensive rehabilitation training combined with DHA treatment. However, 
another skilled behavioural test (grid exploration) did not reveal a significant effect of 
rehabilitation training. It is clear from our data that the acute administration of DHA 
combined with early rehabilitation greatly increases synaptic plasticity and nerve 
sprouting in the spinal cord caudal to the lesion site. 
 
7.4.1 Rehabilitation effects following cervical SCI 
In this chapter, we showed that specific-task training in rats following cervical 
hemisection can significantly enhance the recovery of that particular task regardless of 
DHA treatment. Rehabilitation training is a non-invasive therapeutic approach with the 
potential for profound effects in SCI patients. From animal SCI experimental studies, it is 
clear that training can promote plasticity and functional recovery by inducing cellular and 
molecular changes.  
 
Probably the most established and investigated rehabilitation paradigm following SCI is 
treadmill training, which has been successfully translated into a clinical treatment. 
Training effects have been seen in experimental mice (Goldshmit et al. 2008), rats 
(Fouad et al. 2000; Fouad et al. 2004), and cats (Rossignol 2006) as well as in humans 
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(Wernig et al. 1992; Dietz 1995; Dietz et al. 1998). Recently, the promising effects of 
task-specific training were demonstrated in rodents following cervical SCI with or 
without pharmacological treatment (Girgis et al. 2007; Krajacic et al. 2010). An essential 
difference between these two methods is that forelimb task-specific training involves 
fine motor control that is directly organized by the brain and brainstem centres. On the 
other hand, repetitive locomotor training is modulated by central pattern generators. 
 
Successful food pellet retrieval is required for animals to pick-up sugar pellets and put 
them in their mouth. The wells in Montoya staircase are small and deep, and the rats 
need to use their digits to winkle the pellets out of the wells and pick them up. In the 
initial stage of forelimb functional recovery, the rats recovered gross forelimb movement 
but still lacked the ability to grab the food pellets successfully with fine control. The food 
pellets were flicked out of the wells during the test. In our data, the rehabilitation training 
significantly increased the number of food pellets displaced and eaten in the Montoya 
staircase test. Recovery of this substantial skilled task has been correlated to the 
number of collateral CST sprouts after treatment (Krajacic et al. 2010). With DHA 
treatment, the displacement of food pellets seems not significantly different between 
trained and untrained animals. However, the number of food pellets eaten showed a 
significant increase after 2 weeks rehabilitation training. Such data add to the view that 
the rehabilitation did not improve gross movement, but led to a significant success in 
food retrieval, with delicate digit control after DHA treatment. Interestingly, the 
histological analysis of the number of collateral CST sprouting axons in trained rats‘ 
cervical spinal cord did not reveal any significant enhancement. It is postulated that 
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rehabilitation training strengthens good connections and removes the incorrect 
connections, to achieve the synergistic effect of combined therapy (Fawcett et al. 2009). 
 
Some studies report that the training-induced improvement in one particular task may 
be at the cost of an untrained task (Girgis et al. 2007; Garcia-Alias et al. 2009). This 
supports the hypothesis that there is a limited resource for new nerve circuit formation 
following SCI, and different behaviours may compete for that resource (Garcia-Alias et 
al. 2012). In order to address this question, we employed the grid exploration test to 
examine if task-specific training interfered with another untrained skill. Interestingly, in 
the vehicle group, we found that rats receiving training made fewer foot slips compared 
to untrained rats. In the DHA treatment group, there was no significant difference. Our 
data are similar to the results from other groups. After cervical lesion, rats receiving 
forelimb skilled grasping training make fewer mistakes while running along a ladder or 
beam (Krajacic et al. 2010; Wang et al. 2011).  
 
In one study, after unilateral pyramidotomy, rats were trained on either the single pellet 
grasping or the horizontal ladder task. Single pellet grasping training led to a smaller 
improvement on the horizontal ladder, but the same degree of recovery on the single 
pellet grasping task as horizontal ladder trained animals. Anatomically, only single pellet 
grasping training was associated with enhanced sprouting of the intact corticospinal 
tract across the midline of the cervical spinal cord to innervate the denervated side 
(Starkey et al. 2011). These results imply that skilled paw reaching, which relies heavily 
on the CST, only recovers with treatment promoting CST sprouting. However, the grid 
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exploration test, ladder walking or other less skilled tasks, may also involve other spinal 
pathways. Promoting CST sprouting is not sufficient to fully support functional recovery 
in these tasks. 
 
7.4.2 Histological changes following rehabilitation training 
A possible mechanism contributing to functional recovery is the sprouting of lesioned 
and spared CST fibres. Several studies have revealed that rehabilitative training alone 
or in combination with other therapies promotes reorganization of the CST after SCI 
(Fouad et al. 2000; Girgis et al. 2007; Krajacic et al. 2010). In the vehicle group, we 
found that contralateral sprouting of CST axons was enhanced in animals that 
underwent rehabilitative training. In the DHA treatment group, the difference in sprouting 
CST fibres was not obvious between trained and untrained groups. Although our 
approach of quantifying midline-crossing collaterals in the cervical spinal cord did not 
provide evidence for the desired rewiring in the combined treatment group, this does not 
prove that there is no beneficial re-arrangement of the CST. Already established 
connections might merely be strengthened, or primary collaterals might branch and 
create secondary collaterals within the vicinity of the lesion site, to increase connectivity. 
 
It is unlikely that sprouting of CST fibres is the only mechanism for the restoration of 
forelimb function. This enhancement could be achieved by an increase in other axon 
sprouts and/or by increasing the number of receptors at functional synapses. Thus, we 
focused on the change in synaptic terminals and in serotonin fibres in the spinal cord 
caudal to the lesion site, where motor neurons are located related to fine motor control. 
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The analysis of serotonin fibres 5 mm below the lesion site revealed that training 
significantly increased serotonin fibre density. This data is consistent with previous 
studies (Wang et al. 2011). The possible explanation of how combined therapy can 
increase the serotonin fibres is that brain derived neurotrophic factor (BDNF) is 
upregulated after DHA and exercise (Wu et al. 2008). BDNF is associated with structural 
changes including increased sprouting of serotonergic axons in the rat brain 
(Mamounas et al. 1995). Previous studies demonstrated that BDNF secreting grafts 
enhance sprouting of serotonergic fibres at the site of injury, and that exercise can 
induce increased serotonin fibre density in the lumbar spinal cord of mice after 
moderate contusion injury (Engesser-Cesar et al. 2007). 
 
7.4.3 Timing of training 
The current work demonstrates that early task-specific rehabilitation improved functional 
outcome in rats following cervical hemisection, which correlated with increased axonal 
sprouts and synaptic terminals. Several studies have documented that rehabilitation is 
more efficacious when carried out within a few days after injury (Norrie et al. 2005; 
Winchester et al. 2005). Various potential issues for the decline in responsiveness after 
delayed rehabilitation training have been addressed. An early approach is considered 
most effective as injury induced upregulation of various growth-promoting factors is only 
transient (Hayashi et al. 2000; Song et al. 2001; Di Giovanni et al. 2005). The 
expression of plasticity promoting genes and growth factors, which are upregulated 
immediately following SCI (Song et al. 2001; Di Giovanni et al. 2005; Jacobi et al. 
2014), declines over time. Another potential reason is the increase in growth inhibitory 
227 
 
proteoglycans after SCI (Massey et al. 2008). It is also notable that degradation of 
neuronal and muscle function occurs following SCI (Dietz et al. 2004). Axonal injury 
triggers degeneration of severed axons within 2-3 days (Court et al. 2012). However, a 
previous study showed that swimming rehabilitation delayed by 2 weeks post-injury is 
more effective than delivery at 3 days (Smith et al. 2006). In addition, the authors 
observed increased extravasation at the epicenter of the lesion, suggesting increased 
secondary damage and neuronal loss in the 3 day group. In further studies, we could 
explore the temporal aspect of intervention with rehabilitation training in order to 
maximise our treatment strategy. 
 
7.4.4 Synergistic effect of DHA and rehabilitation 
The most compelling effect of treatment on motor function was achieved when DHA was 
combined with rehabilitative training. How might DHA and rehabilitation work together to 
promote functional recovery? One reason why training has such an impact on the 
emergence of DHA effects might be the fact that any plastic changes in the nervous 
system rely heavily on activity for development, maintenance and fine-tuning of new 
synaptic connections. This enhancement can be promoted by the increased activity of 
existing receptors and /or by increasing the number of receptors at functional synapses. 
A role for DHA in synaptic plasticity is well established in both in vivo and in vitro 
studies. To evaluate a possible functional role for synaptic upregulation, we measured 
the level of a presynaptic protein (synaptophysin) in the cervical spinal cord. The levels 
of synaptophysin were significantly elevated in the spinal cord of rats receiving 
combined treatment; however, the elevation was not linked to a significant difference in 
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functional outcome between the control and rehabilitation only groups. Although the 
expression of synaptophysin was not significantly elevated in the cervical spinal cord in 
the rehabilitation group, it would be interesting to explore if rehabilitation can upregulate 
other synaptic proteins such as bassoon, which is an established active zone marker 
protein for the synapses of the CNS (Dondzillo et al. 2010; Chen et al. 2012). 
 
As an alternative to the hypothesized synaptic up-regulation, what other mechanisms 
might mediate the observed significant benefits of DHA treatment on motor recovery? A 
secondary effect is to promote sprouting of axons above and below the lesion. We 
observed a similar magnitude of CST sprouting in single treatment and combine 
therapy. However, the significant sprouting of serotonergic axons was only detected in 
the combined treatment. A possible mechanism to promote axonal sprouting is BDNF 
upregulation after combined treatment. There are a few studies indicating that training 
can upregulate expression of BDNF in the nervous system and that this is pivotal for 
recovery after SCI (Ying et al. 2008; Weishaupt et al. 2013). The level of BDNF is also 
elevated after DHA treatment and a synergistic effect with exercise has been 
demonstrated in different animal models (Wu et al. 2008; Wu et al. 2013). Therefore, 
some of the functional effects seen in this study might be mediated by an increase in 
overall activity in motor systems affected by increased availability of BDNF signalling. 
 
Additionally, the synergistic effect of training and DHA might be attributable to a 
significant neuroprotective effect of DHA at an early stage of SCI. In our group‘s 
previous studies, DHA has been shown to provide neuroprotection when administered 
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acutely, consistent with reducing cell apoptosis and preventing axon demyelination 
effects. On the other hand, increased neuronal survival after exercise was also reported 
to be associated with elevated expression of several key intermediates of the PI3K/Akt 
pathway (Chen et al. 2005). That might imply that functional recovery is a consequence 
of a synergistic effect on neuroprotection. 
7.5 Summary 
 On the basis of what is reported in the present study, the hypothesis that a 
synergistic effect of DHA and rehabilitative training contributes to functional 
recovery via synaptogenesis and neuroplasticity processes, is strongly supported. 
 These data demonstrate that implementing task-specific training shortly after SCI is 
advantageous up to 3 weeks after injury. 
 In our hemisection animal model, the rehabilitation training improved specific-task 
function; however, there was no negative impact on a non-trained task. 
 In the combined treatment group, tissue caudal to the lesion site showed a 
significant increase in axonal sprouting, and a trend towards increased synaptic 
contacts, which in combination may promote functional recovery. 
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8 General discussion 
8.1 Summary 
The most promising findings from the experiments carried out in this thesis were as 
follows: 1) Characterization a cervical SCI animal model by applying a left hemisection 
at C4/5 level. This model is useful to determine the neurological deficit following cervical 
SCI in the acute stage. A recovery of locomotion was observed in our animal model; 
however, the ability to exert fine motor control was not regained. 2) The therapeutic 
effects of an acute DHA injection (250 nmol/kg) following cervical SCI are demonstrated 
by skilled movement recovery. The significant neurological functional improvement is 
likely to be related to neuroprotection by DHA. More neuronal cells survived at 3 weeks 
in the epicentre site after injury. An overall modest effect of DHA was observed on 
microglial activation and lesion size reduction. 3) Parallel to the neuroprotective effect of 
DHA, we also demonstrate that DHA promotes neuroplasticity in cervical SCI. The 
histological analysis showed that DHA treatment can up-regulate synapse formation 
and promote axonal sprouting of CST and increase serotonin fibres. In an alternative 
injury model and species, mouse pyramidotomy, acute DHA administration was found to 
improve forelimb skilled locomotion at a higher dose (500 nmol/kg). In addition to 
enhanced CST sprouting after treatment, the quantitative analysis also showed that the 
number of V2a interneurons contacting sprouting fibres was positively related to the 
functional recovery. 4) In an effort to explore the possible mechanism underlying the 
neuroplasticity promoting effect, we observed an altered expression of miR21 and 
PTEN in CST neurons one day after cervical hemisection in an in vivo study. In an in 
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vitro study, a primary cell culture of DRG neurons was treated with different 
concentrations of DHA to demonstrate the neurite promoting growth effect of DHA. 
Subsequently, a PTEN activator (sodium selenite) was used to determine whether 
PTEN plays a critical role in promoting axonal growth, and to gain more insight into the 
mechanism of acutely administered DHA-induced neuroplasticity following traumatic 
SCI. 5) Finally, I combined the task specific rehabilitation with acute administered DHA 
treatment to examine the synergistic effect in terms of specific neurological functional 
recovery. The combined therapy had a significantly beneficial impact on traumatic SCI 
compared to each single treatment. 
 
Several conclusions have been drawn from this study, but a number of fields should be 
further explored. Some of these will be summarized and discussed in the following 
sections. 
 
8.2 Promoting neuroplasticity: a novel effect of DHA following SCI 
An extensive body of evidence shows that the neuroprotective effect of DHA can 
contribute to neurological functional recovery in thoracic SCI animal models. In this 
thesis, chapter 5 and chapter 6 together provide a novel insight into the mechanism 
underlying the effect of DHA promotion of neuroplasticity following SCI in vivo and in 
vitro, showing that acute DHA administration can enhance axonal fibre sprouting 
through a mechanism involving miR21 upregulation and PTEN downregulation. 
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In this thesis, we show that functional recovery is promoted after acute administration of 
DHA following cervical SCI. However, the question is raised as to whether the functional 
recovery is just linked to the neuroprotection effect of DHA. In my fourth chapter, the 
acute delivery of DHA is shown to alleviate the loss of neuronal cells in the epicentre of 
lesion; the data are consistent with our previous study in the rat thoracic hemisection 
model (King et al. 2006). Our spinal cord lesion is located between C4 and C5 levels 
which are relevant to shoulder movement and gross forelimb movement. It is obvious 
that the acute administration of DHA can significantly improve locomotor functional 
recovery within one week following cervical hemisection, which could reflect the 
neuroprotective effect of DHA treatment. However, the skilled forepaw function with fine 
control is dependent on the interneurons and motoneurons of C6-T1 (McKenna et al. 
2000). From the quantitative analysis of immunochemical staining, there seems to be no 
significant difference between DHA and vehicle group in the number of neuronal cells 
caudal to the lesion site. Another key feature of DHA treatment that emerged from our 
analysis is the axonal sprouting that occurs from the spared CST tract and synaptic 
upregulation. Thus, the modulation of synaptic function and axonal sprouting play a vital 
part in achieving this complex task. 
 
Recently, numerous agents have been shown to improve functional recovery following 
SCI. However, it appears that several chemical compounds could possess multifaceted 
effects on SCI treatment. Systemic administration of some non-steroidal anti-
inflammatory drugs have been investigated such as ibuprofen whose neuroprotective 
effects have been linked with inhibition of inflammation following SCI. However, 
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ibuprofen recently has been shown to promote locomotion recovery in rats via Rho-A 
inhibition, in a manner related to a neuroplasticity effect (Fu et al. 2007). On the other 
hand, ChABC, a promising compound used to promote axonal sprouting or regeneration 
following CNS injury, was found in one study to ameliorate degenerative changes in the 
cell bodies of injured CNS projection neurons (Carter et al. 2008). This suggests that 
neuroprotection may be a possible mechanism of ChABC-mediated repair. 
Neurotrophin-induced sprouting of descending cortico-spinal tract projections has been 
shown to depend on immune cell activation (Chen et al. 2008). These examples 
demonstrate that neuroprotective or neuroplasticity-promoting strategies may be linked 
to each other by a variety of mechanisms. 
 
Another issue which has to be taken into consideration when evaluating the efficacy of 
plasticity-promoting treatments is the animal model design. It is an unquestionable fact 
that the functional recovery related to plasticity promoting strategies depends on a 
certain degree of spared neuronal tissue being available. In a complete transection 
animal model, because of no sparing of neuronal tissues following injury, neuroplasticity 
events that happen above the lesion site will fail to rebuild the circuits below the lesion 
site which are necessary to promote functional recovery. To access the efficacy of 
plasticity-promoting treatment, it is essential to understand what degree of injury 
severity and what kind of injury model and behavioural assessment should be applied. 
In thoracic SCI animal models, several animal studies suggested that if as little as 10-
15% of the spinal cord is spared, stepping abilities and overground locomotion can 
recover (Schucht et al. 2002). In contrast, in cervical SCI animal models, there appears 
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to be no recovery in food grasping ability even just in a partial lesion. From previous 
work in our lab, it is well accepted that DHA has promising neuroprotective effects in 
rodent contusion or compression models. However, when using models with extensive 
lesions, like contusion or compression injury, the neuroprotective effects of DHA may 
play an essential role in functional recovery. Thus we might underestimate or 
completely mask the potential plasticity-promoting effect of DHA. As a result, here we 
applied a cervical hemisection spinal cord injury animal model, which has less neuronal 
damage and correlated well with clinical SCI, to evaluate the plasticity-promoting effect 
of DHA. 
. 
8.3 The therapeutic effect of acute DHA bolus injection  
The cascade of events that occurs following SCI involves a sequence of processes. The 
vital role of acute DHA administration post SCI has been demonstrated in our group‘s 
previous work. Continuous dietary DHA supplementation without an initial acute bolus 
DHA injection did not confer any neurological functional recovery in rat or mouse SCI 
(Huang et al. 2007; Lim et al. 2013). Other studies also found that DHA pretreatment 
has a therapeutic effect and improves neurological outcome following SCI (Figueroa et 
al. 2012). The lack of efficacy of DHA dietary treatment alone may simply be due to 
insufficient DHA reaching the spinal cord tissue during the critical time window after SCI, 
and may indicate that a rapid intervention with intravenous DHA or pretreatment with 
DHA is essential. However, pretreatment with DHA of patients who are suffering SCI is 
impracticable clinically. The acute bolus of DHA seems an ideal approach for patients 
suffering SCI, in the acute stage. 
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It is also important to note that the combination of acute DHA administration with dietary 
DHA achieved a better neurologic effect compared to acute DHA treatment alone in rat 
thoracic SCI (Huang et al. 2007). As we know, the concept of neuroprotection is based 
on the premise that attenuating the aforementioned pathophysiological process 
following primary injury will contribute to neurological functional recovery. The 
therapeutic window for neuroprotective agents is restricted to an early time following 
injury. Chronic DHA enriched diet could support functional improvement by means of 
promoting neuroplasticity. It will be essential to analyse in future, the neuroplasticity 
events in the spinal cord associated with DHA provided chronically in the diet. 
 
8.4 Consideration of the histological evaluation following cervical 
SCI 
The histological finding in our studies showed robust changes related to SCI 
with/without treatment. Regarding anatomical plasticity, we have demonstrated that 
behavioural recovery is correlated with sprouting fibres contacting interneurons and 
motor neurons. However, the conduction properties of individual sprouting fibres 
following spinal cord injury have not been studied. There is a paucity of information 
regarding the functional status of these sprouting fibres, whether the sprouting fibres 
make contact with the appropriate neurons, whether function can be restored because 
of sprouting fibres, and whether the sprouting fibres are a major contributor to functional 
recovery. In addition, surviving axons following injury might play a role in functional 
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improvement. Immunohistological analysis is limited methodologically when there are 
problem involved the neurological functional evaluation. 
In future work, we could perform a detailed functional and anatomical assessment to 
address this issue by an electrophysiological approach. In the meantime, we can also 
correlate changes in conduction with quantitative histological data and behavioural 
analysis, to elucidate the potential neuroplasticity mechanism responsible for functional 
recovery. Neuroplasticity may also provide the right support for sensory information to 
guide the formation of useful connections. 
 
8.5 Modulation of PTEN and miR-21 following SCI and DHA treatment 
The neuroplasticity-promoting effect of the DHA acute intravenous injection led us to 
explore one possible underlying mechanism in acute stage. One of the targets of 
particular interest is the PTEN pathway, which is reported to be a central negative 
regulator of the PI3K/Akt signalling pathway. This protein, which is present in most 
central neurons, has been reported to be up-regulated following SCI, with a peak at one 
day after traumatic injury, and then reduced at 3 days (Ding et al., 2013; Hu et al., 2013). 
PTEN has been shown to be involved in axonal regeneration in optic nerve (Park et al., 
2008), corticospinal neurones (Liu et al., 2010), sensory neurons (Christie et al., 2010) 
and in synaptic plasticity (Liu et al., 2012). PTEN is also an important target of miR-21. 
Some studies report that upregulation of miR-21 can improve functional recovery by 
suppressing PTEN (Han et al., 2014; Sandhir et al., 2014). Our preliminary observations 
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suggest that the neuroplasticity promoting effect of DHA may be partly associated with 
its action on miR21 upregulation and PTEN suppression following SCI.  
However, we did not reveal the exact casual effect of miR21 and PTEN expression 
under DHA treatment. Although miR-21 is shown to target negative regulators of PTEN, 
overexpression of miR-21 also protects against neuronal death, probably mediated by 
its downregulation of FASLG (Fas ligand (TNF superfamily, member 6)), an important 
cell death-inducing ligand (Buller et al. 2010). DHA is also known as endogenous ligand 
for PPARPPAR agonists also show the ability to suppress PTEN expression and 
increase Akt phosphorylation in ischaemia-reperfusion cell line (Kim et al. 2011). DHA 
might inhibit PTEN expression by PPAR- mediated pathway. Furthermore, our findings 
provide a counterbalance to proposed strategies in breast cancer treatment, in which 
DHA treatment blocks miR-21, thereby increasing PTEN (Mandal et al. 2012). The 
opposite response of neurons and cancer cells could be related to differences in 
phosphatidylinositol species of phosphatidylinositol phosphates (PIPs) (Gu et al. 2013). 
It will be essential in future studies to define the signalling molecules that activate miR-
21 and suppress PTEN in response to DHA treatment. 
 
8.6 Neurogenesis effects of DHA following SCI 
Adult neurogenesis is limited in mammalian spinal cord. Although the cord retains 
multipotent neuronal stem cells that could generate functional neurons in vitro 
(Yamamoto et al. 2001; Dromard et al. 2008), production of new neurons by such 
endogenous cells occurs to only a very limited extent after injury in vivo (Yang et al. 
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2006; Wrathall et al. 2008; Grande et al. 2013). Manipulated differentiation of 
endogenous stem cells with growth factors and transcription factors could stimulate the 
production of new neurons and oligodendrocytes (Ohori et al. 2006). Interestingly, a 
recent study showed that astrocytes, which are highly activated following SCI, can be 
converted to neuroblasts by a single transcription factor, SOX2, in the injured adult 
spinal cord. The induced neuroblasts can give rise to synapse-forming interneurons (Su 
et al. 2014). These results indicated that neurogenesis could be completed by 
conversion of endogenous cells to neurons following SCI. 
 
DHA has shown promising effects on neurogenesis in vivo and in vitro (Kawakita et al. 
2006; Dyall et al. 2010). Reduced neurogenesis in the cerebral cortex (ventricular and 
subventricular zones) and dentate gyrus is found in the DHA deficient embryonic rat 
brain (Coti Bertrand et al. 2006). On the contrary, adult fat-1 transgenic mice with high 
endogenous DHA levels revealed an increased number of proliferating neurons and 
neuritogenesis in hippocampus, which correlated with better spatial learning 
performance (He et al. 2009). However, the underlying mechanism of the neurogenesis 
promoting effect of DHA has not been fully established. Some studies have revealed 
that DHA as well as other omega-3 fatty acids broadly regulate the expression of genes 
(Kitajka et al. 2002; Deckelbaum et al. 2006). The expression of genes could be 
regulated at the transcriptional level by nuclear receptors. DHA is an endogenous ligand 
for PPARs, which are nuclear transcription factors and play a vital role in neural stem 
cell proliferation and differentiation (Wada et al. 2006; Mullen et al. 2007). A recent 
study showed that a PPAR agonist can promote neural stem cells differentiation by 
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upregulating SOX2 levels (Bernal et al. 2015), which suggests that DHA might have the 
potential to promote neurogenesis following SCI by increasing SOX2-induced neurons 
from astrocytes.  
 
In addition to PPAR activation, the PUFA–GPR40 interaction might have a critical role in 
neurogenesis in the adult primate hippocampus (Yamashima 2008; Boneva et al. 2011). 
DHA can also promote the neuronal differentiation of rat neural stem cells via the 
GPR40-linked signalling pathway (Ma et al. 2010). Furthermore, one study reported that 
DHA may elicit the GPR40-linked signalling pathway for the regulation of adult bone 
marrow-derived stromal cells (BMSC), leading to expression of neuronal markers in 
vitro (Kaplamadzhiev et al. 2010). Therefore, it is possible that DHA may act as an 
extracellular signaling molecule at the membrane of the GPR40 receptor to regulate 
neurogenesis following SCI. 
 
8.7 Future work 
8.7.1 Do we need a different administration route or a higher dose of DHA?  
The route of administration of DHA after injury is of interest for future potential clinical 
applications. Previous studies have reported that after intravenous radiolabelled fatty 
acid injection, omega-6 PUFAs have a rapid disappearance from plasma with a half-life 
of less than 1 min, and that only 1% of the injected dose is rapidly incorporated into 
brain lipid, particularly phospholipids (Robinson et al. 1992; Rapoport 2001; Rapoport 
2003). Direct delivery in the CNS could be considered as another effective route of 
administration of DHA after SCI, such as intrathecal injection or topical application at the 
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lesion site. It has been suggested that intrathecal injection or intracerebroventricular 
injection of DHA contributed to neuropathic pain relief in experimental studies 
(Nakamoto et al. 2012; Lu et al. 2013). Topical DHA treatment also enhanced corneal 
nerve regeneration after an epithelial wound (Esquenazi et al. 2005). A treatment 
strategy following incomplete SCI is surgical intervention, which aims to decompress, 
realign and stabilise the injured cord. Immediate decompression alleviates the impact of 
secondary injury following SCI. From a neurosurgeon‘s viewpoint, it would be very 
interesting to explore the effect of DHA applied directly to the injured spinal cord after 
surgical intervention. 
 
In our study project, DHA at the dose the 250 nmol/kg delivered to hemisection injury 
rats is adapted from our group‘s previous data in rat thoracic SCI animal models (Huang 
et al. 2007). In this study in rats, no clear dose-dependent effect was seen with the 
bolus of DHA post-SCI, and no obvious toxicity was observed when DHA 2500 nmol/kg 
was injected 1 h after thoracic SCI. As discussed in chapter 3, the pathology and 
functional recovery after cervical SCI are rather different from that observed in thoracic 
SCI. In thoracic SCI animal models, locomotor evaluation is the main neurological 
assessment following injury. Subtle neurological recovery due to neuroplastic changes 
may not be observed in locomotor function following thoracic SCI. More detailed specific 
skilled and segmental neurological function recovery is easy to identify in the cervical 
SCI animal model. Therefore, a more extensive examination of higher doses of DHA 
would be useful in the future. It is essential to keep in mind that the beneficial effects of 
DHA may follow an inverted U-shaped curve. In a model of cerebral ischaemia, one 
study reported that a DHA–albumin complex exerts neuroprotective effect at 0.63 
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mg/kg, but not at 1.25 mg/kg (Belayev et al. 2005). Multiple dose studies in cervical SCI 
models should be considered in the future to achieve optimal therapeutic effect. 
 
8.7.2 Negative effects of neuroplasticity 
Another principle is that not all plasticity has a positive impact on clinical status; in some 
cases, plasticity might have negative consequences. Maladaptive neuroplasticity in 
patients following SCI includes muscle spasticity, chronic pain, allodynia, autonomic 
dysreflexia (Brown et al. 2012). In experimental studies, numerous data have showed 
that treatment aimed at enhancing spinal plasticity which is incorrectly directed can lead 
to enhanced pain states and autonomic dysreflexia (Romero et al. 2000; Hofstetter et al. 
2005; Weaver et al. 2006). Neuropathic pain following SCI has many underlying factors 
such as an increase in neuronal excitability due to the products of microglial activation, 
changes in sodium channel expression and changes in glutamate receptor expression 
(Deumens et al. 2008). The increased density of serotonergic axons rostral to the SCI in 
one study appeared to promote at-level neuropathic pain through actions of serotonin 
on pro-nociceptive 5-HT3 receptors (Oatway et al. 2004). Another report revealed that 
the neuropathic pain is related to the collateral sprouting of calcitonin gene-related 
peptide (CGRP) containing primary afferent fibres in the spinal cord dorsal horn 
(Christensen et al. 1997). Strategies to promote neural plasticity also have possible 
effects on the growth of CGRP expressing fibres in the injured spinal cord and may 
affect neurological outcome. Such strategies include manipulation of NGF expression 
(Cameron et al. 2006), or OEG transplantation (Richter et al. 2005). In future studies, 
we could assess mechanical sensitivity after SCI by measuring the paw withdrawal 
threshold using Von Frey test (Chaplan et al. 1994) and thermal sensitivity by 
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measuring the time taken for a radiant heat source to elicit a flexion reflex, using 
Hargreaves‘ method (Hargreaves et al. 1988). 
 
8.7.3 Are there are any other mechanisms contributing to the neuroplasticity 
promoting effect of DHA? 
DHA is an endogenous ligand for RXR, which is one of several members of the retinoic 
acid nuclear receptor family. After SCI, RXRs appear in the cell nuclei of reactive 
microglia, macrophages and neuronal cells. This RXRs expression began at 4 days, 
was most prominent at 7 and 14 days and had decreased at 21 days after injury 
(Schrage et al. 2006). It is possible that the DHA bolus could target transcription factors 
and influence retinoic acid signalling after SCI. Several studies have demonstrated that 
retinoid pathway activation can promote neurite outgrowth in vitro (Corcoran et al. 2000) 
and axonal regeneration in vivo (Taha et al. 2004). In a SCI experimental study, a 
retinoic acid receptor (RAR) agonist was shown to act through PI3K signalling to 
induce axonal outgrowth of CST fibres and promote functional recovery (Agudo et al. 
2010). Fenretinide, a semisynthetic analogue of retinoic acid, also reduces tissue 
damage and promotes neurological functional recovery following SCI (Lopez-Vales et al. 
2010). Of note, the recovery of neurological function is accompanied by reduced AA but 
increased DHA levels in plasma and injured spinal cord tissue. DHA is also an 
endogenous ligand of PPARs. One study showed that PPAR𝛾 is crucial for coupling 
ibuprofen to RhoA inhibition and a subsequent neurite growth in neurons. RhoA 
inactivation with PPAR𝛾 agonists overcomes the growth restriction of CNS axon 
inhibitors (Dill et al. 2010). Therefore, it will be interesting to determine if the effect of 
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DHA on promoting neuroplasticity is linked to the retinoid pathway or PPARs activated 
by the bolus DHA administration following SCI. In fact, dissection of this molecular 
pathway may offer novel molecular targets for effective SCI treatment. 
Apart from promoting intrinsic regrowth ability, DHA appears to have the ability to 
modify the glial scar after SCI (our group unpublished data). Glial scar formation is a 
reactive cellular process involving astrogliosis that inhibits axonal growth following SCI. 
One strategy to promote axonal growth is to overcome the inhibitory environment. A 
recent study has demonstrated a potential role for miR-21 in regulating astrogliosis after 
SCI by using  transgenic mice that overexpress in astrocytes either miR-21 or a miRNA 
sponge designed to inhibit miR-21 function (Bhalala et al. 2012). The result indicated 
that manipulation of miR-21 can modulate the astrocyte expression in the SCI chronic 
phase. Further studies could focus on whether the glial scar modified by DHA treatment 
correlated with axonal sprouting or neurological functional recovery in SCI models. 
 
8.7.4 Are other omega-3/omega-6 PUFAs beneficial to neuroplasticity after SCI? 
In addition to DHA, previous data from our group showed that EPA and AA also have 
the ability to enhance neurite growth in DRG cell cultures (Robson et al. 2010). Dietary 
supplementation with EPA leads to a significant increase in synaptic proteins such as 
synapsin-1, postsynaptic density-95 protein and syntaxin 3 in brain (Cansev et al. 
2007). It is therefore worth investigating further the other omega-3/omega-6 PUFAs, that 
might have an effect on neuroplasticity or synaptogenesis in SCI. 
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To summarize, DHA has emerged as a substance with significant therapeutic potential 
in various neurological diseases. This thesis has assessed the neuroplasticity promoting 
effect of DHA in vivo and in vitro following SCI, which shows much promise as a 
potential therapy for the treatment of SCI.  
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Appendices 
Table 1 Basso, Beattie, and Bresnahan (BBB) locomotor rating scale used to assess hindlimb function 
after rats SCI (Basso et al., 1996) 
Score  
0 No observable hindlimb (HL) movement 
1 Slight movement of one or two joints, usually the hip and/or knee 
2 Extensive movement of one joint or extensive movement of one joint and slight movement of 
one 
3 Extensive movement of two joints 
4 Slight movement of all three joints of the HL 
5 Slight movement of two joints and extensive movement of the third 
6 Extensive movement of two joints and slight movement of the third 
7 Extensive movement of all three joints of the HL 
8 Sweeping with no weight support or plantar placement of the paw with no weight support 
9 Plantar placement of the paw with weight support in stance only (i.e., when stationary) or 
occasional, frequent, or consistent weight-supported dorsal stepping and no plantar stepping  
10 Occasional weight-supported plantar steps; no FL–HL coordination 
11 Frequent to consistent weight-supported plantar steps and no FL–HL coordination 
12 Frequent to consistent weight-supported plantar steps and occasional FL–HL coordination 
13 Frequent to consistent weight-supported plantar steps and frequent FL–HL coordination 
14 Consistent weight-supported plantar steps, consistent FL–HL coordination, and predominant 
paw position during locomotion is rotated (internally or externally) when it makes initial 
contact with the surface as well as just before it is lifted off at the end of stance; or frequent 
plantar stepping, consistent FL–HL coordination, and occasional dorsal stepping  
15 Consistent plantar stepping and consistent FL–HL coordination and no toe clearance or 
occasional toe clearance during forward limb advancement; predominant paw position is 
parallel to the body at initial contact 
16 Consistent plantar stepping and consistent FL–HL coordination during gait and toe clearance 
occurs frequently during forward limb advancement; predominant paw position is parallel at 
initial contact and rotated at lift off  
17 Consistent plantar stepping and consistent FL–HL coordination during gait and toe clearance 
occurs frequently during forward limb advancement; predominant paw position is parallel at 
initial contact and lift off  
18 Consistent plantar stepping and consistent FL–HL coordination during gait and toe clearance 
occurs consistently during forward limb advancement; predominant paw position is parallel at 
initial contact and rotated at lift off  
19 Consistent plantar stepping and consistent FL–HL coordination during gait, toe clearance 
occurs consistently during forward limb advancement, predominant paw position is parallel at 
initial contact and lift off, and tail is down part or all of the time  
20 Consistent plantar stepping and consistent coordinated gait, consistent toe clearance, 
predominant paw position is parallel at initial contact and lift off, and trunk instability; tail 
consistently up  
21 Consistent plantar stepping and coordinated gait, consistent toe clearance, predominant paw 
position is parallel throughout stance, and consistent trunk stability; tail consistently up  
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Table 2 Forelimb Locomotor Scale (FLS) used to assess forelimb function after rats SCI (Cao et al., 2008)  
 
Score  
0 No movements of the forelimb (shoulder, elbow or wrist joints) 
1 Slight movements of one or two joints of the forelimb 
2 Extensive movement of one joint and slight movement of another joint of the forelimb 
3 Slight movement of all three joints of the forelimb 
4 Extensive movement of one joint and slight movement of two joints of the forelimb 
5 Extensive movement of two joints and slight movement of one joint of the forelimb 
6 Extensive movement of all three joints of the forelimb 
7 Plantar placement of the forelimb with no weight support 
8 Dorsal stepping only 
9 Dorsal stepping and/or occasional plantar stepping 
10 Frequent plantar stepping 
11 Continuous plantar stepping 
12 Continuous plantar stepping with paw position rotated (either at initial contact, lift off or both) 
13 Continuous plantar stepping with paw position parallel (either at initial contact, lift off or both) 
14 Continuous plantar stepping with paw position rotated (either at initial contact, lift off or both) 
and occasional toe clearance 
15 Continuous plantar stepping with paw position parallel (either at initial contact, lift off or both) 
and occasional toe clearance 
16 Continuous plantar stepping with paw position parallel (either at initial contact, lift off or both) 
and frequent toe clearance 
17 Continuous plantar stepping with paw position parallel (either at initial contact, lift off or both) 
and continuous toe clearance  
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Figure 1. The correlation between histological finding and behavioural recovery 
 
 
